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Abstract
The form ation of benzo(a) pyrene -  deoxyribonucleoside adducts has been studied in 
several system s of d iffering s tru c tu ra l and cellu lar in teg rity . Marked quan tita tiv e  and 
qualita tive  d ifferences w ere observed betw een the adducts form ed using m icrosom es and 
those observed in isolated  cells, tissue explants in short-term  organ cu lture  and rodent 
skin in vivo, thus illu stra ting  th a t one m ust be very  wary when ex trapolating  resu lts  from 
subcellular studies to  iso la ted  cells, tissues in cu ltu re  or anim als in vivo.
Hydrocarbon-deoxyribonucleoside adducts form ed using m icrosom al p reparations from  ra t  
liver and ra t  lung, in the presence of benzo(a) pyrene and DNA, w ere m ainly derived from 
9-hydroxy benzo(a) pyrene whilst sim ilar studies with m icrosom es from mouse skin showed 
th a t the  DNA -  bound products arose predom inantly through reac tio n  of (-) 4, 5 -  dihydro -  
4, 5 -  epoxy -  benzo(a) pyrene with DNA. In striking con trast, DNA -  adducts form ed from 
benzo(a) pyrene in freshly isolated viable r a t  hepatocy tes, r a t  trach ea l ep ithelia l 2C1 cells
.j.
and mouse skin in vivo w ere mainly derived from reac tion  of (-) 713, 8cC -  dihydroxy -  9<£, 
lOce- epoxy -  7, 8, 9» 10 -  tetrahydrobenzo(a) pyrene with deoxyguanosine.
When m ice w ere tre a te d  topically  with benzo(a) pyrene, deoxyribonucleoside adducts 
derived from reation  of (-) 76 , 8cc -  dihydroxy -  9cc, lOcc -  epoxy -  7, 8, 9, 10 -  
tetrahydrobenzo(a) pyrene with deoxyadenosine w ere form ed in  DNA iso la ted  from the  
tre a te d  skin. This is the  firs t study to  rep o rt the form ation of such products in vivo. No 
qualita tive  or quan tita tive  d ifferences w ere observed in the  binding of benzo(a) pyrene to 
DNA in th e  skin of m ice of d ifferen t strains varying in the ir susceptib ility  to  polycyclic 
arom atic  hydrocarbon -  induced carcinogenesis. However, in r a t  skin benzo(a) pyrene 
becam e bound to  DNA to  a far lesser ex ten t than in mouse skin, possibly partia lly  
explaining the re la tiv e  resistance of ra t  skin to  carcinogenesis inducodby benzo(a) pyrene.
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FOREWORD
D uring my Ph.D . train ing I have enjoyed th ree  exciting and stim ulating  years working 
in  the field of chem ical carcinogenesis. The com petitive n a tu re  of the  work and th e  
fascinating  diversity  of compounds th a t can induce m alignant disease have provided 
an excellent atm osphere for research  work. A lthough the  m ajority  of my work has 
involved the chem ical benzo(a)pyrene, the relationship  betw een chem ical, viral, radiological 
and epigenetic m echanism s of cancer induction hold th e ir  own special in te re s ts  
and I hope to cover som e of the evidence for these processes during the in troducto ry  
chapter. C ancer research  has grown im m ensely since the early  observations of the  
e igh teen th  century  sc ien tists , such as P erciva l P o tt ,  and the cu rren t volume of lite ra tu re  
produced annually c rea tes  a daunting task  for any new research  worker en tering  the  
field.
I t  is perhaps logical to s ta r t w ith an a ttem p t to explain w hat is m eant by the  word 
cancer itse lf. In L atin  'cancer' means a  crab and in its  earlie r term inology, canker, 
i t  was used to  describe a  creeping u lcer which gradually spread, eating  away and destroying 
the tissues in its  neighbourhood. The word cancer was in troduced in the  sev en teen th  
century  and it  is probable th a t in earlier tim es it  was quite a common disease. 
However, the shortened life  span due to other diseases such as cholera, in fluenza 
and tuberculosis and the  lack  of reliab le diagnoses could have reduced recorded  incidences. 
During the past century  the taboo a ttach ed  to the word has led to the  developm ent 
of several o ther term s simply to avoid its  use. Among these  are 'new growth' or its  
G reek equivalent 'neoplasm ', and 'tum our' which lite ra lly  m eans no m ore than a  swelling.
C ancer is a disorder of cellular behaviour. I t  is a disturbance of the grow th controlling 
m echanism , leading to disordered cell p ro liferation , which underlies cancer. C ancers 
o ften  behave in a 'm a lig n an t' fashion in filtra tin g  surrounding healthy tissue in  an invasive 
m anner char act eristic  of uncontrolled growth. There a re 1 th re e  ways in which a cancer 
can spread. The firs t by invading healthy tissue in its  im m ediate neighbourhood, the  
second by blood borne fragm ents of tum our or even single cells being carried  by the  
circulation to form secondary growths (m etastases) in d is tan t organs, and the  
th ird  by lym phatic spread to the lymph glands, in itia lly  those in the im m ediate  v icin ity  
of the tum our and la te r  to the groups nearest to those f irs t invaded. Obviously 
cancer represents a complex group of diseases producing d iffe ren t sym ptom s and 
there fo re  the  likelihood of discovering "a cure for cancer" is ex trem ely  unlikely.
C ancer research  is predom inantly involved in elucidating the  m echanism s by which 
the disease is produced and each worker can only hope to contribute  a  sm all p iece 
of the jigsaw needed to understand and control its  occurrence.
R esearch  is 1% inspiration and 99% perspiration, 
and a chance observation only favours the prepared mind.
A dapted T. Eddison 
L. P asteu r
* * * * * * * * * * * * * * *
Cancer, th a t which m an is always trying to  kill 
but which ends in killing him.
A dapted H. Spencer
***************
Man your tim e is sand,
Your lives are waves upon the sea,
I am the  eyes of Nostradam us,
All your ways are known to me.
A dapted A. S tew art
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A short h istory  of cancer research
The firs t association betw een lifesty le  and cancer was described by R am azzini who, in his 
'De morbis artificum 1 in 1700 (1), reported  th a t tum ours of the b reas t w ere found m ore 
frequently  in nuns than in o ther women. To the p resen t day the cause(s) of b reas t cancer 
are obscure and the role of viruses or chem ical agents, endogenous or exogenous, rem ains 
to be elucidated.
The association betw een chem icals and cancer can be traced  to  the English physician John 
Hill, who, in 1761, reported  the developm ent of nasal cancer due to  "the im m oderate use 
of snuff" (2). L a te r Perc iva l P o tts  (1775) observed the unusually high incidence of cancer 
of the skin of the scrotum  among men who w ere chimney sweeps in the ir childhood (3). 
He correctly  ascribed "its origin from  a lodgem ent of soot in the rugae of the scrotum ". 
P o tt’s observation led to the firs t p reven tative  m easures against chem ically  induced 
cancers in humans since Clem m ensen (4) described th a t th ree  years la te r  the Danish 
chimney sweepers gu ildurged  its  m em bers to take daily baths.
In 1875, von Volkman, in Germany, associated  skin cancer in ce rta in  w orkers w ith ta r  
distilling (5) whilst Bell described the so-called paraffin  cancer of the  skin in workers in 
the then expanding Scottish shale field (6). Rehn (1895) rep o rted  the developm ent of 
cancer of the urinary bladder in th ree  workers in an aniline dye fac to ry  in Germany (7). 
This observation of the higher incidence of a specific tum our in humans exposed to 
p articu la r chem icals led to several a ttem p ts  to induce cancer in experim ental anim als. 
In itia l a ttem pts, such as th a t of F ischer (8) using the azo dye sca rle t red  (l-(4-(o- 
tolylazo)-o-tolylazo) -  2-naphthol) induced skin p ro lifera tion  which did no t progress to 
neoplasia. Since the work of von Volkman and Bell (5,6) several workers sought to 
dem onstrate the carcinogenic activ ity  of coal ta rs  and soot deposits. In 1915 Yam agiwa 
and Ichikawa induced carcinom as on the ears of rabbits by rep ea ted  top ical applications of 
coal ta r  (9). The earlier failures w ere alm ost certain ly  due to  the  length of the la te n t 
period and the Japanese success was very likely a product of Japanese patience . The 
mouse was also shown to be peculiarly  susceptible to ce rta in  ta rs  (10) and these two early  
anim al te sts  provided the basis for research  into the m echanisms by which chem icals 
induce cancer. The observation by Passey th a t e ther ex trac ts  of ta rs  could induce 
tum ours in mouse skin (11) and the work of Bloch and D reifuss (12,13) showing th a t the 
active agent in coal ta r  was concen trated  in the higher boiling fractions as a n eu tra l 
compound led to the suggestion th a t polycyclic arom atic  hydrocarbons (PAH) w ere the 
chem icals responsible. The fluorescence spec tra  of ta r  e x tra c ts  was found to  resem ble 
th a t of synthetic benz(a)anthracene (BA) derivatives (14), however, BA (Fig.l) was not 
carcinogenic when tested  (15).
Figure 1 Benz( a) anthracene
In  1929 C lar had described the synthesis of w hat he took to  be 1,2 ,7 ,8-dibenzanthracene 
(16). However, Cook (17) soon showed i t  was actually  1 ,2 ,5 ,6-dibenzanthracene or, as i t  is 
now known, dibenz (a,h) an thracene (DB(a,h)A) (Fig.2).
OTOIO
Figure  2 D i b e n z ( a ,h ) a n t h r a c e n e
Kennaway and H ieger (18) showed th a t th is  compound was carcinogenic in mouse skin and 
thus the firs t pure syn thetic  chem ical carcinogen had been dem onstrated . The fa c t th a t 
PAH could induce tum ours led to the search  for the active constituen t of coal ta rs . 
Kennaway and his colleagues obtained two tons of w aste p itch  from  the Gas L igh t and 
Coke Company and frac tionated  it  to obtain the  higher boiling fractions. From  these  they  
Obtained seven grams of yellow crystals (19) consisting mainly of benzo(a)pyrene (BP) 
(Fig.3).
Figure 3 Benzo(a)pyrene
BP was the firs t non-synthetic chem ical carcinogen to be iso la ted  and identified .
In te re s t was focussed on the ability  of anim als to genera te  carcinogens in vivo and in th is
connective tissue tum ours (20). The norm al bile acids are readily  am enable to  
dehydrogenations by slight deviations of s te ro l metabolism  and Wieland and D ane (21) 
showed th a t dehydronorcholene (Fig.4) could be readily  dehydrogenated by selenium  to 
yield the fully arom atic , 3-m ethylcholanthrene (3MC) (Fig.5), a  compound of exceptional 
carcinogenic potency.
resp ec t Ghiron observed th a t adm inistration of deoxycholic acid to m ice m ight re su lt in
Figure 4 Dehydronorcho lene Figure  5 3 - m e t h y l c h o l a n t h r e n e
A m ultitude of PAH have since been identified  varying g reatly  in  th e ir carcinogenic 
potency and for some of these chem icals Iball (22) developed a  carc inogen ic ity  index 
based on the yield of tum ours and the la tehcy  period in experim ental anim als.
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The diverse n a tu re  of chem ical carcinogens
I t  soon becam e apparent th a t PAH w ere not the  only class of chem icals able to induce 
tum ours and a  g rea t varie ty  of compounds of widely diverse s tru c tu re s  (Fig.6) have been 
shown to  possess carcinogenic activ ity . Yoshida (23) dem onstrated  th a t 2',3-dim ethyl-4- 
am inoazobenzene (Fig.7) produced liver tum ours in  ra ts  and m ice, and la te r  work showed 
the  isom er N ,N -dim ethyl-4-am ino-azobenzene (Fig.6) to be even m ore po ten t (24).
CH
CH
N NH
/ /
I
F igure 7 2 , 3 - D i m e t h y l - 4  -  a m in o azo b e n zen e
2-N aphthylam ine (Fig.6) was shown to be a p o ten t urinary bladder carcinogen when 
adm inistered orally to dogs (25) and thus several pure chem icals found in  arom atic  am ine 
m ixtures and soots or ta rs  had been dem onstrated as carcinogens. Lacassagne's 
dem onstration of the carcinogenicity  of oestrone (Fig.8) for the m am m ary gland of m ale 
m ice (26) added to the chem ical carcinogens discovered in th e  1930's, m any m ore w ere to 
follow.
HO
Figure 8 Oes trone
E arly  in  the 1940's Wilson e t al (27) dem onstrated  the carcinogenic potency of
2-acetylam inofluorene (AAF) (Fig.6) in  rodent liver and in la te r  studies i t  was shown to 
induce tum ours in various tissues and species (28). Also about this tim e Edw ards (28) 
described hepatom as in m ice produced by carbon te trach lo ride  while u re than  (ethyl 
carbamate) (Fig.6) proved to be a  p o ten t inducer of m ultiple pulm onary adenom as in m ice 
(29) (see chapter four). Thus, small organic m olecules w ere also capable of inducing 
tum ours and the  chem ical diversity  was fu rth er increased when, in  1946, beryllium  sa lts  
w ere shown to produce osteosarcom a in rabbits (31). In  the la te  1940's, Boyland and 
Hom ing (32) dem onstrated  the  carcinogenic ac tiv ity  of the  N -alkyl compounds known as 
n itrogen m ustards, thus providing evidence for a  new group of carcinogenic chem icals, the 
alkylating agents. In th e  1950's several classes of such chem icals proved to  be ac tive  
carcinogens. Dimethylnitrosamine(DM N) (Fig.6) was the "ideal” solvent for industrial 
purposes in th a t i t  was equally effic ien t in dissolving polar and non-polar m a teria ls . 
However, its  use was associated  w ith a high incidence of liver cirrhosis among exposed 
workers. Subsequently M agee and Barnes (33) showed i t  to  be po ten tly  hepato tox ic  and in 
chronic experim ents in  ra ts  i t  gave 100% incidence of m alignant liver tum ours. E thionine 
(34) and the  p lan t products, the  pyrrolizidine alkaloids (35) w ere also shown to have po ten t 
carcinogenic properties and la te r  work showed th a t many plant or m icrobial products 
possessed toxic or carcinogenic activ ity . In  I960 thousands of unexplained m orta lities  
occurred am ongst turkey  poults and ducklings. The condition was te rm ed  tu rkey  X disease 
(36) and the outbreak was traced  to a  consignm ent of B razilian groundnut m eal (37) found 
to be contam inated  w ith the mould Aspergillus flavus. The toxic products of these moulds 
were co llectively  te rm ed  "aflatoxins" and when ex trac ted  they  proved to  be in tensely  
fluorescent (38). Using this property  as a m onitoring m ethod the individual mould 
products were separated  and isolated . The in itia l studies iden tified  four compounds, 
G i,G 2 ,B, and B^ of which B^ and G^ w ere strongly carcinogenic (39). Subsequently i t  was 
shown th a t B^ and G^ were the hydrogenated form s of B^ and G^ (40). A flatox in  B^ 
(AFBj) (Fig.6), a  principle toxic m etabo lite  of many strains of A spergillus flavus, is 
among the m ost po ten t chem ical carcinogens known, inducing liver cancer in ra ts  exposed 
continuously to  a d iet containing lug  afla tox in  B j/K g  (41). The bifuran s tru c tu re  of the 
aflatoxins has also been observed in a  toxic m etabo lite  of Aspergillus versico lor, nam ely, 
sterigm atocystin  (Fig.9), also a po ten t carcinogen (42).
OH
OCH
Figure 9 Sterigmatocyst in
With such a diverse range of. chem ical s truc tu res able to induce tum ours in experim ental 
animals what is the ir relationship to cancer in man?
Chem icals and Human C ancer
Obviously man would not. provide him self as a te s t  anim al for risk assessm ent of chem icals 
th ere fo re  much of the d a ta  is obtained through epidem iological studies. I t is now widely 
recognised th a t as much as 90% of human cancer may be environm ental in origin. Table 1 
lists some of the chem icals thought to  be carcinogenic in humans. Again one m ust no te  
the wide diversity  of chem ical s tru c tu re  involved. Of those listed, several w ere 
recognised as being casually re la ted  to cancers in exposed workers due to  the  unusual type 
of condition they produced, e.g. vinyl chloride and angiosarcom a of the liver (43); asbestos 
and m esotheliom a of the p leura (44); nickel compounds and nasal sinus tum ours (45). The 
m ost p revalen t social carcinogenic agent to which humans are  exposed is c ig a re tte  smoke 
which contains a m ultitude of carcinogenic compounds (46), such as BP in concen tra tions 
as high as 50ng /c igare tte . For more than a q u a rte r of a cen tury  epidem iological d a ta  
have causally linked tobacco smoking with lung cancer (47) and human studies have shown 
a reduction in risk for lung cancer when "low tar" c ig a re tte s  w ere smoked for ten  years or 
m ore (48). D espite o ffic ial health  warnings smoking c ig a re tte s  rem ains a ubiquitous hab it 
and tobacco companies are apparently  unperturbed by the re la ted  human cancer risk. Dr. 
G. Gori of the U.S. N ational C ancer In s titu te  has s ta te d  "to leave millions of sm okers to 
th e ir fa te  is neither humane nor econom ical" (49). Condensates of c ig a re tte  smoke have 
proved carcinogenic in experim ental anim als (50).
Viral, Epigenetic and o ther theories of carcinogenesis
In 1914 Boveri postu la ted  th a t m utagenesis was responsible for cancer (51) and, although 
the s tru c tu re  of DNA was unknown, Bauer (1928) proposed th a t cancers arose through 
som atic m utation (52) implying a d irec t a lte ra tio n  in the genetic  m ateria l, e ith e r by  
chem icals or radiation, as the causal event. The process of v iral carcinogenesis is perhaps 
more elusive because i t  involves two biological en tities , the virus and the host. The virus 
e ra  began in 1908 with the discovery by Eldem an and Bang of the fowl leukosis virus (53). 
Three years la te r  Rous described a virus causing sarcom a in chickens (54), bu t i t  was to  be 
many years before scien tists  seriously considered viruses as po ten tia lly  im portan t cancer 
causing agents. In 1955 S tew art (55) described the polyom a virus which produced tum ours 
in newborn ham sters and mice but was inactive in adult animals. Several viruses w ere 
deem ed responsible for leukem ia in experim ental and dom estic anim als (56) and D alton e t  
al (57) described animal leukem ia -  like viral partic le s  in the blood of children with acu te  
leukemia. The im plications were obvious. However, it  soon becam e apparent th a t the
Table 1
CHEMICALS RECOGNISED AS CARCINOGENS IN HUMANS
Chem ical S ite of C ancers
Chem ical m ixtures:
Soots, ta rs , oils. Skin, lungs.
C ig a re tte  smoke. Lungs
Industrial chem icals:
2-Naphthylam ine. U rinary bladder.
Benzidine. U rinary bladder.
4-aminobiphenyl. U rinary bladder.
H aloethers. Lungs.
N ickel compounds. Lungs, nasal sinuses.
Chromium compounds. Lungs.
A sbestos Lungs, p leurae.
A rsenic compounds. Skin, lungs.
Vinyl chloride. Liver.
Drugs:
Sulphur m ustards. Lungs.
D iethylstilboestro l. Vagina.
P henacetin . Renal pelvis.
C ontraceptive agents. L iver.
N aturally  occurring compounds:
B etel nuts. Buccal mucosa.
A flatoxins. Liver.
P o ten t carcinogens in animals to  which human populations are exposed
S terigm atocystin . Liver.
Cycasin. Liver.
Safrole. Liver.
Pyrrolizidine alkaloids. Liver.
N itroso compounds. Oesophagus, liver, kidney, stom ach.
A dapted from H eidelberger, C., (222).
p artic le s  were not specific for leukem ia in humans. E pstein-B arr virus, a  m em ber of the 
herpes group, has been associated with B urkitts lymphoma (a disease a ffec ting  m ainly 
A frican children) and nasopharyngeal carcinom a (affecting old people in South-East Asia) 
(58). However, in these populations in fection  with the virus is alm ost universal w hereas 
the cancers are quite ra re  and have occasionally been observed in the  absence of virus. A 
re la ted  virus, herpes simplex type n , has been im plicated  in cases of u te rin e  cerv ical 
cancer (59) bu t again the relationship is obscure. Viruses have not been  im plicated  in the 
m ajor human cancers (such as lung, colon, b reast and stomach).
B urdette  (60) showed th a t the chem ically in e rt PAH carcinogens w ere not inherently  
m utagenic, presum ably due to the ir low reac tiv ity  and resu ltan t inability  to  chem ically  
a lte r  genetic m ateria l. Consequently many epigenetic theories of cancer arose a t this 
tim e to explain the mechanism of carcinogenesis. In 1947, the M illers dem onstra ted  th a t 
N ,N '-dim ethylam inoazobenzene becam e bound to liver pro teins (61) and during am inoazo- 
dye induced carcinogenesis it  was found th a t certa in  p ro teins w ere absent in the 
hepatom as. They there fo re  suggested th a t the am inoazo dyes might induce liver cancer 
through reac tion  with, and eventual deletion of, some proteins essen tial for controlled  
grow th o f liver cells (protein deletion hypothesis) (62). Tumours are  qu ite  common in the 
elderly and a  trophic theory of cancer was proposed (63) whereby cancer was a cell 
response resulting from poor nu trition  and im paired m etabolism . Men and women who 
indulged in smoking tobacco in clay pipes with broken stem s often  succum bed to  cancers 
of the tongue or lip and it  was proposed th a t continuous irrita tio n  of the  m outh w ith the 
broken stem  produced a cell response u ltim ate ly  resulting  in uncontrolled  p ro life ra tion  
and cancer (64), however, the tobacco smoke was probably a major contributing fac to r. 
More recen t theories have proposed th a t irr ita tio n  would lead to  a change in cell 
m etabolism  which would in itia te  malignancy (65). The binding of carcinogens to  repressor 
proteins was proposed to resu lt in derepression of a gene product controlling cell grow th 
(66) thus providing a stim ulus for uncontrolled cell m ultiplication. Encom passing these 
proposals several theories arose speculating th a t specific DNA sequences, norm ally 
repressed, could be derepressed by several mechanism s including chem ical carcinogens. It 
could be envisaged th a t these DNA sequences (oncogenes or cancer genes) could occur 
naturally  or through incorporation of v iral genes either d irec tly  (DNA viruses) or 
ind irectly  (RNA viruses using reverse transcrip tase).
R adiation has been im plicated in tum our induction since Curie, R oentgen and the ir 
associates developed skin cancer following exposure to rad ioactive chem icals or X-rays. 
C erta in  individuals w ere found to  be very susceptible to skin cancer following exposure to 
sunlight (67). The condition becam e known as xeroderm a pigm entosum  and is
characterised  by the inability  of the cells of the individual to repair DNA dam age induced 
by u ltrav io le t (UV) light. S im ilarly, the  condition a tax ia  te lan g iec tas ia  renders the  skin 
sensitive to xrrad ia tion  (68) while cells taken from people w ith Fanconi’s anaem ia proved 
highly susceptib le to  DNA cross-linking agents (69). D efective  DNA repair was im plicated  
in  both  diseases. These conditions are recessively  inherited  and the  a ffec ted  individuals 
are  cancer prone (70). The la rge rad ia tion  exposure due to th e  atom ic explosions in Jap an  
in  1945 resu lted  in  a  vast increase in the incidence of leukem ia among inhab itan ts of 
H iroshim a and N agasaki (71). The fu ture would indeed seem  grim during the  a fte rm a th  of 
a  nuclear holocaust.
Tum our P rom otion and M ultistage C arcinogenesis
The early chem ical carcinogenesis studies by both  Japanese (9) and English (18) workers 
involved m ultiple applications of the carcinogen over a  long period. T herefo re  sep ara te  
stages of the m alignant event due to d iffe ren t p roperties of the carcinogen would have 
gone unnoticed. During the early  1940's i t  becam e apparent th a t ce rta in  chem icals or 
oils, not them selves carcinogenic, could induce significant cell p ro life ra tion  (hyperplasia), 
a response ch a rac te ris tic  of cancer grow th. C roton oil, a  strong skin ir r i ta n t obtained 
from the  p lant Euphorbiacea C roton tiglium , proved to be a very  active hyperp lastic  agen t 
(72). Rous and his coworkers (73,74) developed a tw o-stage system  for the form ation  of 
skin tum ours in  rabbits. They showed th a t trea tm e n t of th e  skin w ith  a low dose of 
carcinogen (3MC or ta r), unable in  itse lf to e lic it tum our grow th (in itia ting  dose), followed 
by chronic irr ita tio n  of the skin by hyperplastic  agents such as tu rpen tine , chloroform  or 
skin wounding (promotion stage) resu lted  in tum ours.
1 J No Tumours
2 No Tumours
3 I I I I I I I I I I I I I I I I I I Many Tumours
4 I M  I I I I I I [ I I I I I I I I No Tumours
Many Tumours
e l No T um ours
S ym bo ls :  Time
T
Ini t iator Promoter
Figure 10 T w o -s ta g e  Carcinogenesis
Friedw ald  and Rous (74) postu la ted  th a t the in itia to r caused the presence of ’la te n t 
tum our cells' which p ro life ra ted  following trea tm e n t w ith  the  hyperplastic  agents 
resu lting  in  a  m acroscopic tum our. M ottram  and, Berenblum and Shubik (75,76,77) 
dem onstrated  tw o-stage carcinogenesis in mouse skin using single top ical (initiating) doses 
of carcinogenic PAH followed by chronic topical application of cro ton  oil. I t  was shown 
th a t the application of cro ton  oil prior to a  single adm inistration  of the  in itia to r did not 
yield tum ours (77a) (Fig.10).
In  1968, H ecker (78) iso la ted  several derivatives of the di te rpene  phorbol from  cro ton  oil 
and although the paren t compound was inactive as a tum our p rom oter on mouse skin, 
e s te rifica tio n  a t the 12 and 13 positions m arkedly enhanced the  prom oting ac tiv ity , such 
th a t the  d iester 12-0-tetradecanoyl-phorbo l-13-acetate  (TPA) proved to be th e  m ost 
po ten t prom oter for mouse skin (79) (See F ig . l l) .
F igure  11 1 2 - O - T e t r a d e c a n o y l - p h o r b o l - 1 3 - a c e t a t e
O ther compounds such as ant hr anil (1,8,9" trihydroxy anthracene) (80) and n-dodecane (81) 
w ere found to have prom oting ability  while catechol was shown to have cocarcinogenic 
properties (see C hapter Three) (Fig.12).
I
CO , c o c h 3
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Figure 12
S tru c tu re -ac tiv ity  studies on the phorbol e s te r derivatives established th a t ce rta in  
fea tu res  were essential for maximum prom oting ac tiv ity  (refer to  F ig .l l) .
a) a  prim ary allylic hydroxyl group a t C-20.
b) an alpha-beta  unsaturated  keto  group a t C-3.
c) a  long chain fa tty  acid esterified  a t C-12.
d) a short chain fa tty  acid esterified  in the -configuration a t C-13.
In addition, the overall configuration of the phorbol m olecule proved c ritica l since 
changing the  C-4 hydroxyl to the -position dram atically  a lte rs  the th ree  dim ensional 
shape of the m olecule and abolishes the tum our prom oting ac tiv ity  of the active  e s te rs  
(reviewed in 82). In mouse skin TP A is poorly m etabolised to  mainly inactive m onoesters 
or phorbol (83) and a t the p resen t tim e it  is widely recognised th a t TPA itse lf  is the  active 
agent. TPA exerts  a wide spectrum  of e ffe c ts  upon cellu lar m etabolism  and p ro life ra tion  
both  in vivo and in v itro , some of which are  sum m arised in Table II. E xactly  how many of 
these e ffec ts  are re la ted  to tum our prom otion is uncertain , e.g., many agents known to 
cause cell pro liferation , such as ace tic  acid, are  inactive as tum our p rom oters (84). I t  is a 
widely held view th a t in itia tion  is a rapid and irreversib le process being com pleted w ithin 
a few hours of a single adm inistration of carcinogen (85,86,87). P rom otion however, is 
apparently  reversible, a t least in the early  stages (86) and although usually s ta r te d  7 days 
a f te r  in itia tion , there  was li ttle  dim inution in tum our response in mouse skin if application 
of the p rom oter was delayed to  112 days (86). However, extending the period betw een  
in itia tion  and prom otion to 350 days m arkedly reduced the tum our yield (88).
As a resu lt of studies using a com bination of croton oil and tu rpen tine, Boutw ell (86) 
suggested th a t prom otion could be divided into two stages. The f irs t stage, conversion, 
resulting in the in itia ted  cell being converted  to  a dorm ant tum our cell, while the  second 
stage, propagation, involved growth activation  of the dorm ant tum our cells to  a grossly 
visible neoplasm. Some elegant work by Slaga e t al using TPA and the  re la ted  d iterpene 
m ezerein  elaborated  this concept. Although m ezerein  induced cell p ro lifera tion , enzym e 
activation  and changes in cAMP levels, as did TPA, (89) it  proved to  be a very weak 
tum our prom oter. Slaga and his colleagues showed th a t m ice in itia ted  w ith 7,12- 
dim ethylbenz(a)anthracene (DMBA), prom oted for two weeks w ith TPA and then for 18 
weeks with m ezerein exhibited a tum our response as high as those prom oted w ith TPA 
alone (90), as illu stra ted  in Fig. 13. E thyl-phenyl-propiolate, an inducer of cell 
p roliferation, could not replace m ezerein in this system  (Fig.13). I t  was also# established 
th a t certa in  chem icals could specifically  inhibit e ither the TPA or m ezerein  dependent 
stages of prom otion (Fig.14). From  this work it  was concluded th a t TPA ac ted  on 
in itia ted  cells to induce a population of prim itive skin stem  cells. M ezerein then ac ted  on
Table II.
BIOLOGICAL ACTIVITIES OF TPA IN VIVO OR IN VITRO.
1 . Hyperplasia 12. N uclear p ro te in  phosphorylation
2. ODC ^ 13. A nchorage Independent grow th
3. SAM f 14. Epiderm al grow th fac to r  binding 
to  recep to rs  on cell m em brane.
4. 2-Deoxyglucose transport
5. A ltered  cAMP levels. 15. M embrane F lu id ity  Changes.
6. Plasm inogen ac tiv a to r ?
A
16. Lipid deacylation
7. PG E1 and PGE2
A
17. HI and H3 h istone synthesis
8. P rogesterone
A
18. Tumour prom otion
9. L ac ta te
A
19. LETS p ro te in
10. Polyam ines A 20.
Cell d iffe ren tia tio n  ^
11. DNA Synthesis. 1
ODC = ornithine decarboxylase 
SAM = S-adenosylm ethionine decarboxylase 
LETS = Large ex ternal transform ation  sensitive 
(reviewed in refe ren ce  90).
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A = m e ze re in  ; ■ = EPP
Figure 13 Two-s tage  Tumour Promotion in Mouse Skin
the stem  cells causing changes in  enzym e ac tiv ity  and levels of endogenous am ines, 
charac te ris tic  of tum our cells, and finally inducing a  cell p ro life ra tive  response leading 
u ltim ate ly  to the m acroscopic neoplasm . Slaga and his group have very  recen tly  divided 
the  m ezerein  stage of prom otion into two stages, such th a t m ezerein  was adm inistered  in 
doses th a t did not cause cell p ro liferation , and then simple irr itan ts  such as ethyl phenyl 
p ropiolate (EPP), tu rpen tine or ace tic  acid could be adm inistered and induce cell 
p ro lifera tion  and com plete the last stage of tum our prom otion. (T.J. Slaga; personal 
com muni cation). Thus, a t the present tim e tum our prom otion in mouse skin can be 
divided into th ree  stages involving induction of embryonic stem  cells (TPA), gene 
activation  (mezerein) and cell p ro lifera tion  (EPP, turpentine or ace tic  acid), as illu s tra ted  
inF ig .14 .
Normal
cel ls
Tumour ^
 — in h ib i to r s
Figure 14 Mult i s tage Carc inogenes is  in mouse  skin
I t  was of in te res t th a t m ice tre a te d  w ith TPA alone som etim es developed one or two 
papillom as (as we found, see chapter 3) possibly because the  anim als had been unknowingly 
in itia ted  by environm ental agents. R ecen tly  i t  was shown th a t hairless m ice developed 
significant numbers of papillom as when tre a te d  topically  w ith TPA alone (91). 
Presum ably the mice possess the genetic inform ation for tum our form ation  (oncogene) 
which was expressed when they w ere trea ted  with the tum our p rom oter. K opelovich e t  al 
(92) dem onstrated  th a t fibroblast cells from humans genetically  predisposed to develop
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cel ls
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p ro l i fe ra t ion
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TPCK
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ce l ls
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a c e t i c  acid
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Gene ac t iva t ion
colonic tum ours w ere m alignantly transform ed when tre a te d  w ith  TPA , again presum ably 
oncogene expression. A lthough the  mechanism of action of tum our prom oters is fa r from 
clear, p resent evidence strongly suggests they a c t as gene ac tiv a to rs . Because of the vast 
number of cellu lar responses evoked by TPA it  was considered th a t i t  m ay a c t as a  
prostaglandin agonist. However, a t le ast in  the case of the  prostaglandin E series, this 
appears untrue (93). TPA does, however, cause increases in  prostaglandin levels which 
may explain som e of its  e ffec ts  on cellu lar m etabolism  (94-97).
A lthough the m ultistage model of chem ical carcinogenesis has been best docum ented in 
mouse skin the system  has been extended to o ther tissues (table HI). A v a rie ty  of tum our 
prom oters have dem onstrated  ac tiv ity  in tissues other than  mouse skin. Of p a rticu la r 
in te re s t is phorbol, inactive as a  prom oter in mouse skin (78) but ac tive , when 
adm inistered system ically , in prom oting mouse lung adenom a form ation  in itia ted  by ethyl 
carbam ate (98). The early  work of Kennaway and H ieger (18) dem onstrated  th a t PAH 
could act as com plete carcinogens, i.e . both  in itia te  and prom ote, in mouse skin while 
la te r  work showed th a t ethyl carbam ate  was a  com plete carcinogen for mouse lung (99). 
H owever, studies using ethyl carbam ate on mouse skin showed th a t i t  was a  pure in itia to r  
and could not in  itse lf prom ote (100). Thus, there  seem  to be subtle d ifferences betw een  
tissues in th e ir response to chem ical carcinogens, the  reasons for which are  not y e t c lear.
Human exposure to tum our prom oters is ubiquitous due to th e ir occurrence as 
environm ental pollu tan ts and in re la tive ly  large quan tities in  the  ta r  frac tio n  of c ig a re tte  
smoke (101). Of the number of chem icals assessed for carcinogenic potency very few 
have been te sted  as tum our prom oters and in view of our curren t exposure to tum our 
in itia to rs  (102) the prom oting ability  of environm ental contam inants should rece ive  
im portan t consideration.
Table m .
SYSTEMS OF TWO-STAGE CARCINOGENESIS
Tissue In itia to r P rom oter R eference
Mouse epiderm is several TPA or croton oil Scribner and Suss, 1978
R at epiderm is 0-rad ia tion C ig a re tte  smoke. M cGregor, 1976.
DMBA TPA G o erttle r  e t al 1980.
H am ster derm is DMBA TPA G o erttle r  e t al, 1980
R at bladder M ethylnitrosourea Saccharin Hicks e t al 1975
R at liver AAF Phenobarbital P eraino  e t al, 1975
DEN Phenobarbital W eisburger e t al, 1975
R at m am m ary gland DMBA Phorbol
4
A rm uth and Berenblum 19'
R a t in testine D im ethylhydrazine Sodium barb itu ra te Pollard  and L uckert 1979
R at stom ach MNNG C roton oil M atsukura e t al 1979
Mouse liver DMN Phorbol A rm uth and Berenblum 19'
Mouse lung Ethyl carbam ate BHT W itschi e t al 1977
DMN Phorbol A rm uth and Berenblum 19'
Trout liver AFBj M ethyl s te rcu la te Lee eit al 1971
Mouse embryo cells 3MC TPA Mondal e t  al 1976
Mouse forestom ach DMBA TPA G o erttle r  e t al 1979
(reviewed in refs. 86 and 90).
b) M etabolic A ctivation  of Chem ical Carcinogens
B iotransform ation of foreign compounds: 
D etoxication routes:
M etabolic activation  of polycyclic hydrocarbons:
M etabolic activation  of other carcinogens:
I) P o ten tia l donors of simple alkyl groups 
IE) A rom atic am ines and am ides 
HI) Mycotoxins
B iotransform ation of Foreign Compounds
Since his appearance on the earth  some 100,000 years ago, man (Homo Sapiens) has 
been exposed to a  m yriad of exogenous chem icals from plants, m icro-organism s and 
the incom plete com bustion of fossil fuels. The onset of the industrial revolution g rea tly  
increased  m an’s exposure to po ten tially  toxic environm ental and industrial m a te ria ls . 
Evolution has provided a  mechanism by which such substances can be elim inated from 
the  body. Foreign compounds are ingested  in food and drink, in  the  inspired a ir, and 
through the skin. They are m etabolised by two phases of reac tion  (103), m etabolic 
transform ation  and conjugation, giving rise to m etabolites and conjugates which are  
then excre ted  in the  urine, the bile and the expired air.
Probably the earliest observation of the m etabolism  of a foreign compound was m ade 
by Gmelin (1824) who noticed a garlic-like odour in the bodies of anim als poisoned 
with te llurium . This was found to be due to  dim ethyl te llu ride . Several oxidative 
b iotransform ations were subsequently discovered, such as the conversion of benzene 
into phenol, and toluene into benzoic acid. Brodie e t al (104) showed th a t the enzym es 
responsible for many m etabolic transform ations are located  in the endoplasm ic reticu lum  
of the liver cell. Homogenisation of liver tissue results in fragm en tation  of the  
endoplasm ic reticu lum  to form small vesicles known as "m icrosom es". The m icrosom al 
frac tion  has been used extensively to study m etabolic transform ations. Although the  m ost 
active drug or xenobiotic-m etabolising organ is the  liver, drug-m etabolising enzym es are 
not confined to th is organ. Their d istribution also depends on the sub stra te  and chem ical 
reac tion  involved (105). Early studies on the natu re  of these oxidative system s showed 
th a t most of the  enzymes require both reduced pyridine nucleotide (NADPH) and oxygen 
(106). It is now known th a t these reac tions are  catalysed  by a series of haem oproteins, 
collectively  known as cytochrom e P450 (cyt.P450) because, in a reduced s ta te ,  they  
exhibit an absorbance peak a t 450nm when com plexed with carbon monoxide. These w ere 
in itia lly  discovered during studies on the m etabolism  of steroids but w ere subsequently 
found to be responsible for the oxidative (phase I) m etabolism  of many drug su b stra tes  
(107,108). The cyt.P450 enzymes require reduced co fac to rs (NADPH) but ca ta ly se  
oxidative transform ations and are there fo re  known as mixed function oxygenases (MFO). 
They are re la tive ly  non-specific and perform  a varie ty  of m etabolic transform ations as 
illu stra ted  in Table IV (109). MFO catalyse the incorporation of an atom  of oxygen, from  
m olecular oxygen, into the substra te  which usually appears as a  hydroxylated product 
(110) (Fig.15) while the rem aining atom  of oxygen appears as w ater.
Table IV. METABOLISM OF DRUGS BY CYTOCHROME P450 ENZYMES 
IN LIVER MICROSOMAL FRACTIONS
Type Substrate P roduct
A rom atic hydroxylation aniline
aliphatic hydroxylation hexobarbital
arene oxide form ation
N -dealkylation
N-hydroxylation
O-dealkylation
S-dealkylation
N-oxidation
S-oxidation
deam ination
desulphuration
dechlorination
dealkylation of 
m etalloalkanes
brom obenzene
aminopyrine
AAF
p-acetanisid ine 
6-m ethylthiopurine 
dim ethy laniline 
chlor opro m azine 
am phetam ine 
parathion
p-am inophenol
hydroxyhexobarbital
brom obenzene epoxide
4-am inoantipyrine
N -hydroxy-AAF
p-hydroxyacetanilide
6-thiopurine
dim ethy laniline-N -oxide
chloroprom azine sulphoxide
phenylacetone
paraoxon
carbon te trach lo ride  chloroform
te tra e th y l lead trie th y l lead
Produc t
R-OH
[ R- h] p - 450  [Fe-O]
3 + Subs t ra te
P - 4 5 0 R-H
3+
P - 4 5 0
H-OH
HOOH
3+ 1 +
[ r - h]  P - 4 5 0[ r - h] P - 4 5 0 HOOH
2H
Figure  15 Drug Hydroxyla t ion
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Purification  of MFO's has recen tly  been achieved (111) and the com plete enzym e com plex 
apparently  consists of NADPH -  cytochrom e reductase (a flavoprotein), cyt.P450 and 
phosphatidylcholine (112,113). Mono-oxygenase ac tiv ity  requires the in teg rity  of an 
electron  chain betw een the flavoprotein reductases and the various form s of cyt.P450 
located  in the endoplasmic reticulum  m em brane of the cell (114). I t is now believed th a t 
much of the  reductase m olecule sits free  of the lipid bilayer w hereas cyt.P450 m olecules 
are  deeply embedded in the m embrane (115K A t the  present tim e i t  is no t known w hether 
the  cyt.P450 molecules are arranged in ro se ttes  around a reductase  m olecule or th e  
reductase  moves through the cyt.P450 m olecules resem bling a ship (116).
The cyt.P450 form s can be resolved into several im m unochem ically d is tin c t 
haem oproteins (117) of which two major forms have been fu rther charac terised  and 
possess slightly d ifferen t carbon monoxide d ifference spectra  and significantly  d iffe ren t 
ca ta ly tic  specificity . These d ifferen t forms of cyt.P450 can be induced in ra t  liver by 
p re tre a tm en t of the animals w ith e ither phenobarbital or 3MC (118). The la t te r  
haem oprotein, cyt.P448 or I|450, has been obtained in purified form (111) and has a 
slightly sh ifted  carbon monoxide d ifference spec tra . It is ch a ra c te ris tic  of m icrosom al 
enzym e induction by PAH (119,120) and is more effic ien t a t m etabolising PAH than
cyt.P450 from e ither un trea ted  or phenobarbital trea ted  animals. The enzym e BP 
hydroxylase (or ary l hydrocarbon hydroxylase (AHH) ) is induced in m icrosom es from  3MC- 
p re tre a te d  animals. In certa in  inbred strains of mice there  is a large varia tion  in the 
induction response such th a t CB57BL/6 m ice are highly responsive, DBA2 m ice are  
nonresponsive and C3H m ice are of in term ed ia te  response (121). AHH responsiveness to 
3MC induction is inheritab le by M endelian genetic  principles governed by a single locus 
known as the Ah locus (121,122). K ellerm an e t al (123) repo rted  th a t AHH inducibility  in 
human lym phocytes exhibited a trim odal distribution, the groups being designated low, 
in term ed ia te  and high inducibility. The resu lts  w ere consistent w ith a  hypothesis of two 
alleles a t a single locus, however, confirm ation of the resu lts  proved very d ifficu lt due to  
the variab ility  of the lym phocyte AHH assay. A t the present tim e it  is far from  clear 
w hether AHH induction in humans is controlled by a single genetic  locus or by two or 
more loci (i.e. polygenic).
Although m ost studies have focused on cyt.P450 haem oproteins in the m em brane of r a t  
liver endoplasmic reticulum , cyt.P450 is also p resen t in the m em brane of r a t  liver nuclei 
(124) and is inducible by 3MC and phenobarbital (125). R ecen t studies have dem onstrated  
th a t nuclear cyt.P450 d iffers from the m icrosom al species in term s of sp ec tra l p roperties  
(126), however, Thomas e t al (127) have shown th a t nuclear cyt.P448 and m icrosom al 
cyt.P448 are im m unochem ically indistinguishable. N uclear mono-oxygenase enzym es may 
play a c ritica l role in carcinogenesis because of the ir close proxim ity to the  genetic  
m ateria l of the cell.
D etoxication R outes:
The prim ary products formed from many substra tes  by MFO's are  epoxides (128-130). 
These are electrophillic  species and have been im plicated  in the toxic e ffe c ts  of many 
exogenous chem icals (131). Two enzyme system s are  p resen t in tissues which can function 
to detoxify these reac tiv e  in term ediates, epoxide hydratase and g lu tath ione-S - 
transferase . Epoxide hydratase was in itia lly  thought to be essentially  a m icrosom al 
m em brane-bound enzym e (132) but recen tly  i t  has also been d e tec ted  as a soluble enzym e 
(133) exhibiting d ifferen t substrate  specific ities (134). The m icrosom al enzym e probably 
exists in close proxim ity to the MFO system  (132) and is inducible by phenobarb ital and 
3MC (132), though to a lesser ex ten t than  AHH. Schmassmann e t ad (135) have rep o rted  
th a t several epoxides of widely varying stru c tu re  w ere able to induce epoxide hyd ra tase  
ac tiv ity  and th a t trans-stilbene oxide selectively  induced the enzym e in p re fe ren ce  to 
AHH. However, a recen t report showed th a t trans-stilbene oxide was an e ffec tiv e  inducer 
of all drug m etabolising enzymes (136). Epoxide hydratase is widely d istribu ted  in
m am m alian tissues w ith highest ac tiv ity  in the te stis  (137). I t has a  broad substra te
enzym e in r a t  liver. Epoxide hydratase catalyses a highly sterospecific  hydration of arene 
and alkene epoxides to produce trans dihydrodiols (132,139). Some epoxides, notably  
AFB^-8,9-epoxide and BP-7,8-diol-9,10-epoxide (BPDE) are not substra tes  for the  enzym e 
and this may, in p a rt, explain the ir tox icity  (140,141), though in the case of AFB^-8,9- 
oxide the evidence is ind irec t. Several assays have been developed using PAH K -region 
epoxides or styrene oxide (142-144) and during this work i t  becam e evident th a t a  wide 
variation  in ac tiv ity  existed tow ards the K -region epoxides of the various PAH (143,145). 
Two recen t developm ents of in te re s t have been the purification  of hum an liver 
m icrosom al epoxide hydratase (146) and the iden tifica tion  of epoxide hydratase as the 
preneoplastic  antigen of hyperplastic nodules form ed in  ra t  liver by feeding 2 -ace ty lam in- 
ofluorene (AAF) (147). As with cyt.P450, epoxide hydratase ac tiv ity  has been d e tec te d  in 
ra t liver nuclear m em brane (148) and this could have im portan t consequences for 
carcinogenesis due to its  close proxim ity to the genetic  m a te ria l of the cell.
Po ten tially  toxic epoxides can also be detoxified  by enzym e-m ediated conjugation w ith 
glutathione (GSH) via a group of enzym es known as g lu ta th ione-S -transferases (GSH- 
transferases) p resen t in the cytoplasm  (148). GSH is a tripep tide, g lu tam yl-cysteiny l- 
glycine, which also serves to p ro tec t thiol groups in  proteins from oxidation (149)> to 
function as an in trace llu la r redox buffer (150), to serve as a reservoir of cysteine (151) 
and to a c t as a  coenzym e for ce rta in  enzym es (152) e.g. glyoxylase I and form aldehyde 
dehydrogenase. The G SH -transferases catalyse the addition of GSH to a v a rie ty  of 
electrophillic  cen tres, as illu s tra ted  in Fig. 16, to  produce GSH conjugates.
specific ity  (138) and no conclusive evidence has been obtained for m ultiple form s of the
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Figure 16 G lu ta th ione  conjugation
These are thought to be m etabolised fu rther by cleavage of the g lu tam ate  and glycine 
residues, followed by ace ty la tion  of the resu ltan t free  amino group of the  cysteinyl 
residue to  produce the  final product, a m ercapturic acid (153). The G SH -transferases of
human and r a t  liver com prise a group of a t least five or six enzym es having d iffe ren t bu t 
overlapping substra te  specific ities (154). In teresting ly , it  was shown th a t the cytosolic, 
anion-binding hepatic  p ro te in  ligandin is iden tical with G SH -transferase B in ra t  liver 
(155). Their presence is w idespread in v e rte b ra te  species (154) and, although m ost 
ac tiv ity  is associated with the liver, they have been d e tec ted  in o ther tissues such as 
kidney (156), lung (157), and sm all in testine  (158). R ecen t repo rts  have dem onstrated  th a t 
G SH -transferases from ra t  and mouse tissues can be induced w ith phenobarbital and 3MC 
(157,158) whilst U otila e t al found th a t c ig a re tte  smoke could induce th e  ac tiv ity  in r a t  
lung (159). Several arene oxides of PAH including naphthalene-1,2-epoxide and the K- 
region epoxides of phenanthrene, BA and BP form ed GSH conjugates in incubations with 
subcellular fractions of liver (189,161) and consequently a num ber of assays w ere 
developed using such epoxides (189,161,162). Hayakawa e t al (161) com pared the ab ility  
of several arene oxides derived from carcinogenic PAH to  ac t as su bstra tes  for a purified  
G SH -transferase from sheep liver. D MBA-5,6-epoxide and BP-4,5-epoxide w ere 
substra tes  for the enzyme whereas BP 7,8 and 9,10-epoxides w ere very poor or inactive as 
substrates. Thus, a p ro tec tiv e  role for GSH against PAH carcinogenesis v ia arene oxides 
is not evident from these studies. However, GSH has a c lear p ro tec tiv e  ro le in the 
hepatic  necrosis induced by halobenzenes (163) and recen tly  a GSH conjugate of AFB^ was 
identified  as the major m etabolite  of AFBj in the ra t  in vivo (164).
Two other m echanism s of detoxication exist, nam ely glucuronide and sulphate 
conjugation. These pathw ays serve to increase the po larity  of m etabo lites genera ted  
through phase I processes, by cyt.P450 with or w ithout epoxide hydratase , and so 
fac ilita te  their excretion via the urine or bile. G lucuronidation catalysed  by m icrosom al 
uridine diphosphate glucuronyl-transferases is probably the quan tita tively  m ost im portan t 
conjugation reac tion  because many reac tiv e  groups (-0H, -C00H, “NH^, -SH) form 
glucuronides (165). Moreover, glucuronic acid is readily  available from  carbohydrates. 
The active agent in glucuronide synthesis is uridine diphosphate glucuronic acid (UDPGA) 
(Fig.17) and the products have a B-configuration and are the re fo re  substra tes  for 13- 
glucuronidase. U D P-glucuronyltransferase ac tiv ity  is m arkedly ac tiv a ted  by a wide 
varie ty  of m em brane pertu rban ts, the degree o f activation  depending on the sub stra te  
(165). There is evidence suggesting th a t the enzyme exists in a constrained form (166) bu t 
the m echanisms of constrain t are s till debated (167). R ecen t evidence ind icates a 
m ultip licity  of glucuronyltransferases. Two forms have recen tly  been separa ted  and 
partia lly  purified, one form u tilizes morphine as p re fe ren tia l substra te  and is induced by 
phenobarbital while the other form p re fe rs  1-naphthol and nitrophenol as substra tes  and is 
induced by 3MC (168,169). Glucuronyl transferases are p resen t in all m am m alian species 
investigated  though several species of F elidae, including the ca t exhibit a low capacity  to 
form phenolic glucuronides (170). The enzym e is p resen t in the m icrosom al frac tion  of 
many tissues such as liver, lung, adrenals, kidney, spleen and in testine  (165).
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Sulphotransferase enzym es located in the cytoplasm  often  com pete w ith glucuronyl 
transferases for th e  sam e substrates. The active  agent in sulphate e s te r conjugation is 3 '- 
phosphoadenosine-5’-phosphosulphate (PAPS) which is genera ted  from inorganic sulphate 
(Fig.17). Sulphate is poorly absorbed from the  gut and can only be obtained in lim ited  
am ounts from the cysteine pool, which is required  elsew here. Consequently the sulphate 
conjugation pathw ay is readily  sa tu ra ted  and in the ra t, increasing su bstra te  concen tra tion  
leads to an increased proportion of glucuronide ra th e r than sulphate being excre ted  (171). 
The soluble cytoplasm ic sulphotransferases are  responsible for addition of sulphate to  
phenols, alcohols, arom atic  amines and n itro  compounds and probably endogenous steroids. 
There is evidence for m ultiple sulphotransferases in th a t phenolic steroids, alcoholic 
steroids, simple phenols and arom atic am ines are  all known to be conjugated v ia  separa te  
enzym es (172). The endoplasmic reticulum  and Golgi m em branes contain a  second type of 
sulphotransferase involved in the sulphation of sugars and glycoprotein synthesis bu t no t 
drug m etabolism .
Glucuronide conjugates tend to be excre ted  in the bile and sulphate conjugates in the 
urine. E xcretion  of chem icals in the urine seem s to  be lim ited by the ir size and po la rity  
such th a t in the ra t, compounds with a m olecular w eight 300 tend to be ex cre ted  in the 
bile. The m olecular weight threshold for humans is n eare r 500.
Conjugates with glucuronic acid or sulphate usually lead to inactive products, however, 
conjugates of certa in  arylam ines are more reac tiv e  than the ir paren t compounds. The N - 
0-glucuronide and sulphate esters of AAF bind covalently  to nucleic acids and pro teins
(173) and the sulphate es te r is believed to be the u ltim a te  carcinogen derived from  AAF
(174) (see la te r  discussion). R ecently  Mulder e t al repo rted  th a t the N-O-glucuronide and 
sulphate es ters  of N-hydroxyphenacetin bind covalently  to  p ro tein  (175) and although the  
reac tiv e  glucuronide may be less im portan t for tox icity  in liver, i t  is highly co ncen tra ted  
in the kidney and bladder and this could explain the nephrotoxicity  of paracetam ol.
T here also exist several other detoxication pathw ays of re la tive ly  minor im portance. 
Phosphate conjugation is a surprisingly ra re  pathw ay, considering the cellu lar levels of 
adenosine triphosphate, and one of the few known exam ples is the form ation of bis(2- 
am ino-l-naphthyl) phosphate from 2-naphthylam ine (176). N - and 0 -m ethy lation  v ia  S- 
adenosylm ethionine serves to conjugate many endogenous am ines such as the 
catecholam ines (177). A cetylation via coenzym e A occurs for ce rta in  drugs such as 
sulphanilam ide (178) and is a general pathw ay for arom atic amines. Finally, arom atic  
carboxylic acids can undergo conjugation with glycine and o ther amino acids to  form 
peptide conjugates
M etabolic A ctiva tion  of P o lycyclic  H ydrocarbons
The m etabo lic  ac tiv a tio n  of BP in m icrosom al incubations, iso la ted  cells, m ouse skin and
only a b rie f  rev iew  will be p resen ted  here.
PAH are  ubiquitous environm ental po llu tan ts  (102) and th e  m ost ex tensively  stud ied  
rep re sen ta tiv e  has been  BP. In itia l studies on the m etabolism  of BP described  m e tab o lite s  
of a  phenolic n a tu re  in the b ile of r a ts  tre a te d  w ith BP (179). Pheno lic  m e tab o lite s  of BP 
w ere no t carcinogenic (180,181) and i t  was generally  assum ed th a t carc inogen ic PAH w ere 
biologically  ac tiv e  per se. H owever, M iller (182) rep o rte d  th a t BP form s covalen t p ro te in  
bound deriva tives in mouse skin and Brookes and Law ley (183), using tritiu m  labelled  PAH 
of high specific  ac tiv ity  (SA), showed th a t several PAH re a c t  w ith DNA, RNA and p ro te in  
in mouse skin. They observed th a t, although th e  binding to  DNA was very  low, a 
co rre la tio n  ex isted  betw een  the biological a c tiv ity  of the  PAH and th e ir  re a c tio n  w ith 
DNA bu t no t RNA or p ro te in . The la t te r  two observations im plied th a t th e  re la tiv e ly  
in e rt PAH m ust undergo m etabolism  prio r to reac tio n  w ith ce llu la r m acrom olecules. 
This was conclusively dem onstra ted  by G rover and Sims (184), and Gelboin (185) who 
investiga ted  the  m icrosom e-m ediated  binding of PAH to  nucleic acids and p ro te in . They 
rep o rted  th a t m etabolism  was obligatory  for m acrom olecu lar binding. Various reg ions of 
chem ical re a c tiv ity  in PAH m olecules have been  described (Fig.18).
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Figure  18 Im p o r tan t  Metabolic Regions of PAH
The L-region tends to exhibit photo lability  and is exem plified by th e  9,10 positions of 
an th racene . The K -region is a  region of high e lec tro n  density  exem plified  by the  9,10 
double bond of phenan threne (Fig.32). The M -region is generally  a  s ite  of secondary  
substitu tions (reviewed in re f . 186) whilst the bay region is the  basis of re c e n t concep ts of 
PAH carcinogenesis and will be discussed la te r . In 1950, Boyland (187) proposed th a t  
epoxides could arise following m icrosom al ac tiv a tio n  of PAH and e lec tro n ic  ca lcu la tions
resp ira to ry  tissues is review ed in the  experim en tal section  (C hapters One to  Four) and
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im plicated  the K -region as the  m ajor s ite  of activation  (188). Although K -region epoxides
not observed am ongst the DNA adducts form ed when cultures of rodent cells were tre a te d  
w ith 7-m ethylbenz(a)anthracene (7MBA) (190) or BP (191). PAH, such as BP, are  
m etabolised to  a vast array  of oxidative and conjugative products (192) (Fig.19) and i t
carcinogenesis. Using m icrosom al preparations, Bor gen e t al (193) showed th a t 7 ,8- 
dihydro-7,8-dihydroxybenzo(a)pyrene (BP-7,8-diol) could be m etabolised and bind to  DNA 
to  a  g rea te r ex ten t than  the  paren t hydrocarbon or any other m etabo lite  te s ted . Sims e t 
al reported  th a t DNA adducts form ed in rodent cells in cu lture tre a te d  w ith BP or BA 
w ere iden tica l to those form ed by reac tion  of vicinal dihydrodiol-epoxide derivatives w ith 
DNA. In  the case of BP the m etabo lite  im plicated  was the bay-region 7,8-dihydrodiol- 
9 ,10-epoxide (BPDE) (194) w hereas w ith BA the non bay region 8,9-dihydrodiol-10,11- 
epoxide was responsible (195) (Fig.20).
la te r  denoted syn and an ti, such th a t for BPDE the 7-hydroxyl group could be cis or trans 
respectively  to the oxide ring, thus giving rise  to 70, 8<*-dihydroxy-9B,10B-epoxy-7,8,9,10- 
tetrahydrobenzo(a)pyrene (syn BPDE) and 70 , 8<* -dihydroxy-9<* , 10®< -epoxy-7 ,8,9,10- 
tetrahydrobenzo(a)pyrene (anti BPDE) (Fig.21).
of PAH proved to be m utagenic, carcinogenic and able to transform  cells (189) they w ere
obviously seem ed an im possible task  to identify  which m etabolite(s) w ere responsible for
H<
OH OH
BP -  7 , 8 - d i o l - 9 , 1 0 - epoxide BA-8 9 - d i o l - 1 0  11-epoxide
Figure 20
H ulbert (196) proposed th a t diol-epoxides of PAH could exist as two geom etrica l isom ers,
SYN ANTI
OH OH
Figure 21 B e n z o (a )p y re n e - 7 ,8 -d io l -9  , 1 0 - epoxides
H ulbert also ind icated  th a t the syn isom er would be chem ically m ore reac tiv e  since 
hydrogen bonding betw een the 7-hydroxyl proton and the epoxide oxygen would s tra in  the 
epoxide ring and fac ilita te  form ation of a carbonium ion a t C-10. In the  an ti isom er, the 
7-hydroxyl group and the epoxide oxygen are in a  trans configuration such th a t hydrogen 
bonding betw een the two cannot tak e  place (Fig.22).
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Figure 22 Carbonium ion formation in BP-7 8 - d i o l - 9  10 -ep o x id e s
Deoxyribonucleoside adducts form ed by reac tion  of syn and anti BPDE's w ith DNA w ere 
inseparable by Sephadex LH-20 chrom atography using m ethano l/w ater grad ien t elution 
(197). King e t al recognised th a t when the  anti BPDE reac ted  w ith DNA the  hydroxyl 
groups a t positions 8 and 9 would be in a cis configuration and could com plex w ith bo rate  
(see Fig.23). This was not the case with the  syn isom er and these w orkers u tilised  this 
fa c t to separate  DNA-bound products of syn and anti BPDE’s (198). They showed th a t 
m icrosom e-m ediated binding to DNA of BP-7,8-diol involved exclusively an ti BPDE. DNA 
adducts form ed when rodent cells were tre a te d  in  culture w ith BP w ere predom inantly  
derived from anti BPDE though some syn BPDE involvem ent was also observed. The 
ex ten t of form ation of DNA adducts derived from syn and an ti BPDE’s in  cell cu ltu res 
exposed to BP was m arkedly tim e dependent (199). Huberman e t al confirm ed th a t liver 
m icrosom al metabolism  of BP-7,8-diol produced exclusively the an ti BPDE (200) by 
analysis of the  te tro ls  produced upon spontaneous hydrolysis of the diol epoxide. O ther 
workers showed th a t liver m icrosom al m etabolism  of BP produces highly op tically  pure (-) 
BP-7,8-diol (201) and (+) anti BPDE (202). It has recen tly  been rep o rted  th a t the  
m etabolism  of BA, phenanthrene and chrysene by liver m icrosom al p reparations produces 
highly optically  pure 3,4-,1,2-and 1,2-dihydrodiols respectively  which are  then m etabolised 
stereospecifically  to the corresponding bay-region diol epoxides (203). Thus, m etabolism  
of PAH exhibits broad regiospecificity , e.g . BP is m etabolised a t m ost of its  available 
carbon atoms (Fig.19), broad substra te  specific ity , e.g. BP, BA e tc  are all su b stra tes , and 
high stereospecificity . There are two possible op tical isom ers (-) and (+) of each of the  syn
and anti BPDE's. As a m utagen in m am m alian cells (204), a tum our in itia to r in mouse skin 
(205) and a com plete carcinogen in mouse lung (206) the (+) an ti isom er is the  m ost active, 
a ra th e r unfortunate occurrence in th a t this is the isom er predom inantly  form ed 
biologically from BP. In con trast to this all four stereoisom ers a re  ac tive  b ac te ria l 
m utagens (204) which, to  a certa in  ex ten t, invalidates the use of b a c te r ia l m utation  as a 
model for carcinogenicity  in vivo.
Alm ost sim ultaneously two groups of w orkers repo rted  th a t reac tio n  of the an ti (207) and 
syn (208) BPDE's w ith DNA and polyguanylic acid (poly G) respectively  involved 
predom inantly  binding of the C-10 position of the BPDE to the exocyclic 2-am ino group of 
deoxyguanosine (dG) and guanosine respectively . I t was subsequently shown th a t the  
absolute stereochem istry  of the anti BPDE-dG and-guanosine adducts form ed in DNA and 
RNA, respectively , of bronchial explants exposed to  BP, was a trans addition of the  2 - 
amino group of the base to the C-10 position of the 7R form of an ti BPDE (209,210) 
(Fig.23).
Meehan and Straub (211) have recen tly  reported  th a t reac tion  of racem ic (+) an ti BPDE
2with double stranded DNA resu lts  in s tereospecific  reac tion  of (+) an ti BPDE w ith the  N -
amino group of dG. In con trast to this, when (+) an ti BPDE re a c ts  w ith sing le-stranded
2DNA both enantiom ers re a c t to the  sam e ex ten t w ith N -dG. In teresting ly , th e  ra tio  of 
2
N -dG products form ed from (+) and (-) an ti BPDE's when the  racem ic (+) an ti BPDE
reac ted  with double stranded DNA was approxim ately 20:1, in good ag reem ent with the
d ifferences in m am m alian cell m utagenicity  (204), tum our in itia ting  ability  (205) and
carcinogenicity  (206) of these enantiom ers. Thus, th e re  is an apparen t co rre la tion
2betw een ex ten t of reac tion  with N -dG and biological ac tiv ity  of the op tical isom ers of
anti BPDE. Many workers have shown th a t a v arie ty  of cell and tissue cu ltu res, from
anim als and humans, incubated with BP could m etabolically  ac tiv a te  the carcinogen and
th a t the m ajor DNA and RNA adducts form ed w ere anti BPDE-dG and -  guanosine
products respectively  (212). In vivo experim ents also reported  these adducts to  be  the
m ajor DNA and RNA-bound products form ed in mouse skin (213) (see C hapter Three) when
anim als were trea ted  topically with BP. R eaction  of anti BPDE with DNA also produces
several minor adducts via reac tion  with deoxyadenosine (dA), deoxycytidine (dC) (214) and 
7the N position of dG (215). Some of these products have been observed in biological 
system s, though usually only in sm all am ounts (see C hapter Three).
Both syn and anti BPDE's were reported  to cause DNA dam age in hum an fibroblast cell 
cultures. The resulting excision (216) and postrep lication  (217) DNA repair responses 
evoked resem ble closely those seen a fte r  the induction of pyrim idine dim ers by UV 
irradiation, e.g., excision repair involved rem oval of a base lesion toge ther w ith several 
neighbouring nucleotides and then insertion of a "long patch" of newly synthesized DNA. 
O ther workers showed th a t DNA dam age elic ited  by syn and an ti BPDE's in hum an 
alveolar tum our cells was only slowly repaired  (218), these adducts persisting  in the DNA
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for several generations (219). This is possibly because the hydrocarbon residues can be 
accom m odated in the  minor groove of the DNA-helix w ithout causing m ajor 
conform ational d istortion  (220), suggesting poor excisability  of BPDE-dG lesions. 
M icrosom e-m ediated binding of BP to DNA involves 4 ,5-dihydro-4,5-epoxy benzo(a)pyrene 
(BP-4,5-epoxide) and fu rth er m etabolites of BP-phenols (see C hapter One) w ith l i t t le  
involvem ent of the  diol epoxide m etabo lites. Thus, one m ust be wary when ex trapo lating  
from  m icrosom al system s to  in ta c t cell system s, whole anim als and u ltim a te ly  humans. 
Much evidence has accum ulated im plicating vicinal diol epoxide m etabo lites of PAH as 
the  major DNA-bound forms of the carcinogens in a varie ty  of biological system s (212). 
For some carcinogens, such as DMBA, 7-MBA and 3-MC d irec t com parison of 
experim entally  obtained DNA adducts w ith syn thetic  diol-epoxide-DNA products has not 
been possible due to the  d ifficu lty  of synthesizing vicinal diol epoxides of m ethy la ted  
PAH. R ecently  Cooper e t al (213) synthesized 3 ,4 -d ihydroxy-l,2 -epoxy-l,2 ,3 ,4-tetrahydro- 
DMBA in situ  and showed th a t th is reac ted  with DNA to yield iden tica l products to those 
form ed in the DNA of mouse skin when mice w ere tre a te d  topically  w ith DMBA.
Whilst many workers consider diol-epoxides to be the u ltim a te  carcinogenic form s of 
PAH, the involvem ent of other types of m etabolites has also been considered (222). One 
such exam ple is the suggested role of hydroxym ethyl m etabo lites of DMBA in the adrenal 
necro tic  action of this compound (223). There is li t t le  evidence for the ro le of such 
m etabo lites in th e  carcinogenicity  of BP or other PAH.
M etabolic A ctivation of O ther Carcinogens
I) P o ten tia l Donors of Simple Alkyl groups:
This is a large group (see Fig.24) including the dialkylnitrosam ines, dialkylhydrazines, 
aryldialkyltriazenes and alkylnitrosam ides. The first th ree  classes are  m etabo lically  
dealkylated by MFO's and the resu lting  monoalkyl derivatives spontaneously decom pose to 
the  corresponding monoalkyl diazonium ions (224) which can fu rth er decom pose to yield an 
alkyl carbonium ion (exem plified by DMN, Fig.25).
O = N -  N
Figure  25 Metabolic Act iva t ion  of DimethyInit rosamine
The alkylnitrosam ides do not require enzym ic activation  since the presence of
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nucleophiles, including w ater, resu lts in the ir decom position to the sam e alkylating 
in term ed iates . A wide varie ty  of nucleophilic sites in nucleic acids and pro teins are  
possible ta rg e ts  for the alkylating species (Fig.26).
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Figure 26 Typical nucleophilic c e n t r e s  in nucleic acids and proteins
Classical alkylating agents, such as m ethyl m ethane sulphonate and ethyl m ethane 
sulphonate re a c t w ith DNA to yield several alkylated  bases (225), how ever, Loveless e t al
(226) showed th a t only agents capable of producing 0^-alkyl-dG lesions w ere biologically 
active in bacteriophage. These lesions also resu lt in miscoding of DNA tem p la tes  in v itroi 1 ——
(227) and m isincorporation of bases in to  copolym ers (228). I t seem s, th e re fo re , th a t w ith 
sim ple alkylating agents the quan tita tively  minor O^-alkylation of dG, ra th e r  than the
7
quantita tively  m ajor N -alkylation of dG* is more im portan t in m utagenesis and 
carcinogenesis (226,229,230). The organ specific ity  of m onofunctional alkylating  agents, 
such as DMN and DEN appears to co rre la te  well with the re la tive  persis tence  of 0^-alkyl- 
dG products com pared to N -alky 1-dG products in  the DNA of the ta rg e t tissue (231). 
However, two recen t reports failed  to support this view (232,233) and thus, the  form ation  
and persistence of 0^-alkyl-dG may constitu te  a necessary  though, in itse lf , in su ffic ien t 
event for organ specific carcinogenesis by mono functional alkylating agents.
II) A rom atic Amines and Amides:
The most extensively studied arom atic am ide carcinogen has been AAF (Fig.6). In I960, 
C ram er e t al (234) showed th a t ra ts  fed AAF converted  i t  to a new m etabo lite  N-hydroxy- 
AAF which proved a more po ten t carcinogen than the paren t compound and was shown to 
be active in a wider range of tissues and species (235,236). A dm inistration of AAF and its
N-hydroxy derivative to ra ts  yielded nucleic acid- and protein-bound derivatives in the 
liver (237), how ever, these carcinogens are not reac tive  in v itro  and fu rth er m etabolism  of 
N-hydroxy-AAF seem ed necessary . Subsequent studies showed th a t N-hydroxy-AAF was a 
substra te  for sulphotransferase (238,239) and a  good corre la tion  was found to exist 
betw een hepatic  sulphotransferase levels and the carcinogenicity  of N-hydroxy-AAF in 
several rodent species (240), such th a t depletion of the  'su lphate pool1 produced a 
concom itant decrease  in carcinogenicity . The sulphate es te r of N-hydroxy-AAF proved to 
be a powerful electroph ile , reac ting  with DNA in vitro  (241) and exhibiting high m utagenic 
ac tiv ity  in a  DNA transform ing system  (242). Although N-sulphonoxy-AAF has been 
proposed as the  u ltim a te  carcinogen of AAF in  r a t  liver, su lphotransferase ac tiv ity  for N- 
hydroxy-AAF was shown to be low or undetectab le  in the m am m ary gland and ear duct of 
the ra t  (243), tissues in which AAF has dem onstrated  carcinogenic ac tiv ity  (27). 
T herefore , o ther es te rs  of N-hydroxy-AAF have been investigated . The 0-glucuronide has 
been de tec ted  as a  m etabo lite  of AAF (224). I t is a  re la tive ly  weak electroph ile  (245) but 
has been proposed as a  transportab le  form of N-hydroxy-AAF such th a t B-glucuronidase 
enzym es, e.g. in the m am m ary gland, could hydrolyse the e s te r and re lease  N-hydroxy- 
AAF a t its  s ite  of action  to  undergo fu rther activation  reac tions. B artsch e t al (246) 
showed th a t r a t  liver cytosol form s the  pow erful e lectrophile N -acetoxy-2-am inofluorene 
by enzym ic tran sfe r of the ace ty l group from the N -atom  of N-hydroxy-AAF to  the 0- 
atom  of N-hydroxyam inofluorene. The ace ty l transferase  enzym e involved m ay be 
im portan t in  the ex trahepatic  carcinogenicity  of AAF in view of the wide range of tissues 
in which this activ ity  occurs (247). Finally, B artsch and H ecker (248) showed th a t N- 
hydroxy-AAF could undergo a one electron  oxidation to yield a  n itroxide free  rad ical and 
two of these radicals could d ism utate  to yield the electrophiles N -acetoxy-A A F and 2-i
nitrosofluorene. There is some electron  spin resonance d a ta  to support the  prosposed 
form ation of a free  rad ical from N-hydroxy-AAF but the mechanism  of ac tiva tion  of AAF 
in  ex trahepatic  tissues rem ains to  be established.
Initial studies of the  DNA bound products form ed in the liver of ra ts  tre a te d  w ith AAF
and N-hydroxy-AAF indicated  th a t the m ajor adducts contained deace ty la ted  AAF
derivatives (249). Subsequent work iden tified  two DNA-adducts of which the  m ajor one,
N-(dG-8-yl)-AAF, disappeared rapidly from the DNA w ith a biological half life  of seven
days (250). In the  sam e report the minor DNA -adduct proved p ers is ten t in the  DNA up to
eight weeks a fte r  trea tm en t and was provisionally assigned the s tru c tu re  3-(dG-8-yl)-
AAF. L a te r work established th a t this la t te r  s tru c tu re  was in co rrec t and th a t th e
persis ten t DNA-adduct involved reac tion  of th  2-amino group of dG w ith C-3 of AAF
(241). Thus the proposed route of m etabolic activation  for AAF is shown in Fig.27.
Yam asaki e t al (251) dem onstrated  p re fe ren tia l excision of the C-8-dG adduct of AAF 
2re la tive  to the N -dG -adduct when DNA modified with N -acetoxy-A A F was hydrolysed
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with single strand-specific  endonucleases. This is consisten t w ith the earlie r finding th a t
substitu tion of the  C-8 position of dG in DNA by AAF m oieties causes base d isplacem ent
(252) leading to  localised regions of denaturation  of the double-stranded DNA helix which
2would be repaired  by single strand  specific nucleases. In co n trast to  th is the  N -dG - 
adduct of AAF apparently  resides in the minor groove of the DNA-helix, has very  l i t t le  
freedom  of ro ta tion  and causes li ttle  helical d isto rtion  (220). R ecently  high pressure 
liquid chrom atographic (HPLC) analysis of AAF-DNA adducts has shown th a t two 
pers is ten t adducts are  p resen t in ra t  liver DNA two weeks a f te r  tre a tm e n t of anim als 
with N-hydroxy-AAF (253). One adduct corresponds to 3-(dG-N -yl)-AAF as shown 
previously (241), however, the m ajor pers is ten t adduct co-chrom atographed w ith N -(dG-8- 
yl)-2-am inofluorene. This C -8-dG -2-am inofluorene adduct however, should d is to rt the 
DNA-helix and be excised in a m anner analogous to  N-(dG-8-yl)-AAF. Thus the iden tity  
of this m ajor p ers is tan t adduct rem ains to  be established.
2Excisable C -8-dG -arylam idation products and re la tive ly  p ers is ten t N -dG -ary lation  
products have been d e tec ted  as the m ajor DNA adducts of N -m ethyl-4-am inoazobenzene 
(254), 4-acetylam inobiphenyl (255) and N -hydroxy-4-acetylam ino-4*-fluorobiphenyl (256) 
form ed in vivo in ra t  tissues. This is generally  in good agreem ent w ith the adducts form ed 
by reac tion  of highly electrophillic N -0-esters of these carcinogens w ith DNA in v itro  
(254,255,256,241). However, Scribner and Naimy (257) reported  th a t sulphate and a c e ta te  
este rs  of N -hydroxy-2-acetam idophenanthrene (N-hydroxy-AAP) form ed l-(dA -N ^-yl)- 
AAP and N-(dG-8-yl)-AAP when reac ted  with DNA in v itro , w hilst in vivo no adducts in 
DNA from ra t liver w ere observed to co-chrom atograph with these products when anim als 
w ere trea ted  with AAP (258). AAP is not a hepatocarcinogen bu t is a p o ten t m am m ary 
carcinogen (259) and it  may be more p e rtin en t to investigate  AAP-DNA adducts form ed in  
the la t te r  tissue. R ecen t reports have shown th a t N -hydrbxy-l-naphthylam ine re a c ts  w ith 
DNA in v itro  by arylation and arylam ination of the 0^ position of dG (260) w hilst the
bladder carcinogen 2-naphthylam ine forms DNA adducts in dog bladder and, to  a lesser
Z 6ex ten t, the non-targe t organ liver by ary lation  of the  N -am ino group of dG and the  N -
amino group of dA, and by arylam ination of the C-8 position of dG (261), the  la t te r
adduct predom inating in the  DNA of both  tissues. 4-A m inostilbene and its  N -ace ty l and
N -m ethyl derivatives are  po ten t carcinogens in the ra t  (262) and have been shown to give
rise to as many as ten adducts in DNA isolated  from the liver of ra ts  tre a te d  w ith these
compounds (263). R eactions of the electrophillic N -acetoxy-4-acetam idostilbene and N -
hydroxy-4-am inostilbene with DNA in v itro  was shown to resu lt in alkylation of the  N -l
6  4position of dA, the 0 -position of dG and the N -am ino group of dC (264), how ever, the
relevance of such products to  carcinogenesis rem ains to  be established.
IQ) M ycotoxins:
The bifuran fungal m etabolite  AFB^ (Fig.6) has been subjected to in tense m etabolic 
investigation  due prim arily  to its  p o ten t hepatotoxic and hepatocarcinogenic p roperties. 
Much evidence im plicates AFB ^ -8,9-epoxide (formally AFB^-2,3-epoxide) as the most 
likely u ltim a te  carcinogenic and m utagenic m etabo lite  of A FB j. The 8,9-double bond is 
required  for strong carcinogenic ac tiv ity  (265) and the conversion of AFB^ (but no t AFB^,, 
its  8,9-dihydro derivative) to a  toxic, m utagenic and nucleic acid binding deriva tive  (266). 
The pred ic ted  high chem ical reac tiv ity  of AFB ^ -8,9-epoxide has resu lted  in  failu re  to 
iso late i t  from chem ical or m etabolic reac tions. However, the analog A FB j-8 ,9- 
dichloride is a  powerful electrophile and a po ten t m utagen and carcinogen (267). Several 
workers have shown th a t m icrosom al ac tivation  of AFB^ and binding to  exogenous 
(268,269) or b ac te ria l DNA (270) resu lts  in  alkylation of the  N-7 position of dG to  form 
8,9-dihydro-8-(dG-N -yl)-9~hydroxyAFB ^ . This product is subsequently re leased  from  the
DNA by acid degradation or spontaneous depurination and the m ajor D N A -adduct iso la ted
7 7is 8 ,9-dihydr o-8-(guan-N -yl)-9-hydroxyA FBj(A FBj-N  G) (Fig.28). One would expect th is
product to be lost from DNA in vivo re la tiv e ly  quickly by spontaneous depurination.
However, A FB ^-treated  cells in culture actively  repaired  the resu ltan t DNA lesions (271)
by a short patch  incision process. It was recen tly  reported  th a t adm in istration  of a single
dose of A FBj to ra ts  in  vivo resu lted  in the form ation of several DNA adducts in the liver
(272,273), how ever, the nature of the products isolated was largely  dependent on
conditions (272). Although the m ajor A FB .-D N A -adduct form ed in ra t  liver was A F B .-
7 5N G, another adduct was ten ta tiv e ly  iden tified  as 8,9-dihydr o-2-(N form yl-2 ,5 ,6-
5triam ino-4-oxopyrim idin-N  -yl)-9*-hydroxyAFB, (A FB,-triam ino-Py) (268,272) and i t  was
7proposed this adduct was a degradation product of A FB .-N  G and th a t i t  would be m ore
7 ■ • 1
stable in DNA than AFB^-N G because opening the im idazole ring would stabalise  the  
deoxyglycosidic bond (274) (Fig.30). Wang and C eru tti (275) rep o rted  th a t,  in  epithelioid
7
human lung cells 24 hours a f te r  AFB^ trea tm e n t, the m ajor DNA-adduct was AFB^-N G,
how ever, this was rapidly lost from the DNA and 48 hours a f te r  tre a tm e n t th e  major
DNA-bound product was proposed to correspond w ith A FB .-triam ino-Py . A utrup e t  al
7
(277) showed th a t AFB ^ -N G and AFB ^ -triam ino-Py were p resen t in  approxim ately  equal 
am ounts in  DNA of cultured human bronchus and colon when these tissues w ere incubated
7
with AFBj for 24 hours. R ecently  Wogan e t  al (274) reported  th a t AFB^-N G was rapidly 
lost from the  DNA of ra t liver in  vivo during a 70 hour period w hereas A FB ^-triam ino-Pyr 
was pers is ten t. The sam e workers also showed th a t when ra ts  were dosed rep ea ted ly  w ith
7
A FB j, an e ffic ien t carcinogenic regim en, AFB^-N G levels in DNA from the  livers 
decreased when dosing was ceased for a period, however, over the sam e period AFB^- 
triam ino-Py rem ained a t a  stable level and was the m ajor adduct over a period of two 
weeks. The la t te r  study (274) reported  several AFB^-DNA adducts in vivo, two of which 
w ere rela tive ly  persis ten t. The re la ted  bifuran fungal toxin s te rigm atocystin  (Fig.9) has 
recen tly  been reported  to bind to DNA in v itro , in the presence of m icrosom es, to  form
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7l,2-dihydro-2-(guan-N  -y l)-l-hydroxy-sterigm atocystin  (277), indicating th a t its  m etabolic
activation  is analogous to AFB Finally the epoxide group of the  tricho thecenes has been
im plicated  in the ir tox ic ity  (278), however, d a ta  re la tin g  to th e ir m etabolic ac tiva tion  is
7not ye t available. It is in te resting  th a t alkylation of th e  N position of guanine is 
proposed to be the prom utagenic and procarcinogenic lesion of AFB^ and s te rigm atocystin  
whilst alkylation a t this position is regarded as a  re la tive ly  unim portant lesion in 
carcinogenesis and m utagenesis by simple alkylating agents, e.g . DMN.
A Theory of Polycyclic A rom atic Hydrocarbon Induced Carcinogenesis.
The work of Sims e t al (194) estab lished  the  im portance of BPDE in the  m etabo lic  
ac tiv a tio n  of BP. The syn and an ti isom ers of BPDE are  among the  m ost m utagen ic  
compounds known (204) and anti BPDE is also highly tum ourigenic (279). T he high 
m utagen ic ity  (280) and carc inogen icity  (281,282) of B P-7,8-diol upon fu rth e r  m etabolism  
has im plicated  this as the  p rox im ate carcinogenic form  of BP which could b e  fu rth e r  
m etabolised  to  the u ltim a te  carcinogenic form  an ti BPDE.
This evidence suggested the possibility  th a t diol epoxides w ere u lt im a te  carc inogenic 
m e tabo lites  of o the r PAH . The unique s tru c tu ra l fea tu re  of BPDE is ap p aren tly  th a t  th e  
epoxide is on a  sa tu ra te d  angular benzo ring which form s p a r t  of a  s te rica lly  h indered  
region w ith a  bay-like appearance which was called  a  "bay region".
Je r in a  and D aly  (283) proposed th a t th e  high chem ical re a c tiv ity  of bay  reg ion  diol 
epoxides could be  a ttr ib u te d  to th e ir unique e lec tro n ic  p ro p erties . P e r tu rb a tio n a l 
m olecular o rb ita l calcu la tions, which p red ic t TF-electron energy changes in d ica te  th a t 
epoxides on sa tu ra te d  benzo rings which form  p a r t  of a bay-reg ion  of a  PAH undergo ring 
opening to  a carbonium  ion m uch m ore easily  than  do nonbay-region epoxides. 
F u rtherm ore , a rela tionship  was found to  ex ist be tw een  th e  carc inogen ic ity  of PAH and 
the  ca lcu la ted  energy change (A E ^ j^ /1 3 )  for the  fo rm ation  of a  carbonium  ion in th e  bay 
region (Table V)
T able V
RELATIONSHIP BETWEEN CARCINOGENICITY OF PAH AND CALCULATED ENERGY 
CHANGE RESULTING FROM FORMATION OF A CARBONIUM ION IN THE BAY 
REGION.
PAH C arcinogenicity AE , . /G* deloc
BP ++++ 0.794
BA + 0.766
benzo(e)pyrene ++ 0.738
chrysene + 0 .722
phenanthrene + 0 .714
DB(a,h)A + ++ 0.658
DB(a,c)A + 0.640
b enz o( c)phenanthr ene ++ 0.600
* D ata from  Je r in a  and L ehr (284).
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Fig.29 shows some of the recognised carcinogenic PAH. All these  po ten t carcinogens 
possess a bay region and much evidence indicates th a t BP, DMBA, 7MBA and 3MC are 
m etabolically  ac tiva ted , e ither in  mouse skin or cells in cu ltu re , to  bay-region diol 
epoxides (Fig.30) which re a c t w ith DNA (reviewed in re f . 212). R ecen tly  Slaga e t al have 
dem onstrated  th a t two o ther positions on the PAH m olecule, as illu s tra ted  in Fig.31, can 
m odulate the ir biological ac tiv ity .
d is ta l  pos i t ion
OJOIO
Peri pos i t ion
F ig u re  31 Im por tan t  pos i t ions  for b io log ica l  a c t iv i t y  of PAH
These workers showed th a t, for maximum biological ac tiv ity  an unhindered peri position is 
necessary, such th a t e.g. 5-methyl-DMBA is a w eaker tum our in itia to r  in mouse skin and 
m utagen in  m am m alian cells than DMBA (285). They also reported  th a t the  presence of a 
m ethyl group in a position distal to the bay region, e.g. 11-m ethyl-BP, increased  the 
biological ac tiv ity  of the PAH. In this re sp ec t 11-methyl-BP proved to be 3 tim es as 
p o ten t as BP for the in itia tion  of tum ours on mouse skin, (286). Several PAH which exhibit 
weak or negligable carcinogenicity  also possess a bay-region (Fig.32) and re la tiv e ly  high 
AEdeioc/®  values, and should the re fo re  be able to form bay region epoxides, or diol 
epoxides (Fig.30) which would open re la tive ly  easily to form carbonium ions a t the bay 
regions. Two groups of workers have investigated  the biological ac tiv ities  of proxim ate 
and u ltim ate  carcinogenic forms of PAH to a scerta in  the ir im portance in such ac tiv ity . 
The bay-region anti diol epoxides of phenanthrene, chrysene and BA w ere found to be 
more active than the parent hydrocarbons as b ac te ria l m utagens (287,288) and as 
pulmonary carcinogens in newborn m ice (289,290). U nfortunately  the  synthesis of bay- 
region diol epoxides of the m ore biologically active  PAH such as DMBA and 3MC has not 
yet been achieved in pure form , how ever, the proxim ate carcinogens of such PAH, nam ely 
the dihydrodiols which can be m etabolically  ac tiv a ted  to bay-region diol epoxides, have 
been synthesized in pure form . In general proxim ate carcinogens of m any carcinogenic 
PAH are more biologically active than the parent hydrocarbon (Table VI ) (reviewed in 
reference 291). It was of in te res t th a t the proxim ate carcinogens derived from  the  
weakly carcinogenic chrysene and BA can be m etabolically  ac tiv a ted  to po ten t b ac te ria l
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m utagens and are highly tum ourigenic on mouse skin (Table VI). The proxim ate 
carcinogens derived from benzo (e)pyrene are only weakly m utagenic and tum ourigenic in 
the  sam e type of assay. The bay region theory  predicts th a t bay-region epoxides of BA, 
benzo(e)pyrene and chrysene should open to form carbonium ions in the bay region and 
exhibit high energy changes (Table V). Why then are  these PAH not p o ten t carcinogens?
M acNicoll e t al (292) reported  th a t BA-DNA adducts form ed in mouse skin or cells in 
cu lture  following trea tm e n t w ith the hydrocarbon, or in m icrosom al incubations 
containing the  hydrocarbon and DNA, involved both diol epoxides in th e  1,2,3,4 region (bay 
region) and also the  8,9,10,11, region (see Fig.32). I t may well be, the re fo re , th a t th e  low 
carcinogenicity  of BA is d irec tly  re la ted  to a lack  of m etabolism  to its  bay-region diol 
epoxides.
The proxim ate carcinogen from benzo(e)pyrene, the  9,10-dihydrodiol, is analogous to  9,10- 
dihydro-9,10-dihydroxy-benzo(a)pyrene (BP-9,10-diol) in th a t i t  exists in  a  bay region. BP- 
9, 10-diol exists in  a  quasidiaxial conform ation due to s te ric  h inderance a t  the bay region 
(Fig.33).
•  =OH
B P - 9 , 1 0 - d i o lBenzo(e) p y r e n e -  9 , 1 0 -  diol
F igure  33 C on fo rm a t io n s  of Dihydrodiols of PAH
R ecent workers have shown th a t metabolism  of BP-9,10-diol does not go via diol epoxides 
by epoxidation of th e  7,8-double bond (293,294) (Fig.29), whilst BP-7,8-diol, which ex ists 
in  a  quasidiequatorial conform ation (Fig.33) is m etabolised to diol epoxides (194,202). The 
9,10-dihydrodiol of benzo(e)pyrene exists in a quasidiaxial conform ation (Fig.33) and as 
such (c.f. BP-9,10-diol) is not m etabolised to diol epoxides (295). 9>10-Dihydro- 
benzo(e)pyrene can be m etabolically  ac tivated  to a  po ten t m utagen (295) and carcinogen 
(296) probably by m etabolism  to a bay region 11, 12-epoxide which is p red ic ted  to be highly 
reac tiv e  (Table V), however, benzo(e)pyrene is m etabolised predom inantly  to its  K -region
4,5-dihydrodiol and not to bay-region m etabolites (297). T herefo re , both a lack  of 
m etabolism  a t the bay region and the conform ation of such m etabo lites explain why li t t le  
benzo(e)pyrene is m etabolised to bay-region epoxides and as a resu lt i t  exhibits weak 
tum ourigenicity.
Very recen tly  in te res ting  developm ents have em erged concerning the PAH 
benzo(c)phenanthrene (Fig.34).
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Figure 34 B e n z o (c )p h en an th ren e
This environm ental pollu tan t has a highly hindered bay region betw een carbon atom s one 
and tw elve and this enclosed area  has been term ed  the  "Fjord region" (298). The high 
degree of s te ric  crowding was suggested to a f fe c t the p referred  conform ation of its  F jord 
region diol epoxides and it  was reported  th a t both d iastereom eric  3,4-dihydro d io l-1,2- 
epoxides (anti and syn, benzylic hydroxyl group and epoxide oxygen trans and cis 
respectively) p referred  the  conform ation in which the  hydroxyl groups are  
quasidiequatorial. In the past, only anti diol epoxides, which have this p re fe rred  
conform ation, had been found to possess high tum ourigenic ac tiv ity . Both anti and syn 
benzo(c)phenanthrene Fjord-region diol epoxides were found to  have very  high m utagenic 
activ ity  tow ard m am m alian and b ac te ria l cells and are the m ost p o ten t diol-epoxide 
tum our in itia ting  agents yet te s ted  in the mouse skin papillom a model (298). These F jord- 
region diol epoxides are  re la tive ly  stab le  in aqueous solution and probably less polar than 
the corresponding bay-region diol epoxides of BP. These fac ts  could explain th e ir high 
tum ourigenicity  com pared to an ti and syn BPDE.
d) C ritica l C ellular T argets of Chem ical Carcinogens
I) P ro te in
II) Ribonucleic Acid
m ) D eoxyribonucleic Acid
I) P ro te in :
Since the early work dem onstrating the binding of am ino-azo-dyes to  liver p ro teins (62) 
many chem ical carcinogens have been shown to  bind to  pro teins (174). The finding th a t 
carcinogenic hydrocarbons also showed p re fe ren tia l binding to  a p a rticu la r p ro tein  
frac tion  (299) toge ther with the discovery of repressor pro teins (300) provided additional 
support for the "protein deletion" theory.
S or of and Young (301) identified  a  p ro tein  of m olecular weight 88,000 known as the  slow 
5S p ro tein  which bound am ino-azo-dyes in the  liver, whilst K e tte re r  e t  al (302) identified  
two fu rther carcinogen binding proteins in r a t  liver. The firs t, ligandin, is a dim er of 
m olecular w eight 45,000 since charac terised  as g lutathione transferase  B (303). Ligandin 
can bind a number of substrates both covalently  and non-covalently (304) and m akes up 
4.5% of soluble liver p ro te in  (303). Both slow 5S p ro tein  and ligandin are  known to  bind 
3MC. K e tte re r 's  group (302) also characterised  a p ro tein  from ra t  liver of approxim ate 
m olecular weight 14,000 which had sim ilar binding ch a rac te ris tics  to  ligandin. This 
p ro te in  does no t possess any glutathione transferase  activ ity  and can be frac tio n a ted  into 
th ree  com ponents by isoelectric  focusing.
Tokam a and Terayam a (305) proposed th a t an am ino-azo dye binding p ro te in  in r a t  liver 
was alcohol dehydrogenase. I ts  physical p roperties  resem bled those of ligandin, slow H 
pro te in  and alcohol dehydrogenase.
Numerous carcinogens have been reported  to bind to nuclear p ro teins (306) especially  in 
r a t  liver. Such in teractions are  im portan t in th a t these proteins are  in tim a te ly  associated  
with the genetic  m ateria l. i
R ecently  T oft and Spelsberg (307) reported  the isolation of a lung p ro te in  th a t binds 3MC 
and DMBA covalently.
Chem ical carcinogens can be m etabolised to electrophilic  species which in te ra c t with 
nucleophilic cen tres in protein . Such cen tres  are the sulphur atom s of m ethionine and 
cysteine, the basic amino and ring nitrogen groups of lysine and histidine respectively , and 
the alcoholic and phenolic hydroxyl groups of serine and tyrosine respectively .
The level of binding of chem ical carcinogens to proteins is very low such th a t 
H eidelberger (299) indicated  th a t PAHs reac ted  with only one in 170 soluble p ro te in  
m olecules in mouse skin. Thus a high degree of specific ity  of a tta c k  on a p articu la r 
p ro tein  would be necessary to explain carcinogenesis, and the ubiquitous d istribu tion  of 
pro teins with sim ilar ta rg e t sites available is suggestive of nonspecific binding. One can 
also envisage th a t m odification of a p ro te in  m ust occur a t a c ritic a l position, e ith er 
s tru c tu ra l or cata ly tic , to  a lte r its  biological activ ity . The te r tia ry  s tru c tu re  of many 
pro teins serves to p ro tec t such sites. In addition several chem icals, e.g. iodoacetam ide, 
are known to re a c t extensively with proteins (but not nucleic acids) and are  not usually 
carcinogenic (308).
The above evidence indicates th a t the binding of chem ical carcinogens to  p ro te in  may be 
a necessary  but no t c ritica l event in chem ical carcinogenesis, and th a t such binding may 
be, a) a consequence of nucleophilic cen ters in the p ro tein  being random ly exposed to 
electrophilic  m etabolites, or b) a detoxication  rou te  for the rem oval of p o ten tia lly  toxic 
m etabolites, e.g. ligandin (glutathione transferase  B) binds a v arie ty  of su b stra tes  largely 
a t cysteinyl residues.
II) R ibonucleic acid:
Since the dem onstration by Brookes and Lawley (183) th a t PAH could bind to  RNA in 
mouse skin, many chem ical carcinogens giving rise  to  electrophilic  m etabo lites have been  
shown to bind to  the nucleophilic bases of RNA (309). C ellular RNA's play a  key ro le as 
m ediators in the transfer of genetic m ateria l betw een DNA and pro tein . When techniques 
becam e available to separate  the d iffe ren t types of RNA Fink e t al (310) showed th a t N - 
acetoxy-AAF reac ted  with ce rta in  tRNA’s. The resulting  nucleic acids w ere less ac tive  a t 
accepting ac tiva ted  amino acids, binding to ribosom es and recognising codon functions. 
Chem ical carcinogens tend to  re a c t w ith the  sam e position or group in the equivalent 
bases of RNA and DNA (see la ter). G runberger and W einstein (252) m ade extensive 
studies of the s tru c tu ra l m odifications in RNA's by ac tiv a ted  form s of AAF. This 
carcinogen binds to the C-8 position of guanine and displaces the base from its  norm al 
planar position. This was term ed the "base displacem ent" model. I t  was also found th a t 
N -acetoxy-A A F only modified guanine residues th a t are in single strand  regions of tRNA 
m olecules and are exposed to  the exterior.
Margison e t al showed tha t base specific excision repair does not exist for alkylation 
products form ed in ham ster liver ribosom al RNA in vivo following adm inistration  of DMN 
(311). Thus, it  would seem th a t such lesions do not provoke a p ro tec tiv e  response from 
the cell and this supports the hypothesis th a t the excision of DNA-bound products is an 
im portan t fac to r in the p ro tec tion  of tissues against carcinogenesis by alkylating agents.
The work of W einstein e t al (312) dem onstrated  a very low m odification of tRNA's by 
several carcinogens such th a t only one in 300-600 such molecules would be m odified. 
T herefore, i t  is unlikely th a t so few m odifications in molecules of which th e re  are  many 
copies, and of which more may be readily  synthesized from the respective  genes, would 
resu lt in the in itia tion  of carcinogenesis.
m  Deoxyribonucleic acid:
The m utation theory of cancer (51,52) im plies a d irec t a lte ra tio n  of DNA is necessary  to  
in itia te  m alignant growth. Most chem ical carcinogens are also m utagenic tow ard 
b ac te ria l (313) and m ammalian (314) cells, and m ost workers now agree th a t th e re
is a d irec t re la tionship  betw een  m utagenesis and carcinogenesis. F o r many chem ical 
carcinogens a  good co rre la tion  ex ists b e tw een  e x te n t of reac tio n  w ith  DNA and 
carcinogenesis, in a  suscep tib le  tissue (315).
C e rta in  hum an individuals su ffer from  inhe ritab le  conditions, no tab ly  xeroderm apigm ento  
sum, ch a rac te rised  by a  defect(s) in ce llu la r DNA rep a ir  (67). Such persons a re  
p articu la rly  prone to  develop skin tum ours when exposed to  prolonged periods of TJV 
irrad ia tio n  (sunshine).
C hem ical carcinogens re a c t  w ith a  v a rie ty  of s ite s  in DNA and every  base  is m odified to  
some e x te n t by one or m ore groups of chem icals as illu s tra ted  in T able V II(review ed in  
re f . 316). C erta in  positions on the  bases a re  involved w ith the  fo rm ation  of hydrogen 
bonds to  cause base repairing  (Fig.35).
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Figure 35 Base pai r ing in DNA
B ase-pairing stabalises  the  double helix  of DNA and th e re fo re , any chem ica ls which 
re a c t w ith th e  H-bonding positions on th e  bases, e.g . th e  exocyclic am ino groups 
of dG and dA, will w eaken the  base-pairing  and possibly cause localised  regions of 
helical destabalisa tion . If a  d isto rtion  of th e  helix  occurs, as when AAF is bound 
to  the C-8  position of dG, enzym es can recognise this and excise th e  re le v an t bases, 
i.e ., the  tissue p ro tec ts  its  genetic  m a te ria l against m odification . I t has also been  
shown th a t a  specific  rep a ir  m echanism  exists to  excise 0 -alkyldeoxyguanosine adducts 
from  th e  DNA of various tissues (229), and th a t the  pers is tence  of th e se  lesions in 
p a rticu la r tissues is positively  co rre la ted  w ith the fo rm ation  of tum ours in  th a t tissue . 
Brain tissue of ra ts  slowly excises O ^-ethyldeoxyguanosine from  its  DNA follow ing 
tre a tm e n t in vivo w ith  ethy ln itrosourea  (317) and consequently  the  nervous system  
is a  ta rg e t for carcinogenesis by such agen ts. For th e  m ajo rity  of chem ical carc inogens 
the rela tionsh ip  betw een chem ical reac tio n  w ith DNA and m olecular b io logical e f fe c t  
are  less w ell understood.
Alm ost all studies w ith DNA and chem ical carcinogens have focused on to ta l  tissue  
or organ DNA. Alm ost all of th is is nuclear DNA and i t  is usually assum ed th a t  w hat 
is being exam ined in  studies on cellu lar DNA is nuclear m a te ria l. H ow ever, W underlich
Table VH. MODIFICATION OF DEOXYRIBONUCLEOSIDE BASES IN DNA BY CHEMICAL 
CARCINOGENS
Carcinogen or 
u ltim a te  carcinogen
Modified bases 
dG dA dC dT
an ti BPDE N2 N6 N4
7-BrMeBA N2 N6 N4
N -acetoxy-A A F N2,C-8
N -acetoxy-A A P C-8  N6
N-hydroxy-1- 06
-naphthy lamine
2-naph thy 1 amine N2,C-8  n
N -m ethyl-4-am ino- N2,C-8
-azobenzene
4-acetylam inostilbene 06 N 1 , N4
AFBX N7
8-propiolactone 7 3 N NJ
DMN n 7 ,o6,n 3 N3 N1 (04)
1,2-dim ethy lhydrazine n 7,o6, n 3
3-m ethy l-l-pheny l- n 7,o6, n 3
triazene
1-ace toxysafro le 06
(reviewed in re f . 316).
e t al reported  th a t both  m ethylnitrosourea (318) and DMN (319) when in jected  into ra ts  
reac ted  p referen tia lly  with m itochondrial DNA in the  liver. R ecen tly  B acker e t  al showed 
th a t m itochondrial DNA is a m ajor cellu lar ta rg e t for anti BPDE (320), the  proposed 
u ltim a te  carcinogen form of BP.
In conclusion, DNA is the la rgest molecule in the cell and is the re fo re  a re la tive ly  lsurge 
ta rg e t for reac tive  species. There is only one copy of DNA and th e re fo re  any 
m odifications or dam age to its  s truc tu re  or function, if not repaired , can be inherited  
during replication. DNA is highly nucleophilic and a particu la rly  susceptible ta rg e t for 
e lectrophilic  species genera ted  during cellu lar m etabolism . This, toge ther w ith the 
p resen t view th a t one stage of tum our prom otion involves gene activation , im plicates 
DNA as the probably c ritica l cellu lar ta rg e t of u ltim a te  chem ical carcinogens.
The Scope, R elevance and Aims of the P resen t Investigations
BP is a ubiquitous environm ental po llu tan t, a m ajor com ponent of c ig a re tte  smoke and is 
p resen t in rela tive ly  high concentrations in smoked or charcoal broiled  food (102). 
P recancerous lesions w ere found in human skin a f te r  topical application of BP in vivo 
(321). BP was reported  to be the  m ajor PAH found in human bronchial carcinom a 
specim ens and was p resen t in rela tive ly  high concentrations com pared to  adjoining 
"normal" tissue (322). Thus BP is probably causally re la ted  to human lung and skin cancer. 
Whilst one could feasibly stop human co n tac t w ith BP, this would probably m eet w ith 
much public resistance. T herefore while we are exposed to  this carcinogen, i t  is re levan t 
to understand it’s chem ical and biological mode of action.
The presen t study has investigated  the form ation of BP-DNA-bound products following 
m etabolic activation  of BP in several biological system s. The investigations have involved 
tissues both  susceptible (mouse lung and skin; r a t  lung) and res is tan t (ra t skin and liver) to 
the carcinogenic action of BP, and have u tilized  whole animals, tissue explants, iso lated  
cells and subcellular fractions from several tissues.
The p resen t study was undertaken to ascerta in  w hether d ifferences in species and tissue 
susceptib ility  to BP-induced carcinogenesis is re la ted  to the form ation of p a rticu la r  DNA- 
bound products of BP.
MATERIALS
AND
METHODS
Animals
Male W istar Albino ra ts  (bred a t the U niversity of Surrey), Fem ale Swiss, DBA/2 and 
C57BL/6 m ice (Bamtin and Kingman L td ., Grimston, Aldborough, Hull, N orth  H um berside, 
U.K.) and m ale A s tra in  m ice (London H ospital M edical College, London, U.K.) m aintained 
on in e rt bedding (Tolsa bedding, T rouspacet, Spain) or wood shavings w ere used w here 
s ta ted . All anim als w ere allowed food (Spillers No. 1 laboratory  diet) and tap w ater ad 
libitum  and m aintained under conditions of constan t tem pera tu re  (22°c), hum idity (50%) 
and lighting (12 hour cycle).
Chem icals
3G enerally tr i tia te d  BP (S.A. 16-56 Ci/mMole) and dA (S.A.25Ci/mMole) and 8-( H)-dG
(S.A. 2.6 Ci/mMole) were obtained from The Radiochem ical C entre , A m ersham ,
Bucks, U.K., a t 97.99% purity  and used w ithout fu rther purification . U nlabelled BP was
obtained from Koch-Light L aboratories, Colnbrook, Bucks, U.K. and used as such.
Glucose-6-phosphate, 3MC, dA, dG, calf-thym us DNA, hydrocortisone, re tin y l a c e ta te ,
insulin (ex. beef pancreas), collagenase Types I and 31 (EC 3.4.24.3.), hyaluronidase Type II
(EC 3.2.1.35.) and alkaline phosphatase Type HI (EC 3.1*3.1.) w ere obtained from  the
Sigma Chem ical Company, Poole, D orset, U.K. NADP, glucose-6-phosphate
dehydrogenase Grade I (EC 1.1.1.49.), deoxyribonuclease I Grade H (EC 3.1.4.5.) and snake
venom phosphodiesterase (EC 3.1.4.1.) w ere obtained from the  Boehringher Manheim
Chem ical Company (BCL), Lewes, E ast Sussex, U.K. Ribonuclease A was obtained
through Millipore U.K. L td., Abbey Road, London, U.K. Gelfoam sponge was obtained
from the Upjohn Company, Crawley, Sussex, U.K. Leibovitz L-15 cu ltu re  medium was
obtained from Flow Laboratories, Irvine, Ayrshire, U.K. and foe ta l ca lf serum  from Sera
«
Laboratories, Crawley Down, Sussex, U.K. CMRL-1066 culture medium and penicillin-
streptom ycin  solution were obtained from G ibco-Biocult L td .,Paisley , Glasgow, U.K.
Sephadex LH-20 was obtained from P harm acia  F ine Chem icals, Uppsala, Sweden and
M etapol from Durham Chem icals D istributors L td., B irtley, Tyne and Wear, U.K.
Generally tr itia te d  9-0H-BP (S.A. 3.82 Ci/mMole), BP-7,8-diol (S.A. 298mCi/mM ole), B P-
144 ,5- epoxide, (S.A. 366mCi/mMole), an ti BPDE (S.A. 466mCi/mMole) and 7-( c)~ syn BPDE 
(S.A. 50.9mCi/mMole) together with the ir respective  unlabelled m etabo lites and B P-4,5- 
diol and TPA w ere kindly provided by the Chem ical Repository, N ational C ancer In s titu te , 
Carcinogenesis R esearch Program , Bethesda, MD, U.S.A. R adioactiv ity  determ inations 
were made using a scin tillation  cocktail containing, in 5ml, 25mg PPO (2,5- 
diphenyloxazole), lm g  dim ethyl P0P0P (l,4-bis-(2-(4-m ethyl-5-phenyloxazolyl)-benzene) ), 
1.67ml m etapol and 3.33ml toluene. All o ther chem icals w ere AR grade or of the  h ighest 
available purity.
Equipm ent
U ltrav io le t (UV) spectroscopy was perform ed using a Pye-U nicam  SP 1800 UV-visible 
spectrophotom eter (Pye-Unicam L td., York S tree t, Cam bridge, U.K.), and fluorescence 
sp ec tra  w ere obtained using a Perkin-E lm er MPF-3 fluorescence spectrophotom eter 
(Perkin-Elm er L td ., P ost O ffice Lane, Beaconsfield, Bucks, U.K.). High speed 
cen trifugation  was achieved using High Speed 18 and Super Speed 50 cen trifuges (M.S.E. 
L td ., Crawley, Sussex, U.K.), or a Beckm an Model L5-65 u ltracen trifu g e  (Beckman RUC 
L td., High Wycombe, Bucks, U.K.). C hrom atographic separations w ere perform ed using 
e ither a 120cm Wright column system  (Wright Scien tific  L im ited, Kenley, Surrey, U.K.), 
and a Watson-Marlow variable p e ris ta ltic  pump (Watson-Marlow L td ., Falm outh, Cornwall, 
U.K.), to deliver solvent onto the column, or a L aboratory  D ata  C ontrol (Laboratory D ata  
Control, Stoke, S taffordshire, U.K.) high pressure liquid chrom atograph f it te d  with 
constam etric  I, II and HE solvent delivery system s, a 254nm UV m  m onitor (model 1203), 
an u ltra -rac  fraction  co llecto r (LKB Instrum ents L td., Selsdon, South Croydon, Surrey, 
U.K.), and a  W aters uBondapack column (0.39x30cm, octadecylsilane, W aters A ssociates, 
Milford, MA, U.S.A.) f it te d  with a precolum n (5x0.21 cm, octadecylsilane, W hatman 
Incorporated, M aidstone, Kent, U.K.). Liquid Scin tillation  counting was perform ed  using 
e ither a P ackard  T ri-carb  Scintillation S pectrom eter Model 3320 (Packard Instrum ent 
L td ., Caversham , Berks., U.K.) or m ore frequently  a R ackbeta  Scin tillation  S pectrom eter 
Model 1216 (LKB Instrum ents L td., Selsdon, South Croydon, Surrey, U.K.). 
Homogenisations of mouse and ra t skin were perform ed using an A tom ix blender (M.SJE. 
L td., Crawley, Sussex, U.K.) and a Poly tron  PT-10-0D hom ogeniser (N orthern M edia 
Supply Lim ited, Hull, N orth Humberside, U.K.). S hort-term  organ culture  of r a t  lung was 
perform ed using a Bellco incubator Model 7741-10010 and Bellco R ocker p la tfo rm  Model 
6K2-1083 (supplied through R.A. Horwell L td ., Kilburn, London, U.K.).
P rep ara tiv e  Methods 
I. Subcellular Experim ents
a) P repara tion  of r a t  liver and lung m icrosom es:-
Male W istar Albino ra ts  (100-150g) received  daily in traperitoneal injections of 3MC 
(20mg/Kg) in corn oil for 3 days to induce m icrosom al MFO activ ity . On the fourth day 
the anim als w ere killed by cerv ical dislocation and the livers and lungs im m ediately  
excised and placed in ice-cold  1.15%(w/v)KCl. A pproxim ately 9g of liver or 3g of lung 
w ere scissor minced and homogenized in 4 vols. of 0.1M potassium  phosphate b u ffe r pH 
7.6, containing 1.15%(w/v)KCl, using a P o tte r-E lveh jem  hom ogenizer w ith a  te flon  pestle . 
The hom ogenates w ere centrifuged  a t 15,000xg for 20 m inutes a t 4 °c  and the resu lting  
supernatan t fractions centrifuged a t 105,000xg for 60 m inutes to  produce m icrosom al 
pelle ts . These w ere resuspended in 30% glycerol/0.25m  potassium  phosphate bu ffer, pH
7.4, to  an approxim ate pro tein  concentration  of 20m g/m l. P ro te in  con ten t was 
determ ined by the m ethod of Lowry e t al (323) using crystalline bovine serum albumin as 
standard.
b) P repara tion  of mouse skin m icrosom es:-
C57BL/6 m ice (9-10 weeks of age) w ere shaved on their backs two days p rio r to  
trea tm en t. 3MC (500 nmoles) in acetone (0.2ml) was applied to the  shaved areas 24 hours 
prior to isolation of m icrosom es to  induce m icrosom al MFO ac tiv ity . The anim als w ere 
killed by cerv ical dislocation and the tre a te d  areas of skin rem oved and crushed to powder 
in liquid n itrogen using a m ortar and pestle . The powder was hom ogenised in 65mM T ris- 
HC1 buffer, pH 7.3, containing 1.15%KC1 (4ml/skin). This required  several 
hom ogenizations and a 30 second burst of a  polytron hom ogenizer (setting  4) to  ensure 
hom ogeneity. The hom ogenate was centrifuged a t 10,000xg for 20 m inutes a t 4 °c  and th e  
resulting supernatant fraction  centrifuged a t 105,000xg for 60 m inutes a t 4 °c  to  produce a 
m icrosom al pelle t. This was resuspended in 20mM Tris-H Cl buffer, pH 7.4, containing 
0.25M sucrose to an approxim ate concentration  of 15 m g/m l and p ro te in  was determ ined  as 
before (323).
3c) M icrosom e-m ediated binding of ( H)BP to DNA::-
M icrosomal incubations were perform ed essentially  as outlined by Grover and Sims (184)
and modified by Boobis and N ebert (324). R eaction  m ixtures contained calf-thym us DNA
(20mg) dissolved in w ater (5ml), co fac to rs (NADP, 7umol; glucose-6-phosphate, 100 umol;
glucose-6-phosphate dehydrogenase, 3.5 units), and in some experim ents, magnesium
chloride (various concentrations). M icrosomes (4mg of protein) w ere added and finally
potassium  phosphate buffer, pH 7.5, to  a concentration  of ImM in a final volum e of 8ml
(skin m icrosom al experiments) or 10ml (liver and lung m icrosom al experim ents). The
3reac tion  was s ta rted  by adding 160nmol of ( H )-B P,lm C i, (skin m icrosom al experim ents) 
3
or 42nmol of ( H )-BP,lm Ci (liver and lung m icrosom al experim ents) in ace tone (200ul). 
The incubations were perform ed in a shaking w ater ba th  a t 37 °c  for 30 m inutes in subdued
light. R eactions w ere te rm inated  by placing the flasks on ice and the  m icrosom al p ro te in
was sedim ented by centrifugation  a t 105,000xg for 60 minutes a t 4°c.
3
In some experim ents ( H)BP m etabo lites such as 9-0H-BP (447nmoles;3.82Ci/mMole) and 
BP-7,8-dioI (525nmoles; 298mCi/mMole) or unlabelled 9-0H-BP (1.25umoles) rep laced  BP 
in ra t  liver m icrosom e m ediated  DNA reactions. The incubations, DNA isolation and 
purification  w ere perform ed exactly  as described for BP. DNA sam ples w ere sto red  a t -  
20°c  until analysis.
d) Isolation and purification  of DNA:-
C ontam inating m icrosom al p ro te in  was rem oved from the DNA using a sodium dodecyl 
sulphate/sodium  chloride procedure originally devised by Kay e t  al (325) and m odified by 
Pelkonen e t  al (326). The DNA solution was ex tra c ted  with d iethyl e th e r  (3x1 vol. shaken 
vigorously by hand for 3 m inutes during each extraction) and the layers separated  by 
cen trifugation  (1500xg for 5 minutes). A fte r the final ex trac tion  excess e th er was 
rem oved from the  DNA solution using a  stream  of nitrogen. Sodium chloride (0.4g) was 
then  dissolved in the solution. DNA was p rec ip ita ted  by the addition of 96% (w/v) ethanol 
(2vol.) and the  DNA rem oved on a glass rod and washed in 96% ethanol overnight. The 
DNA was dissolved in w ater (10ml) and 0.46m l of a solution containing 5% (w/v) sodium 
dodecyl sulphate (SDS) in 45%(v/v) ethanol was added. A fte r mixing for 1 hour, sodium 
chloride (0.32g) was dissolved in the DNA solution and p rec ip ita ted  p ro te in  im purities 
w ere sedim ented by centrifugation  a t  12,000xg for 60 m inutes a t room tem p era tu re . The 
supernatan t W e is  rem oved and 96% (w/v) ethanol (1vol.) was added. The p rec ip ita ted  DNA 
was washed in 96% (w/v) ethanol (2vol.) for 2-3 hours,then, washed in ace tone  (1.5 vol.) and 
finally le ft to dry overnight in air. The DNA was dissolved in w ater (10ml) and sodium 
chloride (0.08g) dissolved in the DNA solution. As before, p rec ip ita ted  p ro te in  im purities 
w ere sedim ented by centrifugation  a t 12,000xg for 60 m inutes a t room tem pera tu re . 
Sodium chloride (0.44g) was dissolved in the supernatan t and then 96% (w/v) ethanol added 
(1vol.). The p rec ip ita ted  DNA was washed in 96% (w/v) ethanol (2vol.) for 3 hours, washed 
in acetone (1.5 vol.) and finally dried overnight in air. The re su ltan t DNA contained less 
than 1% protein , as determ ined by the m ethod of Lowry e t al (323).
n) H epatocy te  Experim ents
a) P repara tio n  of viable ra t  hepatocy tes:-
Where necessary  to induce m icrosom al MFO activ ity  anim als w ere in jec ted  daily for 3 
days with 3MC (20mg/Kg) in corn oil. When using ra ts  p re tre a te d  in th is way, 6 anim als 
w ere used. In experim ents using control anim als 4 ra ts  w ere used.
H epatocytes w ere p repared  by enzym ic dissociation of liver slices essentially  as described 
by F ry  e t ad (327). The anim als w ere killed by cerv ical dislocation and the liver rem oved 
as separa te  lobes and placed in phosphate buffered  saline (PBSA). The lobes w ere cu t in to  
approxim ately 0.5mm thick slices using a m icrotom e blade (British A m erican O ptical 
Company, Slough, Bucks, U.K.) previously degreased with carbon te trach lo ride . The slices 
from one liver w ere washed with PBSA (3x10 ml) and then  PBSA + ethylene glycol-bs-( -  
am inoethyl e th e r)-N ,N '-te traace tic  acid (2x10ml) in a shaking w ater ba th  a t 37°c. The 
medium was rem oved and rep laced  by 10ml of Hanks basic sa lt solution containing 
collagenase (5mg), hyaluronidase (lOmg) and 250mM calcium  chloride (0.2ml), th e  pH 
being adjusted to pH 7.5 using 2.8%(w/v) sodium bicarbonate . The liver slices w ere 
incubated with this medium for 60 m inutes in a shaking w ater b a th  a t 37°c . The resu lting  
cloudy solution was strained  through a single layer of bolting cloth  (Nybolt, 125um pore 
size, John S tan ier and Co., M anchester) with constan t ag ita tion  to  com plete cell 
dissociation. The f i l tra te  was centrifuged  a t 50xg for 1 m inute a t room tem p era tu re  and 
the resulting cell pe lle t washed with PBSA (3x10ml) and recen trifuged  as before, a f te r  
each  washing. The cells from 6 (3MC p re trea ted ) or 4 (control) anim als w ere resuspended 
in 30ml of Leibovitz L - l5 cu lture  medium containing 2mM glutam ine and 10%(v/v) fo e ta l 
calf serum. Cell v iability  was assessed by trypan blue exclusion, in con tro l cells this was
i
>90% but in cells from 3MC p re tre a te d  anim als v iability  decreased  to  >80% . T o ta l viable 
cell yields were determ ined m icroscopically w ith an im proved N eubauer counting 
cham ber.
3b) Incubation of hepatocy tes with ( H)BP:-
The cells w ere preincubated for 5 m inutes in a shaking w ater ba th  a t 37 °c  and 
BP(55um;4.2Ci/mMole) was then added in N ,N -dim ethylform am ide (DMF) (300ul) and 
incubation continued for 30 or 80 m inutes. This concen tration  of DMF or BP was no t 
toxic to the cells during the  incubation period. A t the end of the incubation the  cells 
w ere sedim ented by centrifugation  a t lOOOxg for 15 m inutes a t room tem p era tu re  and the  
medium rem oved and frozen a t -20°c. DNA was iso la ted  from the cell p e lle t.
c) E x traction  of DNA from hepatocy tes:-
A brief outline of the procedure is shown in Fig.36.
The cell pe lle t was im m ediately resuspended in 5ml of ice-co ld  6% (w/v) sodium p - 
am inosalicylate containing 1%(w/v) sodium chloride and DNA ex tra c ted  essentially  as
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described by Diamond e t al (328). To the cell suspension was added 10%(w/v)SDS (0.1vol.) 
and the m ixture shaken vigorously for 2-3 m inutes. When th e  cell suspension becam e 
viscous owing to  cell lysis, an equal volume of phenol m ixture (500:70:55:0.5, phenol/m - 
c:resol/w ater/8-hydroxyquinoline,w/w) was added and the m ixture ex tra c te d  for 40-60 
m inutes. The layers were separated  by cen trifugation  a t 3000g for 20 m inutes a t room 
tem peratu re , the aqueous layer rem oved and 30% (w/v) sodium chloride (0.1 vol.) was 
added. This was re -ex trac te d  with phenol m ixture (0.5 vol.) as befo re  and the phases 
again separated  by centrifugation. DNA was p rec ip ita ted  from th e  aqueous layer by the 
addition of 2-ethoxyethanol (1 vol.) and dissolved in 2-3m l of 0.01M potassium  phosphate 
buffer, pH 7.3. R ibonuclease (590 un its/m l of DNA solution) was added and incubation 
continued for 30 m inutes a t 37 °c. A t the end of the incubation 2.5M potassium  phosphate, 
pH 7.2 (1 vol.) was added, followed by very cold (-20°c) 2-m ethoxyethanol (0.5 vol.). The 
m ixture was shaken vigorously and kep t cool by frequent im m ersion in ice. E x trac tio n  
was continued by vigorous shaking for 10-15 m inutes and then the  layers separa ted  by 
cen trifugation  a t 2000xg for 20 m inutes a t room tem peratu re . The aqueous layer was 
carefully  rem oved and l%(w/v) cetyltrim ethylam m onium  brom ide (0.5 vol.) added to  it. 
The p rec ip ita ted  DNA was washed with w ater (6-8 times) and converted  back to  the 
sodium salt with 2%(w/v) sodium a c e ta te  in 70% (v/v)ethanol (3x10ml). The DNA was 
washed with 96%(w/v)ethanol (4x15ml) and diethyl e th er (2x15ml) befo re  finally being 
dried in a  s tream  of n itrogen  gas. Samples w ere sto red  a t -20°c  un til analysis.
HE) S hort-term  explant cu lture of r a t  lung
a) P repara tion  of r a t  lung explants:-
Male W istar Albino ra ts  (150-180g) w ere killed by cerv ical d is lo c a tio n  and the  lungs
excised and im m ersed in Leibovitz L-15 cu lture medium. The surfaces of 40 p lastic  p e tr i-
dishes were prepared  by scratch ing  2 sm all areas on opposite sides of the dish with a
3
scalpel. P ieces of Gelfoam sponge m easuring approxim ately 5mm , which had previously 
been  soaked in Leibovitz L-15 cu lture medium a t 37 °c, w ere p laced  on the abrasive
surfaces, i.e . two sponges per dish. The lungs w ere cu t in to  sm all p ieces weighing
approxim ately lOmg and 5 explants were placed in each dish, 3 on one sponge and 2 on the  
o ther. CMRL-1066 culture medium (2.5ml) containing 5%(v/v) fo e ta l ca lf serum , insulin 
(lug/m l), hydrocortisone (O.lug/ml), re tiny l a c e ta te  (0.lug /m l), penicillin  (100 units/m l) 
and strep tom ycin  (lOOug/ml) was placed on each dish. The dishes w ere p laced  in  a  Bellco 
incubator and gassed with filte red  96% 0^:5% CO^ un til the medium was approxim ately pH
7.4. The incubator was p laced on a Bellco rocker p la tfo rm  m aintained a t 37°c  rocking a t 
10 cycles/m inute for 18 hours so th a t the explants w ere in the medium for 50% of each 
cycle.
b) Incubation of ra t  lung explant cultures with ( H)BP:-
A fte r 18 hours cu lture the dishes w ere rem oved from the incubator and the medium from 
each dish decanted and rep laced  with 2.5ml of the same medium containing ( H)-BP 
(2uM;50uCi/dish). The tissues were then cultured as before a t 37°c for 24 hours, a f te r  
which the medium from each dish was decanted, pooled and frozen a t -20°c  prio r to  
analysis of B P-m etabolites. The explants from each of the  40 dishes w ere pooled and k ep t 
on ice. C ontrol tissue was taken fresh, then a t 18 hours and finally a t 42 hours for
histology to assess tissue viability  throughout the experim ent.
c) E x trac tion  of DNA from ra t lung explants:-
The 40 explants w ere suspended in ice-cold  6% sodium p-am inosalicy late : 1% sodium 
chloride(w/v) (10ml) and homogenised with a  polytron hom ogeniser a t se tting  2 for 30 
seconds. 10% (w/v) SDS was added to com plete cell lysis and the m ixture shaken 
vigorously for 2-3 minutes. A small sam ple (0.5ml) o f the m ixture was frozen  a t -20°c  for 
investigation of in tracellu larly  form ed BP m etabolites. The rem ainder of the  m ixture was 
ex trac ted  with phenol m ixture (as described for hepatocy te  DNA isolation) and DNA 
isolated as described in the hepatocy te  experim ents using the m ethod of Diamond e t  al 
(328). DNA sam ples w ere stored  a t -20°c for analysis.
IV) E xperim ents on mouse skin in vivo
a) Tumour experim ents:-
F em ale  inbred Swiss m ice (10 anim als/group; 6-8 weeks) w ere shaved on the ir backs with 
e lec tric  clippers 24 hours prior to  trea tm en t. The te s t group rece ived  a single top ical 
application of an in itia ting  dose of BP (200nmoles) in acetone (200ul) to  the  shaved area  
followed 1 week la te r  by tw ice weekly applications of the tum our prom oter, TPA 
(17nmoL), in acetone (200ul). Tumour yields w ere assessed a f te r  15 weeks of prom otion. 
C ontrol groups received  either, TPA (17nmol.) in ace tone (200ul) tw ice w eekly or a  single 
dose of BP (200nmol.) in acetone (200ul) followed by tw ice weekly applications of acetone 
(200ul). During the prom oting period the animals w ere reshaved periodically  so th a t th e  
ace tone (+TPA) was distribu ted  evenly over the tre a te d  a rea  of the skin.
3
b) T rea tm en t of mice with ( H)BP:-
F em ale inbred Swiss, DBA/2 and C57BL/6 m ice (8-10 anim als/group; 6-8 weeks of age)
3w ere shaved on the ir backs with e lec tric  clippers 24 hours p rio r to  tre a tm e n t. ( H)BP
(200nmol; 2.5Ci/mMole) in acetone (200ul) was topically  applied to  the  shaved areas and
the anim als m aintained in subdued light for the  duration of the experim ent. The
experim ent was term inated  a f te r  24 hours when the m ice w ere killed. In some
3
experim ents benz(a)anthracene (300ug 1 day prio r to  ( H)BP), naphthol (2mg, 1 hour prio r
3to  and lm g , 1 hour a f te r  ( H)BP), diphenylacetic acid (2mg, lhou r p rio r to  and lm g, 1 hour
3 3a f te r  ( H)BP) or C atechol (2mg) + benzo(a)pyrene (5ug) (either sim ultaneously w ith ( H)BP
3
or every two days for 8 days prior to ( H)BP) in acetone (200ul) w ere used to  investigate  
the e ffec ts  of AHH inducers, conjugation inhibitors and co-carcinogens on BP-DNA 
in terac tions in mouse skin.
c) E x trac tion  of DNA from mouse skin:
The m ethod used was essentially as described by Brookes and Lawley (183) and m odified 
by Phillips e t al (329). The mice w ere killed by cerv ical dislocation and the tre a te d  areas 
of skin removed, supported dermis side upwards on a cork board and im m ersed in liquid 
nitrogen. The derm al surfaces w ere scraped with a scalpel un til all the  blood vessels had 
disappeared and the rem aining skin layers w ere transluscent. The frozen  epiderm al layers 
rem aining w ere stored  on solid CC^ and then cu t into approxim ately 5mm th ick  strip s  and 
homogenised in liquid nitrogen using an Atom ix blender se t a t full speed for 20 m inutes. 
The fragm ents produced were fu rther homogenised in liquid n itrogen using a Poly tron  
homogeniser a t setting  6 for 1 m inute. The resu lting  powder was re-suspended in ice-co ld  
6% sodium p-am inosalicylate, 1% sodium chloride(w/v; 3ml/skin) and skin cell lysis 
com pleted using 10% SDS (w/v; 0.1 vol.). A fte r vigorous shaking for 2-3 m inutes, the  
m ixture was ex trac ted  with an equal volume of phenol m ixture (as described for 
hepatocy te  DNA isolation), essentially  as described by Diamond e t al (329). The m ixture
was shaken vigorously for 10 m inutes and the layers separated  by cen trifugation  a t 
2000rpm for 20 m inutes a t room tem peratu re , a f te r  which the aqueous layer was rem oved 
and re -e x tra c te d  with the phenol m ixture (0.5 vol.) by vigorous shaking for 5 m inutes. The 
layers were separated  by cen trifugation  as before and DNA was p rec ip ita ted  from the 
aqueous layer by the addition of cold (-20°c) 2-ethoxyethanol (1 vol.). The DNA was 
washed in 96%(w/v) ethanol (4x20ml) and diethyl e th er (2x20ml) and dried under a s tream  
of n itrogen  gas. Yields of DNA ranged from 0.5 -  lm g  per mouse skin. Samples w ere 
sto red  a t -20 °c  until analysis.
V Experim ents on mouse lung in vivo:
a) Tumour experim ents:
Groups of m ale A stra in  mice (10 anim als/group; 6 weeks of age) rece ived  single 
in traperitoneal injections of e ither lOOug/g or lOug/g BP in corn oil (0.2ml). The two 
groups of anim als tre a te d  with lOug/g BP w ere fu rther tre a te d  with tw ice weekly 
in jectiions of e ith e r bu ty la ted  hydroxytoluene (BHT; 250mg/Kg) in corn oil (0.1ml) or corn 
oil (0.1ml). Lung tum our yields w ere assessed a f te r  16 weeks and com pared w ith those 
obtained following in traperitoneal in jection of u rethane (lm g/g) to m ale A s tra in  or 
C57BL/6 s tra in  m ice (10 anim als/group; 6-8 weeks of age) w ith or w ithout fu rth er 
trea tm e n t w ith BHT as s ta ted  above.
3
b) Binding of ( H)BP to mouse lung DNA:
Male A s tra in  m ice (10 anim als/group; 6-8 weeks of age) received  single in trap erito n ea l 
injections of. ( H)BP (lOOug/g or lOug/g; 500uCi/anim al) and w ere killed 24 hours la te r  by 
cerv ical dislocation. The lungs w ere excised and cut into sm all p ieces which w ere 
conveniently homogenised in 6% sodium p-am inosalicy late : 1% sodium chloride(w/v) 
(10ml) using a  polytron hom ogenizer (setting 2 for 30 seconds). DNA was ex tra c te d  from 
the resulting hom ogenate exactly  as described in the hepatocy te  DNA isolation. Sam ples 
w ere stored  a t -20 °c  until analysis.
3VI T rea tm en t of ra ts  w ith ( H)-BP
a) T rea tm en t of animals:
Male W istar ra ts  (6 anim als/group; 40-50g) were shaved on the ir backs with e lec tric
3
clippers 24 hours prior to trea tm en t. ( H)BP (200nmol; 2.5Ci/m M ole or 5Ci/mMole) in 
ace tone (200ul) was topically applied to the shaved areas and the  anim als m aintained in 
subdued light for the duration of the experim ent. Groups of anim als w ere killed a f te r  6 , 
12, 24, and 48 hours and DNA iso la ted  from the tre a te d  areas of skin. The 6 and 12 hour 
groups received  0.5m C i/anim al while the  24 and 48 hour groups received  lm C i/an im al.
b) E x trac tion  of DNA from ra t  skin:
This was essentially as described for mouse skin DNA ex traction , the  only d ifference 
being th a t when the skins had been homogenised to a powder, this was re-suspended in 6% 
p-am inosalicylic acid: 1% sodium chloride (w/v) using 4m l/skin in co n trast to  3m l/skin 
used for mouse skin. DNA yields w ere generally  2 mg per ra t skin and sam ples w ere sto red  
a t -20 °c  until analysis.
VIE R eactions of BP M etabolites w ith DNA, dG and dA.
a) R eaction  with DNA:
To DNA (lOmg) dissolved in 0.05M sodium cacodylate-H C l buffer, pH 6.8 (5.0ml) was 
added e ith er (^H) an ti BPDE (180ug; 466mCi/mM ole), unlabelled an ti BPDE (l.lm g ), 
(^H)BP-4,5-epoxide (200ug; 366mCi/mMole) or 7 - (^ C )  syn BPDE (200ug; 50.9mCi/mM ole) 
in te trahydro fu ran -trie thy lam ine 19:1 (200ul). Sam ples w ere incubated in a  shaking w ater 
ba th  a t 37°c  for 16-24 hours and subsequently ex trac ted  with diethyl e th e r  (3x2 vol; 3 
m inutes vigorous shaking during each extraction) to rem ove unbound BP m etabo lites. 
Following the last ex traction , any rem aining e th er was rem oved by bubbling a  stream  of 
n itrogen gas through the  DNA solution and then DNA was p rec ip ita ted  by the  addition of 
96%(w / v ) ethanol (2 vol.), washed in 96% ethanol (4x2 vol.) and then d iethyl e th e r  (2x2 
vol.) and finally dried in a stream  of n itrogen  gas. In some experim ents h e a t denatured  
DNA (5 m inutes in a boiling w ater bath) was used in place of native  DNA. Sam ples w ere 
stored a t -20 °c  un til analysis.
b) R eaction  with dG and dA:
BP-4,5-epoxide (2.02mg) syn BPDE (1.9mg) and anti BPDE (1.8mg) w ere dissolved in 
m ethanol (1ml) and to each was added 0.5mg of the  appropriate ( H)-deoxyribonucleoside 
(lO .lmCi/mM ole) dissolved in 0.1M Tris-H Cl buffer, pH 7.4 (0.5ml). Sam ples w ere 
incubated in a shaking w ater bath  a t 37°c for 16-24 hours and then frozen a t -20°c un til 
analysis.
VIII Hydrolysis of DNA:
DNA sam ples w ere dissolved in 0.01M Tris-H Cl buffer, pH 7.3, to  an approxim ate
1%concen tration  of 1 m g/m l and quantified  spectrophotom etrically  a t 260nm assuming E
= 260 (330). In b rie f 0.1m l of the DNA solution was diluted to 2.6m l and the  absorbance a t
260nm was recorded, giving the DNA concen tration  in m g/m l of the original solution.
DNA purity  was assessed by measuring the  absorbance ra tio s  A?gn (usually^l.98) and 
A260 A^oU
"j^230 (usually ^2 .21). P ro te in  contam ination w a s< l%  as determ ined  by the m ethod of
Lowry e t al (323). The DNA was hydrolysed to  a m ixture of deoxyribonucleosides and
hydrolysis res is tan t m a te ria l by sequential digestion with enzym es essentially  as described
by Baird and Brookes (331). To the DNA solution was added deoxyribonuclease I (100
units/m g DNA) in 0.01M Tris-H Cl buffer pH 7.3 (lm g/m l) and sam ples incubated in a
shaking w ater bath  a t 37 °c  for 6-16 hours. The DNA solution was then sam pled for
associated  rad ioactiv ity  and the num ber of pm oles BP bound per mg DNA was calcu lated .
0.01M Tris-H Cl buffer, pH 9.3, was added to  the  hydrolysate to  a lte r  the solution to  pH
8.5 -  9.0 and snake venom phosphodiesterase (0.03 units) in glycerol (20ul) was added.
Incubation was continued under the sam e conditions for 24 hours and a rep ea t dose of
snake venom phosphodiesterase (as above) was added and sam ples w ere incubated for a
fu rther 24 hours. F inally alkaline phosphatase (3.6 units) was added to the DNA
hydrolysate as an ammonium sulphate suspension (lOul) and incubation continued for a
fu rther period of 48 hours. Hydrolysed DNA sam ples w ere frozen a t -20°c until analysis.
Analysis of BP-deoxyribonucleoside adducts
a) Sephadex LH-20 column chrom atography:
Sephadex LH-20 was presw ollen overnight in m ethanol, s tirred  with a spatu la  to  rem ove 
air bubbles and then the  slurry poured into a W right glass column (100x1.5cm) to a  height 
of 90cm. M ethanol was pumped through the column a t a  flow ra te  of 1 m l/m inu te for 2 
hours using a  Watson-Marlow p e ris ta ltic  pump. The solvent was then changed to  30% 
m ethanol in w ater and this was pumped through the  column a t the  sam e flow r a te  for 2 
hours. The DNA hydrolysate, containing 4-(-4 '-p-nitrobenzyl-)-pyridine (PNBP) (500ug) as 
a UV m arker, was applied to the top of the column and allowed to  run in to  the Sephadex. 
This was followed by 10ml of 30% m ethanol in w ater which was also allowed to run into 
the column m ateria l. BP-deoxyribonucleoside adducts were elu ted  from the column using 
a  solvent grad ient from 30% m ethanol in w ater (150ml m ethanol + 350ml w ater) to  100% 
m ethanol (500ml methanol) as described by Baird and Brooks (331). F rac tio n s  of 
approxim ately 5ml w ere co llected  and the  rad ioac tiv ity  in 0.5m l of each frac tion  
determ ined by liquid scin tillation  counting upon addition of 5ml of sc in tilla tion  cocktail. 
UV absorbance was m onitored continuously a t 254nm throughout the run and varia tions in 
elution volumes betw een separate  runs w ere norm alised by co rrecting  to  an established 
standard elution volume for the  UV m arker PNBP.
b) High P ressu re  Liquid Chrom atography:
BP-deoxyribonucleoside adducts w ere iso la ted  essentially  as described by W einstein e t al 
(209). DNA hydrolysates w ere applied to a short column of sephadex LH-20 (0.9 x 3cm) 
previously equilibrated with w ater and the column was then washed with w ater (5-10ml) to  
rem ove unhydrolysed DNA and unmodified bases. The less polar B P-deoxyribonucleoside 
adducts were then co llected  by elution with m ethanol (5ml). The m ethanol was 
evaporated to dryness using a  ro tary  evaporator and the  resulting  m a te ria l dissolved in 
50ul of m ethanol. BP-4,5-diol(0.5ug) in ethyl a c e ta te  (2ul) was added to each sam ple as a 
UV m arker and the adducts w ere separated  by HPLC using an isocra tic  m ethanol : w a te r 
(1:1) solvent system  a t a flow ra te  of lm l/m in . UV absorbance of the  e luan t was 
m onitored continuously a t 254nm. F ractions w ere co llected  every 0.5 m inutes and the  
rad ioactiv ity  in each fraction  determ ined by liquid scin tilla tion  counting in 5 ml of 
scin tilla tion  fluid.
CHAPTER ONE
HEPATIC MICROSOMAL-MEDIATED BINDING OF 
BENZO(a)PYRENE TO DNA
Separation of products using Sephadex LH-20 and high pressure liquid chrom atography: 
E ffec ts  of d ifferences in incubation concentrations of magnesium ions:
In troduction
In 1957, Conney e t al (332) observed th a t BP was hydroxylated by an enzym e p resen t in 
the m icrosom al fraction  of r a t  liver cells. The sam e workers developed a  fluorescence 
assay for this enzym e and te rm ed  i t  "BP hydroxylase". The phenolic m e tabo lites  of BP, 
in itia lly  observed as compounds X and F in the bile of anim als tre a te d  w ith BP (179) and 
la te r  m ore fully charac terised  (181) had been shown to  be non-carcinogenic (180). Thus in 
the  la te  1950's and early  1960's i t  was thought th a t PAH, including BP, w ere carcinogenic 
per se. However, these compounds w ere not m utagenic (60) and so the som atic  m utation  
theory  of cancer (51,52), implying a chem ical reac tion  with DNA, was disregarded because 
many PAH are chem ically  inert. In 1964 Brookes and Lawley showed th a t several PAH 
could covalently  bind to  DNA in mouse skin (183). This im plied th a t m etabolism  of PAH 
was a p re-requ isite  to  the ir carcinogenic e ffec ts . The reac tiv e  species of PAH w ere 
thought to  be electrophilic since many of the proposed ta rg e t s ites in DNA are  e lec tron  
rich  and the re fo re  a revival of the epoxide m etabo lite  theory , originally proposed by 
Boyland (187), arose.
G rover and Sims (184) showed th a t r a t  liver m icrosom al preparations cata lysed  the  binding
of several PAH's to  exogenous DNA, RNA and pro tein  only when all the  co fac to rs
necessary  for MFO activ ity , such as reduced pyridine nucleotides, w ere p resen t. These
observations w ere confirm ed by Gelboin (185) and several epoxides of PAH, believed  to  be
the reac tiv e  species, w ere subsequently iso la ted  and charac te rised  as m icrosom al
m etabolites of PAH (128-130). In the la te  1960's Sims showed th a t r a t  liver p reparations
m etabolise BP to  phenols, principally 3-hydroxybenzo(a)pyrene (3-OH-BP) and two
»
dihydrodiol derivatives BP-7,8-diol and BP-9,10-diol (333). Subsequent work showed th a t 
the K -region m etabo lite  4 ,5-dihydro-4,5-dihydroxybenzo(a)pyrene (BP-4,5-diol) is also 
form ed by r a t  and ham ster liver preparations incubated w ith BP (334,335).
Borgen e t al (193) showed th a t Syrian ham ster liver m icrosom es could a c tiv a te  BP and 
several of its  m etabolites to  DNA-bound products, and under these conditions B P-7,8-diol 
was bound to  DNA for a  far g rea te r ex ten t than the paren t hydrocarbon. This prom pted  
Sims e t al (194) to  postu la te  th a t epoxide form ation on the olefinic double bond in the  9»10 
position of BP-7,8-diol could explain the high level of DNA binding exhibited  by th is 
m etabolite  following m etabolic activation . They showed th a t, in cu ltu red  roden t cells 
tre a te d  with BP, only one DNA-bound product was form ed and this was due to  reac tio n  of 
an isom er of the diol epoxide, BPDE, w ith DNA. The sam e group also outlined the  
im portance of a diol epoxide in the m etabolic activation  of BA (195).
The possibility th a t m etabolites of BP o ther than diol epoxides w ere im portan t in its  
m etabolic ac tivation  was also under investigation. In itial studies on th e  r a t  liver
m icrosom al m ediated binding of BP to  DNA resu lted  in the isolation of predom inantly two 
DNA adducts when the DNA hydrolysates w ere chrom atographed on columns of Sephadex 
LH-20 eluted  with w ater-m  ethanol gradien ts (336). The minor product co­
chrom atographed w ith a fu rth er m etabo lite  of BP-7,8-diol bound to  DNA, while the major 
p roduct was shown to be derived from fu rther m etabolism  of BP-phenols and then binding 
to  DNA (337)* Subsequent work established th a t the minor product was derived from 
reac tion  of BPDE with DNA (338), while the m ajor product arose from  9-hydroxy-BP (9- 
OH-BP), probably through conversion to an electrophile, via K -region epoxidation, and 
then reac tion  with DNA (339). King e t al (198) showed th a t cells w ere capable of form ing 
both  syn and anti isom ers of BPDE, though the anti isom er predom inated. Studies of the 
m etabolism  of BP by r a t  liver preparations reported  a highly stereospecific  synthesis of 
the (-) BP-7,8-diol which was stereospecifica lly  converted to the (+) anti BPDE (200-202) 
w ith absolute configuration 7R, 8S, 9R, 10R.
The in troduction of HPLC to  the analysis of hydrocarbon-deoxyribonucleosides g rea tly  
assisted  the resolution of DMBA-DNA adducts, especially when isocra tic  solvent m ixtures 
w ere used as eluants (340). Several groups of workers have subsequently u tilised HPLC 
techniques to analyse BP-DNA and -RNA adducts form ed when BP was incubated w ith 
cu ltured  rodent cells (341), explant cu ltures of human and bovine bronchus (209,210) or 
topically applied to mouse skin (213). In co n trast to the previous studies w ith m icrosom al 
preparations, the m ajor DNA-bound products in all these system s are  derived from 
reac tion  of BPDE's with DNA, the m ajor site  of a ttack  being the exocyclic amino group of 
dG (207,208,210). Meehan e t al (214) used HPLC techniques to  investigate  the BP-DNA 
adducts form ed by reac tion  of an ti BPDE with DNA containing rad ioactively  labelled 
bases. They observed th a t dG, dA and dC bases in the DNA w ere all m odified by anti 
BPDE and the stru c tu re  of the resu ltan t adducts w ere la te r  e lucidated  using m ass 
spectrom etry  (342). The sam e w orkers (214) also investigated  the ra t- liv e r  m icrosom al 
m ediated  binding of BP to  DNA using the sam e HPLC m ethod. They observed the  
form ation of essentially  one adduct derived from anti BPDE, in co n trast to all the 
previous m icrosom al studies, using Sephadex LH-20 column chrom atography, which had 
shown th a t the m ajor BP-DNA adduct resu lted  from fu rther m etabolism  of 9-0H-BP 
(324,326,336,337). Boobis e t al (343) and Legraverend e t  al (344) found th a t various 
m etabolic inhibitors and inducers, various chem icals used in m icrosom al p reparations and 
d ifferen t anim al d iets could a ffe c t the m ouse-liver m icrosom al m ediated  form ation  of 
BP-DNA adducts. Meehan e t al (214) proposed th a t d ifferences in the concen tra tion  of 
magnesium ions in m icrosom al incubations, containing BP and DNA, could a f fe c t the  
re la tive  proportions of BP-DNA adducts formed.
It was of in te re s t to develop a HPLC system  to analyse BP-DNA-bound products in several
tissue system s and the studies were in itia ted  by re-investigating  the BP-DNA adducts 
form ed following ra t  liver m icrosom al ac tiva tion  of BP in the presence of DNA. The 
DNA-adducts were chrom atographed on columns of Sephadex LH-20 e lu ted  with w ater- 
m ethanol grad ients then  re-chrom atographed on HPLC columns and iden tified  by co­
chrom atography with DNA-adducts form ed by incubating various m etabo lites of BP with 
m icrosom es and DNA. The effect(s) of varying magnesium ion concen trations, in 
m icrosom al incubations containing BP and DNA, on the  form ation of B P- 
deoxyribonucleoside adducts was also investigated .
R esults
Sephadex LH-20 column chrom atographic separation  of hydrocarbon-deoxyribonucleoside 
adducts following r a t  liver m icrosom al m ediated  binding of ( H)BP to  DNA is shown in 
Fig.37a. T hree m ajor peaks of rad ioactiv ity , I-HI, w ere obtained although in addition 
several minor products w ere form ed. Peak  I, accounting for 22% of to ta l DNA associated  
rad ioactiv ity  rep resen ted  m ateria l eluting in the in itia l 200ml of e luent and consisted of 
oligonucleotides which appeared to be re s is tan t to fu rther hydrolysis and unm odified 
deoxyribonucleosides which had undergone tritium  incorporation (329). P roduct II (25% of 
to ta l DNA bound products) co-chrom atographed with m ajor deoxyribonucleoside adduct 
form ed following m icrosom al activation  and binding to DNA of ( H) BP-7,8-diol (Fig.37b) 
in agreem ent with o ther w orkers (194,337,326). P roduct IH (36% of to ta l DNA bound 
products) was not fu rth er characterised  using Sephadex LH-20 chrom atography bu t has 
been shown to resu lt from fu rther m etabolism  of BP-phenols (326,337), especially 9-0H-BP 
(338), and then reac tion  with DNA.
3
HPLC separation  of BP-DNA adducts derived from m icrosom al ac tiv a tio n  of ( H)BP was 
in itia lly  a ttem p ted  using a phase separation  Spherisorb ODS column which was in use in 
the laboratory  for the separation  of BP m etabolites. BP-deoxyribonucleoside adducts 
w ere isolated using short columns of Sephadex LH-20 (0.9x3cm), as described in m a teria ls  
and methods, and then analysed by HPLC using a gradient of 40%-80% m ethanol in w ater. 
The resulting profile  of rad ioactiv ity  is shown in Fig.38a. One m ajor peak of rad ioac tiv ity  
was observed and this co-chrom atographed with both II and HI obtained from the  
appropriate fractions following Sephadex LH-20 analysis of BP-deoxyribonucleoside 
adducts (Fig.37a) when the respective fractions w ere analysed separate ly  by HPLC under 
the sam e conditions (results no t shown). A ttem p ts  to  separa te  these two products on the  
Spherisorb column by modifying the gradient conditions or by iso cra tic  solvent elution 
proved unsuccessful and m easurem ents of the effic iency  of the  Spherisorb column 
indicated  th a t whilfe BP m etabolites w ere s till e ffic ien tly  separa ted  (345), th e  column did 
not apparently  resolve the DNA adducts (Fig.38a).
The HPLC system  was subsequently modified by the incorporation of a W aters ubondapak 
ODS HPLC column together with a  precolum n packed w ith ODS to p ro te c t the ubondapak 
column. Hydrocarbon-deoxyribonucleoside adducts derived from m icrosom al ac tiva tion  of 
BP in the presence of DNA and purified as described previously w ere applied to  the 
ubondapak column and elu ted  with a gradient from 40% to  80% m ethanol in w ater 
(Fig.38b). F ive peaks were generally observed A-E, although an additional peak, F, eluting 
betw een peaks B and C was occasionally observed. A ce rta in  am ount of rad ioactive  
m ateria l elu ted  near the origin (fractions 1-15) probably due to  sm all oligonucleotides, 
with bound hydrocarbon residues, escaping the sm all LH-20 column pu rifica tion  procedure.
Legend to F igure 37
Separation  of BP-deoxyribonucleoside adducts using Sephadex LH-20 column chrom atography:
3
L iver m icrosom es from 3M C -pretrea ted  ra ts  w ere incubated  w ith  (a){ H)BP (4.2 uM) 
or (b) (3H)BP-7,8-diol (53uM) in th e  presence of an NADPH genera ting  system  and 
ca lf thym us DNA. The DNA was iso la ted , purified  and hydrolysed enzym ically  to  
deoxyribonucleosides which w ere analysed by Sephadex LH-20 chrom atography as 
described  in M aterials and M ethods. R esults are  expressed as dpm /frac tion .
DP
M
 
(x
iO
“3
)
I
a) BP
3 0 -
2 0
M
b) BP  - 7 , 8  -  DIOL
3 ~
1 0 0 0500
E L U T I O N  V O L U M E  ( m l )
F i g u r e  37
Legend to  F igure 38
HPLC analysis of BP-deoxyribonucleoside adducts: D eoxyribonucleoside adducts
form ed by hydrolysis of DNA previously re a c te d  w ith  ( H)BP (4.2uM) in the presence 
of r a t  liver m icrosom es, as described  for Fig.37a, w ere analysed by HPLC using e ith e r
(a) Phase Separations 'Spherisorb' or (b) W aters 'uBondapak'. ODS colum ns. The adducts 
w ere e lu ted  w ith  a solvent g rad ien t from 40% to  80% m ethanol in w ate r a t a  flow 
r a te  of lm l/m in . F ractions (0.5ml) w ere co llec ted  and analysed for rad io a c tiv ity  
as described  in M aterials and M ethods. R esults are  expressed as dpm /fraction .
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The two m ajor products, B and C co-chrom atographed with m  respectively  (Fig.39) 
obtained from the appropriate fractions during Sephadex LH-20 chrom atographic 
separation  of BP-deoxyribonucleoside adducts (Fig.37a). In th is case an isocra tic  eluting 
solvent (1:1, m ethanol : water) was used. HPLC analysis of peak HE resu lted  in a 
separation  into two com ponents co-chrom atographing with A and B though B was by fa r 
the  m ajor com ponent (Fig.39). A fu rth er ch arac terisa tion  of products B and C was then 
a ttem p ted .
U nlabelled anti BPDE was reac ted  d irec tly  with DNA and unlabelled 9-OH-BP was 
incubated with m icrosom es and DNA (as described in m ateria ls  and methods). Both DNA 
sam ples were separate ly  hydrolysed and the deoxyribonucleoside adducts w ere purified  as 
described previously and isolated  essentially  as single u.v. absorbing peaks by HPLC using 
the Spherisorb ODS column and eluting with 40-80% M ethanol : w ater g rad ien ts in each 
case. U.V. absorption and fluorescence excita tion  and emission sp ec tra  w ere obtained for 
the anti BPDE-deoxyribonucleoside adduct (Fig,40) and fluorescence sp ec tra  only for the 
9-OH-BP-deoxyribonucleoside adduct (Fig.41). The spec tra l data , sum m arised in Table 
VHI, are  in good agreem ent with those obtained by o ther workers (338,339). The 
deoxyribonucleoside adducts derived from anti BPDE and 9-OH-BP w ere then  fu rth er 
analysed by HPLC using a ubondapak ODS column elu ted  with an iso cra tic  1:1 m ethanol : 
w ater eluant and were found to co-chrom atograph with products C and B respectively  
(Fig.42).
The availability  of radiolabelled m etabolites of BP enabled a  m ore accu ra te  qualita tive  
ch arac terisa tion  of both  the m ajor (B and C) and minor (A,D and E) B P- 
deoxyribonucleoside adducts form ed during m icrosom al incubations containing BP and 
DNA. The use of an isocratic  eluant (1:1, m ethanol : water) aided reso lu tion  of the B P- 
deoxyribonucleoside adducts som ewhat, as observed by o ther workers analysing DMBA- 
DNA adducts (340) and this system  was, therefo re , adopted for all fu tu re experim ents.
The two major products B and C, accounting for nearly  80% of the to ta l
deoxyribonucleoside adducts, co-chrom atographed with the m ajor deoxyribonucleoside
3• adducts obtained by m icrosom al activation  and binding to  DNA of ( H)9-0H-BP and 
3
( H)BP-7,8-diol respectively  (Fig.43). The order of elution of these two adducts using 
HPLC on ubondapak ODS (Fig.43) a separation  based mainly on polarity , is a  reversa l from 
the ir elution order on Sephadex LH-20 columns (336) (Fig.37a), w here separation  is based 
on several facto rs including partition , po larity  and size. P roduct D, eluting around
fraction  75 and products A and E eluting around fractions 24 and 109 respectively ,appear
3 3to be minor adducts resulting from m icrosom ally ac tiv a ted  ( H)BP-7,8-diol (D) and ( H)9-
0H-BP (A and E) respectively . P roduct C also co-chrom atographed w ith the m ajor
deoxyribonucleoside adduct form ed following reac tion  of anti BPDE w ith dG (Fig.44). A
Legend to  F igure  39
HPLC analysis of BP-deoxyribonucleoside adducts: Deoxyribonucleoside adducts
(b) product HI and (c) product II in itia lly  sep ara ted  by Sephadex LH-20 chrom atography 
(Fig.37a) w ere fu rth e r analysed by HPLC as described in M aterials  and M ethods. 
Their e lu tion  tim es w ere com pared w ith (a) deoxyribonucleoside adducts form ed 
by hydrolysis of DNA previously reac ted  w ith ( H)BP (4.2uM) in the presence of 
r a t  liver m icrosom es from 3M C -pretrea ted  anim als as described in M aterials  and 
M ethods.
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Legend to  F igure 40
U.V. absorption spectrum  and fluorescence ex c ita tio n  and em ission sp ec tra  from 
deoxyribonucleoside adducts form ed by hydrolysis of DNA previously re a c te d  w ith an ti 
BPDE. The BPDE-deoxyribonucleoside products w ere iso la ted  by HPLC, as described in 
th e  te x t, and subjected  to  sp ec tra l analysis in solution in m ethanol : w a te r.
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F igure 41.
F luorescence ex c ita tio n  and em ission sp ec tra  of deoxyribonucleoside adducts form ed by 
hydrolysis of DNA previously re a c te d  w ith  m icrosom ally a c tiv a te d  9-OH-BP. The 
resu lting  deoxyribonucleoside products w ere iso la ted  by HPLC, as described in th e  te x t, 
and sub jected  to  sp ec tra l analysis in solution in m ethanol : w ater.
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Table VHI. SPECTRAL CHARACTERISTICS OF BENZO(a)PYRENE -  DEOXYRIBONUCLEOSID1 
ADDUCTS
Compound U.V. absorbance m axim a (nm)
antiBPDE-D N A 245,257,266,278,314,327,343.
F luorescence m axim a (nm)
E xitation
w avelength
Emission
m axim a
Emission
w avelength
Exitation
maxim a
anti BPDE-DNA 343 377,388,397
419.
377 (269),280, 
(288),315, 
328,343.
9-OH-BP-DNA 274 380 ,399 ,(419 ) 380 274,314,327
355.
Spectral ch arac te ris tics  of deoxyribonucleoside adducts form ed by hydrolysis of DNA 
previously reac ted  w ith anti BPDE or m icrosom ally ac tiv a ted  9-OH-BP, as described 
in  M aterials and M ethods. The respective deoxyribonucleoside adducts were purified  
by Sephadex LH-20 chrom atography and isolated  by HPLC. Spectra l analyses w ere 
perform ed using solutions of the adducts in  m ethanol : w ater.
Legend to  F igure 42
Id en tifica tio n  of m icrosom al m ediated  BP-deoxyribonucleoside adducts:
D eoxyribonucleoside products w ere obtained by hydrolysis of DNA previously re a c te d  w ith 
3
(a) ( H)BP (4.2uM) or (b) 9-OH-BP (125uM) in the  presence of r a t  liver m icrosom es from  
3MC p re tre a te d  anim als and an N A D PH -generating system , or re a c te d  d irec tly  w ith  (c) 
an ti BPDE (730uM). The deoxyribonucleoside adducts w ere analysed by HPLC as 
described  in M aterials and M ethods. U.V. absorbance was m onitored  continuously a t  
254nm.
Figure 42
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Legend to F igure 43
Id en tifica tio n  of BP-deoxyribonucleoside adducts: L iver m icrosom es from  3MC
p re tre a te d  ra ts  w ere incubated  w ith (a) (^H)BP (4.2uM), (^H) 9-OH-BP (45uM) or (c) 
3
( H )BP-7,8-diol (53uM) in the  presence of an N A D PH -generating system  and ca lf thym us 
DNA. The DNA was iso la ted , purified  and hydrolysed enzym ically  to  deoxyribonucleosides 
which w ere analysed by HPLC as described in M aterials and M ethods. R esults are  
expressed as dpm /fraction .
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Figure 44
Iden tification  of m icrosom al m ediated  BP-DNA adducts. D eoxyribonucleoside adducts,
obtained either by hydrolysis of DNA previously reac ted  w ith ra t- l iv e r  m icrosom ally
3 3ac tiv a ted  H BP (o—o) or by reac tion  of anti BPDE w ith H dG (a—a), w ere purified  and
then analysed by HPLC, as described in M aterials and Methods. R esults are  expressed as
dpm /fraction .
minor product was also form ed during th is reac tio n  which did no t co -ch rom atograph  w ith  
any of th e  m icrosom al m ed ia ted  BP-deoxyribonucleoside adducts (Fig.44). Increasing  th e  
co n cen tra tio n  of m agnesium  ions in  m icrosom al incubations contain ing  BP, calf-thym us 
DNA and an NADPH genera ting  system  resu lted  in a  s tim u la tion  of th e  overall gross 
binding of the  hydrocarbon to  DNA a t low concen tra tions of m agnesium  ions follow ed by a 
m arked inhibition  of th is  s tim u la tion  a t  higher m agnesium  ion co n cen tra tio n s  (Table IX). 
This inhibition was m axim al a t  a  magnesium  ion concen tra tion  of 2.5mM, when binding 
was alm ost 40% low er than  maximum
TABLE IX
EFFECT OF MAGNESIUM ION CONCENTRATIONS ON BOTH THE AMOUNTS 
OF BENZO [a ]PYRENE METABOLITES COVALENTLY BOUND TO DNA AND 
THE RELATIVE AMOUNTS OF DIFFERENT HYDROCARBON- 
DEOXYRIBONUCLEOSIDE ADDUCTS
The hydrocarbon-deoxyribonucleoside adducts were separated by HPLC. as described 
in Materials and Methods. The major adducts B and C are derived from further meta­
bolism of 9-hydroxybenzo[a]pyrene and 7,8*dihydro-7,8-dihydroxybenzo(a]pyrene 
respectively.
[Mg1+]mM pmol bound/ 
mg DNAa
Relative adduct distribution (%)
A B C D E F
0.2 127.7 5.6 58 27 1.7 2.5 1.5
1.0 97.7 6.2 58 25 1.8 3.9 —
2.5 78.7 6.1 57 25 1.7 3.2 1.6
7.5 79.6 6.2 51 24.6 1.7 2.7 2.2
25.0 68.5 6.1 56.3 24.2 1.9 3.9 1.3
aResults are expressed as the means of two determinations. The amount of covalently 
bound benzo[a]pyrene metabolites in the absence of magnesium ions was 91.1 pmol 
bound/mg DNA.
V ariations in magnesium ion concen tra tions in th e  incubations had no e f fe c t  on th e  
qua lita tiv e  fo rm ation  of hydrocarbon-deoxyribonucleoside adducts as judged  by HPLC 
analysis of the  DNA hydrolysates. The ra tio  of the  individual adducts fo rm ed  was 
independent of magnesium ion concen tra tion  and in all cases p roducts derived  from  bo th  
9-OH-BP and B P-7,8-d io l w ere observed (Table IX). In all the  r a t  liver m icrosom al s tud ies, 
th e  m ajor hydrocarbon-deoxyribonucleoside adduct (peak B, F igs. 38,39,42,43 and 44) was 
derived  from  fu rth e r m etabolism  of 9-OH-BP ra th e r  than  from  B P-7,8-d io l.
Discussion
The early  work of K reik (249) w ith arom atic  am ines, and Dipple e t  al (346) w ith the  PAH 
derivatives 7-brom ethylbenz (a) an thracene (7-BrMeBA) and 7-brom om ethyl-12- 
m ethylbenz(a)anthracene (7-BrMe-12-MeBA), established the technique of Sephadex LH- 
20 column chrom atography as an essential analy tical developm ent in the investigation  of 
carcinogen-DNA in tera tions. F u rther m odifications utilising m ethanol-w ater g rad ien t- 
elution system s enabled Baird and Brookes (331) to  separa te  several D N A -adducts of 7- 
MBA. It was shown th a t deoxyribonucleoside-bound products of th is carcinogen form ed in 
cells in cu lture  w ere not derived from a  K-region epoxide (190). Subsequent work by Sims 
e t al (194) and Baird e t  al (191) established the  im portance of the bay-region, not the K- 
region, in the  m etabolic ac tivation  of BP. A som ew hat surprising resu lt was obtained 
when the  r a t  liver m icrosom al m ediated  DNA adducts of BP w ere separa ted  on columns of 
Sephadex LH-20 using m ethanol-w ater gradient elution (336). The m ajor adduct obtained 
was iden tified  as a fu rth er m etabo lite  of 9-OH-BP bound to  both  purine 
deoxyribonucleosides in the  DNA (339), whilst the  BPDE-DNA adduct, the  m ajor DNA- 
bound m etabo lite  in in ta c t cellu lar system s (212), accounted for only a  sm all percen tage  
of the  observed products (336).
The present studies w ere aim ed a t developing a chrom atographic technique to  iden tify  
sm all amounts of these adducts. With th is in ten tion  in mind a  system  was chosen in which 
several BP-DNA adducts had been separated  and characterised . A ttem p ts  w ere then 
made to  reproduce or b e tte r  the  resolution of these products in a system  of g re a te r  
analy tica l capability , nam ely HPLC.
Separation of m icrosom al-m ediated BP-deoxyribonucleoside adducts on columns of 
Sephadex LH-20 yielded th ree  m ajor peaks of rad ioac tiv ity  (Fig.37a) in ag reem en t w ith 
several o ther workers (326,336). The early  eluting m a teria l, P roduct I, has no t been fully 
characterised  but probably contains DNA fragm ents res is tan t to  hydrolysis and a  ce rta in  
am ount of tritium  exchange w ith norm al deoxyribonucleosides. P roduct II co­
chrom atographed with the  m ajor deoxyribonucleoside adduct form ed following m icrosom al 
m ediated  binding to DNA of BP-7,8-diol (Fig.37b), as observed by o ther w orkers (194,338), 
and is probably due to  reac tion  of an ti BPDE with the  exocyclic amino group of dG (207). 
The ch arac te r of product m  was not fu rther established by Sephadex LH-20 
chrom atography but o ther workers have ten ta tiv e ly  iden tified  th is as a  DNA-bound 
product of 9-0H-BP-4,5-epoxide (339). The ra tio  product m  : product II in th is study was 
approxim ately 1:4 while o ther workers have found a much higher ra tio  (337). This m ay 
be a resu lt of the d iffe ren t BP concentrations used in the two studies, since rece n t work
by Legraverend e t al (344) showed th a t the re la tiv e  am ounts of the two adducts form ed 
depended on the  concen tration  of BP used.
The in itia l studies of the  HPLC separation  of m icrosom al m ediated BP-DNA adducts using 
a  Spherisorb ODS column indicated  only one m ajor adduct, in agreem ent w ith M eehan e t 
al (214), w hereas Sephadex LH-20 analysis of an iden tica l sam ple showed two m ajor 
products. This discrepancy was resolved when HPLC analyses w ere perform ed  using a 
uBondapak ODS column which resu lted  in the consistent observation of 2 m ajor products, 
B and C, toge ther w ith severa l minor products (Fig.38b).
Analysis of product II (Fig.37a) by HPLC showed th a t i t  co-chrom atographed w ith C 
(Fig.39a and c) and fu rther ch arac terisa tion  of C showed th a t i t  was iden tica l to  the  m ajor 
product form ed by e ither m icrosom al m ediated  binding to DNA of B P-7,8-diol (Fig.43c) or 
by d irec t reac tio n  of an ti BPDE with calf-thym us DNA (Fig.42a and c) or w ith dG (Fig.44). 
Thus we can conclude th a t product C is m ost probably due to  reac tio n  of an ti BPDE w ith 
the exocyclic amino group of dG (207). HPLC analysis of product IH (Fig.37a) yielded two 
com ponents, a minor product co-chrom atographing with A and a m ajor product which co­
chrom atographed w ith B (Fig.39a and b). M icrosomal m ediated  binding of 9-OH-BP to  
DNA resu lted  in a m ajor adduct which co-chrom atographed w ith B and a  m inor product 
w ith a sim ilar re ten tio n  tim e to  A (Figs. 42a and b : 43a and b). P roduct B is  probably 
form ed by reac tion  of the K -region epoxide of 9-OH-BP with DNA as outlined by King e t 
ad.(339).
Whilst these two adducts (B and C) have been characterised  by Sephadex LH-20
i
chrom atography, this is apparently  the firs t tim e th a t the  DNA adduct resu lting  from 
m etabolic activation  of 9-OH-BP has been analysed by HPLC. It is in te res tin g  th a t the  
ra tio  product B : product C was always approxim ately 2:1, using HPLC, thus tw ice as 
much BP is bound to  DNA as a 9-0H-4,5-epoxide product as is bound via a diol epoxide 
product (Table IX). This is som ew hat surprising in th a t m icrosom es from  a  3MC 
p re tre a te d  anim al w ere used and consequently one would expect low m etabolism  a t the K- 
region of BP and re la tive ly  high m etabolism  a t the bay region (347), how ever, perhaps 
hydroxylation a t the 9-position can d irec t m etabolism  to the 4,5-region of th e  m olecule.
Another, in te resting  face t of the  HPLC analyses was th a t the elution o rder of B and C was 
a reversal of the ir elution order on Sephadex LH-20 columns. Fig.45 shows the  two 
proposed electrophiles form ed from BP by r a t  liver m icrosom es. The an ti BPDE 
m etabo lite  (Fig.45a) has an in tac t pyrene nucleus and polar groups a t one end of the 
m olecule w hereas the  9-0H-BP-4,5-epoxide product (Fig.45b) re ta in s  a ro m a tic ity  in a
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Figure 45 P ro p o se d  reac t ive e l ec t ro p h i le s  formed during
microsomal acti vat ion of Benzo(a)pyrene
chrysene type stru c tu re  and has polar groups a t both  ends of the m olecule. Thus the 9 - 
OH-BP-4,5-epoxide DNA-adduct (B) is probably m ore polar than the an ti BPDE-dG product 
(C) and this would explain the ir re la tiv e  elution positions upon HPLC analysis. Although 
DNA adducts derived from 9-OH-BP have not been observed in any of the  in itia l studies 
using tissue cultures, organ cultures or iso la ted  cells (316), rece n t work suggested th a t 
these adducts m ight be the m ajor ones form ed when BP is m etabolised and bound to  DNA 
in iso la ted  viable ra t  hepatocy tes (348). However, these resu lts  do not agree with our 
p resen t d a ta  (C hapter 2).
Meehan _et al (214) found th a t HPLC analysis of BP-DNA adducts form ed in m icrosom al 
incubations yielded a single m ajor peak which they identified  as an ti BPDE bound to  dG. 
These resu lts  were sim ilar to our in itia l studies using a Spherisorb HPLC column (Fig.38a) 
when poor column effic iency  resu lted  in a  loss of resolution of the p roducts previously 
separa ted  by Sephadex LH-20 chrom atography (Fig.37a). However, M eehan e t al (214) 
suggested th a t magnesium ion concentrations in m icrosom al incubations m ay a ffe c t the 
q ualita tive  ch a rac te r of the deoxyribonucleoside adducts form ed when BP re a c ts  with 
DNA. Table IX shows th a t whilst the q u an tita tiv e  na tu re  of the  BP-DNA reac tio n  can be 
m odulated by variations in magnesium ion concentration , in agreem ent w ith o ther workers
(349), these variations had no e ffe c t on the qualita tive  yield of the p a rticu la r B P- 
deoxyribonucleoside adducts form ed and the re la tiv e  ra tio s  of these p roducts was 
iden tica l in all incubations.
Magnesium ions can inhibit the loss of large and small ribosom al subunits from rough
>
m icrosom es induced by the presence of high concentrations of m onovalent ions, e.g. KC1
(350), which, in the absence of magnesium ions, resu lt in a detachm en t of all the 
m em brane bound ribosomes. Such changes in the m icrosom al m em brane could obviously 
a ffe c t the m etabolic activation  of BP and the subsequent covalent binding of reac tiv e  
m etabolites. The in itia l increase in BP-DNA binding and then the m arked inhibition of 
this increase with increasing magnesium ion concen tration  (Table IX) para lle ls  the 
response of AHH to a ltera tions in the incubation concen tration  of magnesium ions (351). 
T herefore, the quan tita tive  varia tion  in BP-DNA binding w ith magnesium ion 
concentration  is m ost likely a reflec tion  of the am ount of BP m etabolised.
In summary, a HPLC system  was developed for the separation  of hydrocarbon- 
deoxyribonucleoside adducts form ed by m icrosom al activation  of BP. S eparation  of the  
adducts was aided by the use of an isocratic  solvent elution system  ra th e r  than grad ien t 
elution, thus in all fu rther studies a 50% m ethanol 0 50% w ater elution solvent was used. 
The major DNA-adduct formed in these studies was derived from fu rther m etabolism  of 9 - 
OH-BP whilst the adduct derived from an ti BPDE was form ed in sm aller am ounts. The 
re la tiv e  amounts of the two adducts form ed were independent of magnesium ion 
concentration.
CHAPTER TWO
BINDING OF BENZO(a)PYRENE TO DNA IN ISOLATED VIABLE RAT HEPATOCYTES. 
Separation of the  DNA-bound products:
E ffe c t of 3-m ethylcholanthrene p re tre a tm en t on the form ation of benzo(a)pyrene-DNA 
adducts.
In troduction
The previous chap ter dealt only with the m icrosom al activation  of BP to DNA-bound 
products, however, the use of m icrosom al fractions imposes a s tr ic t lim ita tion  upon the 
ex trapolation  of d a ta  to the whole animal. C o-facto rs and in some cases enzymes, 
necessary  for both  the form ation and detoxication  of reac tiv e  in term ed ia tes  may be lost 
when isolated  subcellular com ponents are u tilised  in m etabolism  studies. The use of 
freshly isolated cell suspensions and cell cu ltures ensures an in ta c t ce llu lar in teg rity  
containing enzym es and co fac to rs necessary  for the oxidative and conjugative 
b io transform ations of xenobiotics.
The in itia l studies on the biological e ffec ts  of carcinogenic PAH in iso la ted  cell system s
showed th a t these chem icals could induce m alignant transform ation  in e ith e r embryonic
ham ster fibroblast (352) or C3H mouse p ro s tra te  (353) cell cultures. Ind irec t evidence
th a t PAH are m etabolically  ac tiva ted  by cells in cu lture was obtained when Diamond e t al
(328) showed th a t tritium  labelled DMBA was bound to  the m acrom olecular constituen ts
of a varie ty  of m am m alian cells, a situation  in which hydrocarbon m etabolism  occurs
(354). Cells in cu lture have also been used to study the cy to tox icity  of PAH (328,355,356)
and in general the re  was a correlation  betw een the carcinogenicity  of the  hydrocarbon and
its  toxicity . I t  was suggested th a t tox icity  was co rre la ted  with the level of binding of the
carcinogen to cellu lar m acrom olecules. M etabolism studies with BP (357) and DMBA (354)
showed th a t cells which were re la tive ly  re s is tan t to hydrocarbon tox ic ity  have a  re la tive ly
reduced capacity  to m etabolise the hydrocarbons to w ater-soluble derivatives. Duncan e t
al (358) studied the metabolism  and DNA binding of a series of PAH in mouse em bryo cells
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in culture and found a good correlation  betw een  the  carcinogenicity  of the  hydrocarbons 
and the ex ten t of the ir reac tion  with DNA, in agreem ent with the previous work on mouse 
skin (183). PAH K -region epoxides, once regarded as being the u ltim a te  carcinogens 
derived from PAH, w ere found to bind to the m acrom olecular constituen ts  of roden t cells 
in cu lture  to a g rea te r ex ten t than the paren t hydrocarbons (359), however, this did no t 
co rre la te  with the ir carcinogenic potency when adm inistered subcutaneously or topically  
to m ice (reviewed in ref. 189). M arquardt e t al (360,361) studied the  m alignant 
transform ation  of C3H mouse p ro s tra te  cells by K -region epoxides of PAH and showed 
th a t for some hydrocarbons, the K -region epoxides w ere much m ore ac tiv e  than the 
p aren t hydrocarbons in effecting  transform ation . For others, notably 7 MB A or 7-0H - 
MBA, the ac tiv ities  of the K-region epoxides w ere sim ilar to or even slightly  lower than 
those of the re la ted  hydrocarbons.
The em ergence of a chrom atographic system  able to sep ara te  hydrocarbon- 
deoxyribonucleoside adducts, form ed following m etabolic activation  of PAH and binding 
to  DNA, enabled Baird e t al to show th a t the K-region epoxides of MBA(190) and BP(191)
w ere not the m etabolites responsible for the major DNA adducts form ed by these 
hydrocarbons in cultured rodent cells. A tten tion  then focused on non-K -region 
m etabo lites of PAH in order to establish the m etabo lites which becom e bound to  cellu lar 
DNA. Sims e t al (194) showed th a t the m ajor BP-deoxyribonucleoside adduct form ed in 
rodent cell cultures incubated with BP was derived from a 7 ,8-diol-9,10-epoxide 
m etabo lite  of BP form ed by epoxidation of BP-7,8 -diol on the ad jacen t olefinic double 
bond. BPDE can exist as two geom etrical isom ers (196) nam ely syn and an ti BPDE 
depending w hether epoxide form ation is above or below the plane of the ring. Both 
isom ers w ere reported  to d iffer m arkedly in the ir ability  to m u ta te  (200,362-365) and 
transform  (363,366) cultured m am m alian cells. The an ti isom er always being the m ore 
po ten t. However, in b ac te ria l cells the syn isom er was the m ore pow erful m utagen, thus, 
b ac te ria l cells may be invalid models to  ex trapo la te  m utagenesis d a ta  to m am m alian 
system s. King e t al (198) showed th a t mouse embryo cell cu ltures could form both  syn and 
an ti BPDE-DNA adducts with the la t te r  product predom inant. T im e course studies of th e  
binding of BP to DNA in ham ster embryo cells (199) showed th a t the  re la tiv e  am ounts of 
syn or an ti BPDE -  DNA adducts form ed depended on the tim e of exposure of the  cells to  
BP. In recen t studies using iso la ted  cells to investigate  the form ation of BP-DNA 
products, the m ajor hydrocarbon-deoxyribonucleoside adducts w ere derived from BPDE 
(160,194,198-199,341,367-371), however, a recen t study of Jernstrom  e t al (348) using 
iso lated  hepatocy tes from 3MC p re tre a te d  ra ts , to m etabolically  a c tiv a te  BP rep o rted  
th a t using a d iffe ren tia l fluorescence m ethod, the m ajor BP-DNA was derived from 
fu rther metabolism  of 9-OH-BP not BP-7,8-diol. This 9-OH-BP derived D NA -adduct had 
previously been observed during the ra t  liver m icrosom al m ediated binding of BP to DNA 
(C hapter 1) (336,339) but had never before been observed in th e  DNA of cells incubated 
with BP. The fluorescence evidence for a 9-0H-BP-D N A-adduct in ra t  hepatocy tes (348) 
was obviously an im portan t observation and required  conform ation as such resu lts  could 
explain the re la tive  resistance of the liver to  PAH -induced carcinogenesis.
In this study it  was observed th a t iso lated hepatocy tes from both  con tro l and 3M C- 
p re tre a te d  ra ts  m etabolise BP to reac tive  m etabolites which covalently  bind to  DNA. 
Using HPLC to separate  the BP-deoxyribonucleoside adducts, the m ajor adduct form ed in 
hepatocy tes from both control and 3M C -pretrea ted  ra ts  was due to  the  anti BPDE and not 
due to a fu rther m etabolite  of 9-OH-BP.
R esults
Iso la ted  h ep a to cy tes  from  both  u n tre a te d  or 3MC p re tre a te d  ra ts  w ere incubated  w ith
( H)BP (55uM) and th e  DNA iso la ted , purified  and hydrolysed as described  in M aterials and
: Methods. The hydrocarbon -  deoxyribonucleoside adducts w ere pu rified  by Sephadex LH -
20 chrom atography and analysed by HPLC as described  in m a te ria ls  and m ethods. S everal
d is tin c t B P-deoxyribonucleoside p roducts w ere c learly  p resen t (Fig.46a and b). The m ajor
adduct (C) co-chrom atographed  w ith bo th  th e  m ajor hydrocarbon-deoxyribonucleoside
adducts form ed by enzym ic hydrolysis of DNA previously re a c te d  w ith  e ith e r  an ti BPDE 
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(Fig.46a) or w ith  ( H)BP-7,8-d iol m etabo lica lly  ac tiv a te d  w ith m icrosom es (Fig.46b). This 
adduct genera lly  m ade up about 50-60% of the  to ta l adducts (Table X).
TABLE X
BINDING OF BENZO [a JPYRENE TO ENDOGENOUS DNA IN HEPATOCYTES 
FROM UNTREATED AND 3-MC-TREATED ANIMALS AND EXOGENOUS DNA 
USING MICROSOMES AS THE ACTIVATING SYSTEM
The relative quantitative distribution of hydrocarbon-deoxyribonucleoside products is 
shown as a percentage of the total DNA adducts. The major adducts B and C are derived 
from further metabolism of 9-hydroxybenzo[aJpyrene and 7,8-dihydro-7,8-dihydroxy - 
benzo [a ]pyrene respectively.
Activating Animal Incubation time pmol bound/ Relative adduct distribu-
system pretreatment (min) mg DNA tion % of total
A B C D E F
Hepatocytes Control 80 5.2 7 3 64 — -  5
Hepatocytes 3-MC 80 14.5 10 7 45 — -  3
Hepatocytes Control 30 3.1 <2 <2 65 — — 8.6
Hepatocytes 3-MC 30 4.6 5 5 60 — — 7
Microsomes 3-MC 30 79 6 57 25 2 3 2
Small am ounts of th e  o the r tw o adducts (A and B) w ere also observed (Fig.46b). The 
hydrocarbon-deoxyribonucleoside adduct which chrom atographed w ith  peak  B was m ost 
probably due to  a  fu rth er m etab o lite  of 9-OH-BP as a  sim ilar adduct was observed  when 
ca lf thym us DNA was re a c te d  w ith  9-OH-BP in the  presence of liver m icrosom es from  ra ts  
p re tre a te d  w ith  3MC (Fig.47).
The q u an tita tiv e  binding of BP to  DNA in iso la ted  h ep a to cy te s  was in c reased  
approxim ately  th reefo ld  by p re tre a tm e n t of th e  anim als w ith 3MC (Table X). H ow ever, 
th e  qu a lita tiv e  n a tu re  of the BP-DNA reac tio n  was very  sim ilar a f te r  incubation  fo r 30 or 
80 m inutes (Table X) and in cells from e ith e r uninduced or induced anim als (Fig.46a and 
b).
In strik ing  co n trast to the  resu lts  w ith iso la ted  r a t  liver hep a to cy tes, binding of BP to
Legend to  F igure 46
Id en tifica tio n  of the m ajor deoxyribonucleoside adducts form ed by m etabo lic  ac tiv a tio n  of 
BP by iso la ted  r a t  hepatocy tes. H epatocy tes from contro l (a. o— o) or 3MC p re tre a te d  
anim als (b. o— o) w ere incubated  w ith  BP (55uM) for 80 mins. The DNA was iso la ted , 
pu rified  and hydrolysed enzym ically  to  deoxyribonucleosides which w ere analysed by 
HPLC. Iden tifica tion  of the  m ajor DNA-bound products was achieved by co- 
chrom atography with deoxyribonucleoside adducts form ed by hydrolysis of DNA previously 
re a c te d  w ith  an ti BPDE (a. I— 1) or w ith m icrosom ally ac tiv a ted  ( H)BP-7,8-diol (b.*—*)• 
U.V. absorbance was m onitored continuously a t 254nm. R adioactive  sam ples w ere 
analysed by liquid sc in tilla tion  counting and resu lts  are  expressed as dpm /frac tion .
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Iden tifica tion  of m icrosom e-m ediated BP-deoxyribonucleoside adducts. R a t-liv er 
m icrosom es from 3M C -pretreated  ra ts  w ere incubated w ith ( H)BP (4.2uM) to g e th er w ith 
an NADPH generating  system  and exogenous calf-thym us DNA. The DNA was iso la ted , 
purified  and hydrolysed enzym ically to  deoxyribonucleosides which w ere analysed by 
HPLC (•—•). The m ajor DNA-bound product was identified  by co-chrom atography w ith 
D NA-adducts form ed by hydrolysis of DNA previously re a c te d  w ith m icrosom ally 
ac tiv a ted  (^H)9-0H-BP (o—o). R esults are  expressed as dpm /fraction .
DNA in the presence of r a t  liver microsom es yielded a m ajor BP-DNA adduct which co- 
chrom atographed w ith peak B (Fig.46) and accounted for 50-60% of the to ta l adducts 
(Table X). Previous work (see Chapter"!) showed th a t this adduct (B) co-chrom atographed 
w ith the m ajor adduct form ed by reac tion  of m etabolically  ac tiv a ted  9-OH-BP w ith DNA 
(Fig.47), whilst the  adduct co-chrom atographing w ith peak C, derived from  an ti BPDE, 
m ade up only 25% of the to ta l adducts form ed (Table X).
Discussion
This study was undertaken to  investigate  the binding of BP to  DNA in cells derived from a 
tissue generally regarded  as being re la tive ly  re s is tan t to  PAH induced carcinogenesis. 
Previous workers (372) have shown th a t BP could be m etabolised and bound to  DNA and 
o ther cellu lar m acrom olecules in iso la ted  hepatocy tes but the  n a tu re  of this in te rac tio n  
had not been thoroughly investigated .
Isolated hepatocy tes from both  control and 3MC p re tre a te d  ra ts  m etabolised BP to 
reac tiv e  m etabo lites which w ere covalently  bound to  DNA. Separation of hydrocarbon- 
deoxyribonucleoside adducts by HPLC suggested th a t the m ajor adduct (C) was derived 
from reac tion  of a  fu rther m etabo lite  of BP-7,8-diol, i.e . an ti BPDE, w ith DNA (Fig.46a 
and b). O ther w orkers have shown th a t this diol epoxide is bound predom inantly  to  the 
exocyclic amino group of dG in DNA (207,210). O ther studies using in ta c t cells, in v itro , 
th a t are  susceptible to BP induced transform ation , has shown a sim ilar m ajor BP-DNA 
adduct form ed from the bay-region diol epoxide, an ti BPDE (341).
However, when the norm al balance of the oxidative and conjugating enzym es are  
disrupted, as in the m icrosom al preparations, the  major hydrocarbon-deoxyribonucleoside 
adduct is derived from fu rther m etabolism  of 9-OH-BP m ost likely a t the  4,5-position 
(Fig.47) (336,339). The m ost likely reason for these strik ingly  d iffe ren t BP- 
deoxyribonucleoside profiles betw een hepatocy tes (Fig.46) and m icrosom es (Fig.47) is th a t 
in a m icrosom al system  the  necessary  cofactors to  conjugate 9-OH-BP to  its  glucuronide 
or sulphate derivative w ith e ither UDP-glucuronic acid or 3'-phosphoadenosine-5’-  
phosphosulphate respectively , are not p resen t. However, in hepatocy tes, 9-OH-BP m ay be 
readily  conjugated, as shown by o ther workers (372).
In an a ttem p t to  m odify the form ation of BP-DNA adducts in hepatocy te  suspensions, 
cells freshly iso la ted  from u n trea ted  anim als w ere preincubated for 10 m inutes w ith 
phenolphthalein (50uM), an inhibitor of conjugation in m icrosom al preparations (373). BP 
(55uM) was then added as before and incubation continued for 80 m inutes. In b rie f, when 
the  DNA from the cells was isolated , hydrolysed and analysed by HPLC, the hydrocarbon- 
deoxyribonucleoside profile obtained was identica l to th a t shown in Fig.46a. One could 
conclude th a t e ither phenolphthalein is inactive as an inhibitor of conjugation in the  
hepatocy tes or th a t i t  was unable to p en e tra te  the cell m em brane and a ffe c t the 
necessary  enzym es.
In con trast to  the resu lts obtained in this study, Jernstrom  e t al (348) using a  d iffe ren tia l
fluorescence m ethod reported  th a t the m ajor BP-DNA adduct in hepatocy tes from  animals 
p re tre a ted  w ith 3MC was due to fu rther m etabolism  of 9-OH-BP. I t is d ifficu lt to  
ra tionalise  the  im portan t d ifference betw een the ir resu lts  and the  p resen t study but i t  is 
possible th a t the  re la tive ly  weak signals of the  adducts in hepatocy tes obtained in th e ir 
study m ay have been influenced by fluorescent im purities. The resu lts  obtained in the 
present study showing th a t the m ajor adduct, bound to  DNA in rat hepatocy tes incubated 
w ith BP, is derived from the 7,8-diol-9,10-epoxide is in good ag reem ent w ith m any o ther 
studies using in ta c t cells in cu lture, as ind icated  previously.
I t  is of in te re s t to  no te  th a t r a t  liver, a tissue re la tive ly  re s is tan t to  PAH-induced 
carcinogenesis, is capable of form ing significant am ounts of an ti BPDE bound to  dG, the  
adduct believed to be responsible for the in itia tion  of tum ourigenicity  by BP.
CHAPTER THREE
FORMATION OF BENZO(a)PYRENE -  DEOXYRIBONUCLEOSIDE ADDUCTS IN MOUSE
SKIN IN VIVO
Tw o-stage carcinogenesis in the skin of Swiss mice:
Iden tification  of benzo(a)pyrene-deoxyadenosine adducts in mouse skin in vivo:
Form ation of benzo(a)pyrene-DNA adducts in d ifferen t stra ins of mice:
E ffec t of several compounds on the  form ation of benzo(a)pyrene-DNA adducts:
Analysis of deoxyribonucleoside adducts form ed by mouse skin m icrosom al m ediated  
binding of benzo(a)pyrene to  DNA.
In troduction
The previous two chapters have dea lt w ith the use of m icrosom al fractions or iso la ted  cell 
suspensions to  study the  m etabolic activation  of BP to  DNA binding products. Isolated  
cells and cells in tissue cu lture  provide an excellen t model to  study biological responses 
such as m utagenicity  and transform ation , however, an ex trapolation  from these responses 
to  cancer induction in animals and man in very d ifficu lt.'M ore in vivo system s' such as 
tissue cu lture and whole organ perfusion, where cell to  cell co n tac t is m aintained in an 
in ta c t tissue, have also been adapted to  study the m etabolic ac tiva tion  of PAH. However, 
th e  ideal system  to use is the  whole anim al, where one can re la te  a b iochem ical response, 
such as reac tion  of an ac tiv a ted  m etabo lite  w ith DNA, to  a re levan t biological response, 
such as tum our induction.
As early  as 1940 PAH, such as DB(a,h)A and BP, w ere regarded as p o ten t carcinogens in 
the  skin of m ice when applied topically  (18,19). Subsequent m etabolism  studies w ith BP 
showed the form ation of phenolic m etabo lites (181) which w ere not carcinogenic (180) and 
it  was th e re fo re  thought th a t BP and o ther PAH w ere carcinogenic per se . The early  
studies on the carcinogenicity  of PAH relied  on rep ea ted  applications of the  carcinogen to 
mouse skin, however, in 1947 Berenblum and Shubik described experim ents dem onstrating  
th a t chem ical carcinogenesis in mouse skin could be divided in to  two d is tin c t stages (76). 
The firs t stage , in itia tion , was a ffec ted  by the  single d irec t application of a carcinogen, 
such as a PAH, to  the skin of m ice. This stage , in itse lf, did not resu lt in the  form ation  of 
tum ours. The second stage, prom otion, was e ffec ted  by rep ea ted  applications of a 
prom oter, usually a skin irr ita n t such as croton oil, to the in itia ted  area . Prom oting 
agents by them selves were not carcinogenic and in most instances induced a hyperplasia 
of the skin, though this e ffec t in itse lf  was insufficient to provoke the  prom otion of 
in itia ted  cells (84).
( - ' -
The concept of PAH being carcinogenic per se persisted  un til 1951 when M iller (182) 
dem onstrated  th a t BP becam e covalently bound to  the epiderm al p ro teins of mouse skin. 
A more detailed  study by Brookes and Lawley in 1964 showed th a t several tritiu m  labelled  
PAH becam e bound to  the  DNA, RNA and p ro tein  of mouse skin (183). They also observed 
a correlation  betw een the carcinogenic potency of the PAH and the ir ex ten ts  of reac tio n  
w ith DNA, but not RNA or protein . F u rth er analysis of this DNA bound m a te ria l from 
mouse skin tre a te d  topically  with radiolabelled PAH aw aited a technique able to  sep ara te  
and resolve the  hydrocarbon-DNA adducts.
In 1969, Kreik described the  iden tification  of a DNA adduct of 2AAF in r a t  liver in vivo 
using Sephadex LH-20 chrom atography (249). Raym an e t al (374), using the sam e 
technique and m ethanol as the eluant, identified  dG, dA and dC adducts when 7-BrM eBa 
and 7-BrMe-12Me-BA w ere applied topically to m ice in vivo. Baird and Brookes (331) 
m odified the Sephadex LH-20 technique by using m ethano l/w ater grad ien ts to analyse the 
deoxyribonucleoside adducts form ed by 7-MBA in rodent embryo cells, however, the  
p a rticu la r PAH m etabo lite /s  responsible for the cellu lar DNA bound products evaded 
discovery (190).
In recen t years the most extensively studied PAH has been  the  po ten t carcinogen BP. The 
work of Sims e t al (194) established th a t in rodent cells in tissue cu ltu re  m etabolic  
activation  of BP was m ediated via a 7,8-diol-9,10-epoxide form ed on the  angular benzo- 
ring. During the  la s t six years a w ealth  of inform ation has accum ulated  im plicating such 
diol-epoxides in the m etabolic activation  of several PAH.
Topical application of BP to  mice in vivo resu lted  in the form ation of covalently  bound 
products of which the major one was derived from BPDE(375,376). R ecen t work 
established th a t this DNA-bound product is form ed by stereospecific  reac tio n  of the  7R 
form of anti BPDE with the exocyclic amino group of dG (213). The an ti isom er of BPDE 
has been reported  to induce epiderm al hyperplasia (377) and exhibit tum our in itia ting  
ability  (279) when topically applied to mice. In con trast to the mouse skin studies in vivo, 
mouse skin m icrosom al m ediated  BP-DNA adducts have been  shown to  arise m ainly 
through reac tion  of the K-region m etabolite , BP-4,5-epoxide, w ith DNA (378), how ever 
the relevance of these adducts to carcinogenesis is uncertain . Feldm an e t al (379) have 
recen tly  shown th a t, in A549 cells, BP-4,5-epoxide-DNA adducts are  repaired  re la tive ly  
rapidly com pared to an ti BPDE-DNA adducts. The form ation of an ti BPDE-dG adducts 
has been shown to co rre la te  with m utagenesis in m am m alian cells (367) and carcinogenesis 
in mouse skin (380). Phillips e t al (381) found th a t a good co rre la tion  existed  betw een  the 
carcinogenicity  of various polycyclic hydrocarbons in mouse skin and the  ex ten t of 
form ation of the ir respective DNA-bound products in th a t tissue. However, they found no 
difference in the qualita tive or quan tita tive  natu re  of DMBA-DNA or BPDE-dG adducts 
form ed in the skins of m ice e ither susceptible or re la tive ly  re s is tan t to  PAH -induced skin 
carcinogenesis (329). T herefore the form ation of these products does not in itse lf  explain 
the reported  differing susceptib ilities of these m ice tow ards PAH-induced skin tum our 
form ation (382). One possibility is th a t o ther qualita tively  minor, BP-DNA adducts, not 
detec tab le  by Sephadex LH-20 column chrom atography may also be form ed and be of 
biological im portance.
Many chem icals including TCDD (383), an ti-in flam m atory  agents (384), flavones (385,386), 
PAH (387) and co-carcinogens such as ca techo l and pyrogallol (388) are known to  modify 
the  tum ourigenicity  of PAH in general though, in many cases, th e ir e ffec ts  on the 
form ation of PAH-DNA adducts are unknown. In the case of BP, TCDD has been  shown to  
inhibit bo th  skin tum our in itia tion  and the concom itant form ation of BPDE-dG adducts in 
m ice (378).
Although the exocyclic amino group of dG is the m ajor ta rg e t of an ti BPDE in DNA (207),
several o ther quan tita tively  minor products have been observed in v itro  arising from
7 4a ttack  on the N position of dG (215), the N position of dC (342), the  backbone
phosphates of DNA (389) and with dA (214). This la t te r  product has recen tly  been  fu rth er
characterised  as anti BPDE bound to the  exocyclic amino group of dA (342). DiGiovanni
e t al (390) showed th a t, for a series of PAH, binding of the hydrocarbons, m ediated  by
epiderm al hom ogenates, to  poly-A, bu t not poly-G, co rre la ted  w ith the carcinogenic
potencies of the hydrocarbons on mouse skin. The in v itro  form ation of BP-dA products
has been observed in the DNA of both  ham ster embryo cells (341) and r a t  trachea l
explants (391) tre a te d  in culture with BP. The in v itro  binding of an ti BPDE to dA in DNA
was found to cause a local denatu ration  of the DNA w hereas a  m ore than 10-fold g rea te r
binding to dG did not c rea te  such denatu ration  (392). The relevance of these
quan tita tive ly  minor base arylation products to carcinogenesis is as y e t unknown.
The p resen t study describes the in vivo form ation of such po ten tia lly  im portan t an ti 
BPDE-dA adducts in mouse skin following application of an in itia ting  dose of BP. The 
e ffec ts  of catechol, a  co-carcinogen; BA, a PAH, and 1-naphthol and diphenylacetic acid, 
readily  conjugated compounds, on the form ation of both dG and dA adducts of an ti BPDE 
in mouse skin were also investigated . B ecause of the wide use of m icrosom al 
preparations in studies on PAH m etabolism  and DNA binding i t  was also of in te re s t to 
com pare and con trast the in vivo form ation of BP-deoxyribonucleoside adducts in mouse 
skin to those form ed by mouse skin m icrosom al m ediated binding of BP to  DNA.
R esults:
The resu lts  of a  two stage skin carcinogenesis experim ent using Swiss m ice are  shown in 
Fig.48. Three groups of m ice (10 anim als per group) w ere used. In the f irs t group m ice 
w ere in itia ted  w ith BP (200nmoles) and then received  rep ea ted  applications of acetone 
(200ul tw ice weekly) for 16 weeks. No tum ours w ere observed a f te r  th is tre a tm e n t, 
exem plified in Fig.49. The second group of m ice received  a  single application of ace tone 
(200ul) followed by tw ice weekly applications of TPA (17nmoles). This tre a tm e n t resu lted  
in inflam ed areas of skin and m arked hair loss, a typical illu stra tion  being shown in Fig.50. 
The final group of anim als th a t w ere in itia ted  w ith BP (200 nmoles) and prom oted by 
tw ice weekly applications of TPA (17nmoles) w ere the only group to  show a high tum our 
incidence (Fig.48), a  typical response being shown in Fig.51. Having established the  
susceptib ility  of these m ice to  BP in itia ted  skin tum ourigenesis they  w ere used to 
investigate  the  n a tu re  of the  BP-DNA in teractions occurring in the  susceptible tissue in 
vivo.
3
Swiss mice w ere tre a te d  topically  w ith an in itia ting  dose of ( H)BP (200nmoles) and killed 
a f te r  24 hours. The hydrocarbon-deoxyribonucleoside adducts form ed in DNA iso la ted  
from the tre a te d  areas w ere analysed by HPLC (Fig.52a). Several adducts w ere form ed, 
of which the m ajor one, C, accounted for 60-70% of the to ta l yield of adducts (Table XI). 
This adduct co-chrom atographed with the m ajor DNA bound product (80% of to ta l 
adducts; Table XI) form ed following reac tion  of an ti BPDE with calf-thym us DNA 
(Fig.52c) and has been identified  as anti BPDE bound to the exocyclic amino group of dG 
(207).
Previous resu lts  (see C hapter 1) have dem onstrated  th a t the minor product, B (Fig.52a), 
accounting for approxim ately 10% of the to ta l adducts (Table XI), co-chrom atographed 
w ith the  DNA adduct derived from reac tion  of a fu rther m etabo lite  of 9-OH-BP, m ost 
probably 9-0H-BP-4,5-epoxide (339) bound to  an, as ye t, uncharacterised  base in DNA, 
though presen t evidence indicates th a t both purine bases may be involved. The m ore polar 
adducts, which elu ted  prior to  B and accounted for 3-6% of the  to ta l adducts (Table XI), 
have not been identified , however, the adduct which co-chrom atographed w ith A also 
arose following m icrosom al ac tivation  of BP in the presence of exogenous DNA . (see 
C hapter 1).
Two la te r eluting DNA adducts D and E (Fig.52a), which constitu ted  approxim ately  3-5% 
of the to ta l adducts (Table XI), were also form ed following reac tion  of an ti BPDE w ith 
DNA (Fig.52c). These adducts co-chrom atographed with two of the four products,
Legend to  F igure 48
Fem ale Swiss m ice (10 anim als per group) were shaved 24 hours prior to 
trea tm e n t. BP (200 nmoles) (BP + TPA group) in acetone (200 ul) or 
acetone (200 ul) (TPA group) were topically applied in a single dose and 
both  groups of anim als tre a te d  one week la te r  by tw ice weekly 
applications of TPA (17 nmoles) in ace tone (200 ul) topically. Animals 
were tre a te d  up to  30 weeks and tum our form ation assessed continuously. 
R esults are expressed as (a) to ta l num ber of papillom as per group of 
anim als or (b) number of m ice with papillom as within a group.
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Legend to  F igures 49-51
F em ale  Swiss mice (10 anim als per group) w ere shaved 24 hours prior to tre a tm e n t. 
A nim als w ere tre a te d  topically  w ith (a) a  single application  of BP (200 nmoles) in ace tone 
(200 ul) followed one week la te r  by tw ice w eekly applications o f ace tone (200 ul) for up 
to 30 weeks (Fig.49) or (b) a single application  of ace tone (200 ul) followed one week la te r  
by tw ice weekly applications of TPA (17 nmoles) in acetone (200 ul) for up to 30 weeks 
(Fig.50) or (c) a single application of BP (200 nmoles) in ace tone  (200 ul) followed one 
w eek la te r  by tw ice weekly applications of TPA (17 nmoles) in ace tone (200 ul) for up to 
30 weeks (Fig.51). Photographs rep resen t typ ical positive responses w ithin each group.
Figure 4 9
F i g u r e  5 0
F i g u r e  51
Legend to  F igure 52
Id en tifica tio n  of BP-deoxyribonucleoside adducts form ed in mouse skin. Swiss m ice w ere
tre a te d  top ically  w ith ( H)BP (200 nmoles) and 24 hours la te r  DNA was iso la ted  from the
tre a te d  area , purified , and hydrolysed to  deoxyribonucleosides which w ere analysed by
HPLC (a) as described in M aterials and M ethods. The BP-DNA adducts w ere iden tified  by
3
co-chrom atography w ith deoxyribonucleoside adducts form ed by reac tio n  of ( H)dA w ith
3
an ti BPDE (b) or by hydrolysis of DNA previously re a c te d  w ith  ( H) an ti BPDE (c).' 
R esu lts  are  expressed as dpm /fraction .
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TABLE XI
BENZO (a) PYRENE-DEOXYRIBONUCLEOSIDE ADDUCTS 
FORMED IN MOUSE SKIN IN VIVO AND BY REACTION 
OF an ti BPDE WITH DNA IN VITRO*
System
R elative  adduct d istribution (%)
pm oles BP/ 
mg DNA
A B C D E 2* and 3'
3.1 5 10 63 2 1 0.1
920.0 2 - 81 1 0.2 2
Swiss m ice + BP 
A nti BPDE + DNA
* See M aterials and M ethods for details.
TABLE Xn
EFFECTS OF VARIOUS CHEMICALS ON THE FORMATION 
OF BENZO(a)PYRENE-DEOXYRIBONUCLEOSIDE ADDUCTS IN 
THE SKIN OF SWISS MICE
3
T rea tm en t re la tiv e  to ( H) 
BP application
R elative adduct d istribu tion (%)
P re ­
trea tm e n t
P o s t-
trea tm e n t
pm oles 
BP/mg DNA A B C D E 21 and 3'
- - 3 .1 5 10 63 3 1 0.1
single dose 
of BP + 
catecho l
- 2.3 4 14 60 3 0 .7 —
m ultiple 
doses (4x) 
of BP + 
catecho l
2 .9 6 4 67 2
1-naphthol 1-naphthol 1.8 6 16 64 3 0 .6 -
diphenyl-
ace tic
acid
diphenyl-
ace tic
acid
1.6 5 9 64 - - -
BA - 3 .3 7 15 42 3 0 .5 -
* See M aterials and Methods for details
labelled 1’—4* in accordance with Je ffrey  e t al (393), form ed a f te r  incubation of an ti BPDE 
w ith dA (Fig.52b) whilst the  HPLC system  used in the p resen t study did not fully resolve 
the anti BPDE-dA products this was not necessary  for iden tification  purposes. R eac tion  
of an ti BPDE with calf-thym us DNA gave rise  to several dA-bound products (Fig.52c) of 
which the m ajor one, co-chrom atographing with 3*, is derived from the 7S form of anti 
BPDE bound to the exocyclic amino group of dA (393). In co n trast to  this, when BP is 
bound to  DNA in the skin of Swiss m ice in vivo (Fig.52a) ony two of the four possible anti 
BPDE-dA products w ere form ed, nam ely 1* and 4', derived from reac tio n  of the  exocyclic 
amino group of dA w ith the 7R form of an ti BPDE by trans and cis addition respectively  
(393).
The form ation of BP-DNA adducts in Swiss m ouse-skin in vivo was not m arkedly a lte red  
when catecho l + BP, BA, 1-naphthol or diphenylacetic acid w ere applied top ically  to  the 
skin prior to and/or following BP adm inistration  (Table XII). In all cases the m ajor 
hydrocarbon-deoxyribonucleoside adduct co-chrom atographed with C (Fig.52a) and was 
derived from reac tion  of anti BPDE with the exocyclic amino group of dG. The DNA 
adduct derived from fu rther m etabolism  of 9-OH-BP, co-chrom atographing w ith B, was 
also observed in all cases. A dducts derived from reac tion  of an ti BPDE w ith dA, co­
chrom atographing with D and E (Fig.52a and b) w ere usually p resen t bu t in anim als 
trea ted  with d iphenylacetic acid, prior to and following BP trea tm e n t, they  w ere absent.
P revious work has established m arked d ifferences in the susceptib ility  of d iffe re n t mouse 
strains to PAH -induced skin tum ourigenesis (382). However, subsequent studies on the 
binding of BP and DMBA to epiderm al DNA in these strains revealed  no d ifferences in 
e ither the appearance or rem oval of the quan tita tive ly  m ajor hydrocarbon- 
deoxyribonucleoside adducts, as m easured by Sephadex LH-20 column chrom atography 
(329). In order to explore the possibility th a t d ifferences in the m ore minor adducts, 
d e tec tab le  only by HPLC, may be able to explain the d iffering suscep tib ilities of th e  
various mouse strains, the adducts form ed in DNA iso lated  from the skins of bo th  DBA/2 
and C57BL/6 m ice (Fig.53) have been exam ined. In both  strains the m ajor DNA-bound 
product, C, accounting for g rea te r than 60% of the to ta l adducts (Table XIII), co- 
chrom atographed with the trans 7R an ti BPDE-dG product as for the Swiss m ice (Table 
XI) and in agreem ent with o ther workers (213). The HPLC pro files of the  B P- 
deoxyribonucleoside adducts form ed in the skins of the m ice were v irtually  iden tica l w ith 
the profile obtained for Swiss mice (Fig.52a and Fig53). The skins from all th ree  stra ins 
form ed sim ilar am ounts of adducts which co-chrom atographed with A, B, D and E (Tables 
XI and Xm). The m ajor anti BPDE-deoxyadenosine adduct ( l1) in all th ree  s tra in s co- 
chrom atographed with D.
A vivid con trast was observed betw een the in vivo DNA adducts form ed from BP in the
Legend to  F igure 53
Separation  of BP-deoxyribonucleoside adducts form ed in m ouse skin. DBA/2 or C57BL/6 
m ice w ere tre a te d  top ically  w ith ( H)BP (200 nmoles) and DNA iso la ted  from the tre a te d  
a re a  24 hours la te r . The DNA was hydrolysed to  deoxyribonucleosides which w ere 
analysed by HPLC as described previously (M aterials and M ethods). The BP-DNA adducts 
form ed  in the skins of DBA/2 (a) and C57BL/6 (b) m ice w ere iden tified  by com parison of 
th e ir  e lu tion tim es w ith those of s tandard  m arker products as shown previously (Fig.52).
i
R esu lts  are  expressed as dpm /fraction .
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TABLE XU!
BENZO (a) PYRENE-DEOXYRIBONUCLEOSIDE ADDUCTS 
FORMED IN THE SKIN OF MICE OF DIFFERENT STRAINS
Strain
Susceptibility 
to  PAH -induced 
carcinogenesis
pm oles 
BP/m g DNA
A
R elative
adduct
distribution
B C
(%)
D E
Swiss WR 3 .3 5 10 63 2 1
C57BL/6 ** 3 .4 6 10 67 2 0 .3
DBA/2 * 4 .8 4 9 64 2 0 .3
3
Mice were tre a te d  topically  w ith ( H) BP (200 nmoles), killed 24 hours la te r  and 
DNA iso la ted  from  th e  tre a te d  areas, purified, hydrolysed and analysed by HPLC, as 
described in M aterials and Methods.
TABLE XIV
COMPARISON OF BENZO(a)PYRENE-DEOXYRIBONUCLEOSIDE ADDUCTS 
FORMED IN MOUSE SKIN IN VIVO OR IN INCUBATIONS 
CONTAINING MOUSE SKIN MICROSOMES AND DNA
System pm oles BP/ mg DNA
R elative  adduct d istribution (%) 
A B C  D E BP-4,5-epoxide
* C57BL/6 
m ice in 
vivo
** C57BL/6 
mouse skin 
m icrosom es
3.4
6.1
6 10 67 2 0.3
7 13 17 3 ? 30
3
* Mice were tre a te d  topically w ith ( H) BP (200 nmoles) and killed 24 hours la te r .
3
** ( H) BP (20 uM) was inc ubated  w ith skin m icrosom es, DNA, and an NADPH 
generating  system  for 30 minutes.
DNA was isolated  from  the tre a te d  areas of skin or the m icrosom al incubations, 
purified and hydrolysed to deoxyribonucleosides which were then analysed by HPLC as 
described in M aterials and Methods.
skin of C57BL/6 m ice and those form ed by reac tion  of BP w ith calf-thym us DNA in the 
presence of skin m icrosom es from C57BL/6 m ice and an NADPH generating  system . The 
m icrosom al m ediated BP-deoxyribonucleoside adducts w ere m ostly  la te  eluting and co- 
chrom atographed w ith deoxyribonucleoside adducts form ed by reac tio n  of BP-4,5-epoxide 
w ith calf-thym us DNA (Fig.54). These products constitu ted  approxim ately  20-30% of the 
to ta l  adducts form ed (Table XIV). A dducts w ere also observed which co-chrom atographed 
w ith B and C, derived from  reac tion  of a fu rther m etabo lite  of 9-0H-BP w ith DNA (see 
C hapter 1) and reac tion  of an ti BPDE with the  exocyclic amino group of deoxyguanosine 
(207,210) (Fig.52c) respectively . These two products each rep resen ted  15-17% of the  to ta l 
adducts (Table XIV). The m icrosom al-m ediated binding of BP to  DNA also involved the  
form ation of several products co-chrom atographing with an ti BPDE-dA adducts 1*, 2' and 
4' (Fig.52b), how ever, an accu ra te  quan tita tive  analysis of these products was no t possible 
because 4' also co-chrom atographed w ith a  deoxyribonucleoside adduct derived from  BP- 
4,5-epoxide (Fig. 54b).
Legend to  F igure 54
Separation of BP-deoxyribonucleoside adducts form ed by m ouse-skin m icrosom al m ediated  
binding of BP to  DNA. ( H)BP (20uM) was incubated  w ith 3M C-induced C57BL/6 mouse 
skin m icrosom es, exogenous DNA and an NADPH genera ting  system . The DNA was 
subsequently re iso la ted , hydrolysed and analysed by HPLC as described  in M aterials and 
M ethods. The re su ltan t BP-deoxyribonucleoside adducts sep a ra ted  as shown in a. L a te r 
elu ting  BP-DNA adducts w ere iden tified  by co-chrom atography w ith  deoxyribonucleoside 
adducts form ed by hydrolysis of DNA previously tre a te d  w ith ( H) BP-4,5-epoxide (b) (See 
M aterials  and M ethods). R esu lts  are expressed as dpm /fjraction.
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Discussion
The m etabolic activation  of PAH, such as BP and DMBA, to u ltim a te  carcinogenic 
products was in itia lly  thought to arise by the  form ation of epoxides on the  'phenanthrene 
like' double bonds (K-regions) of these m olecules due to the high e lec tron  density  a t these 
regions (188). However, studies using rodent cells in tissue cu lture established th a t the K- 
region epoxides of 7MBA and BP were not the  m ajor m etabolites involved in the  m etabolic 
ac tiva tion  of the  hydrocarbons to  DNA-bound products (190,191). The iden tification  of 
covalently  bound DNA products of PAH was com plicated by the  possible m ulti-s ite  
m etabolic activation  of these chem icals (192). Since the work of Sims e t al (194), 
indicating the im portance of a  'bay-region' vicinal diol epoxide in the  binding of BP to  
DNA in cells in cu lture , 'bay-region' diol epoxides, and the precursor dihydrodiols, of 
severed polycyclic hydrocarbons have been shown to  exhibit m utagenic and carcinogenic 
properties g rea te r  than or equal to  those of the  paren t hydrocarbon (see Table VI). 
R ecen t evidence has im plicated  "bay-region" diol epoxides of DMBA and BA as DNA- 
bound products of these compounds following m etabolic ac tiva tion  in mouse skin, 
how ever, DNA-adducts derived from o ther, non 'bay-region', m etabo lites w ere also 
observed (221,292). The m ajor DNA-bound products form ed when BP was applied topically  
to  m ice resu lted  from reac tion  of isom ers of the bay-region diol epoxide w ith dG (213). 
However, ham ster embryo cells and sh o rt-te rm  organ cultures of resp ira to ry  tissues have 
been shown to form BP-dA products in the ir DNA following tre a tm e n t w ith BP (341,391). 
The in vivo form ation of hydrocarbon-dA products in mouse skin has previously been 
dem onstrated  using 7BrMeBA and 7BrMe-12Me-BA (374), how ever, no such in vivo 
products have been observed following trea tm e n t w ith paren t PAH.
In the presen t study th e  in vivo form ation of several BP-DNA adducts when an in itia ting  
dose of BP was applied topically  to  the  skin of Swiss mice has been investigated . The 
resu lts  of a tw o-stage carcinogenesis experim ent using these m ice established the ir 
susceptib ility  to  BP-induced skin carcinogenesis (Figs.48-51). In ag reem en t w ith o ther 
workers (213), the m ajor DNA adduct, C, representing  60-70% of the to ta l hydrocarbon- 
deoxyribonucleoside adducts, co-chrom atographed with the m ajor DNA bound product 
form ed following reac tio n  of anti BPDE w ith DNA (Fig.52c) which o ther workers have 
identified  as being due to the trans addition of the 2-amino group of dG w ith the  7R form 
of an ti BPDE (210). We have previously shown th a t the m ateria l elu ting  a t frac tio n  30 (B) 
' (Fig.52a) co-chrom atographs with a fu rth er m etabo lite  of 9-0H-BP, (see C hap ter 1), 
probably the K -region oxide, bound to as ye t uncharacterised  bases in DNA (339). To my 
knowledge this is the firs t tim e th a t a phenolic m etabolite  of BP has been shown to  be 
involved in the in vivo binding of BP to  DNA. However, its  im portance is questionable as
9-OH-BP was shown not to be carcinogenic on mouse skin (394) and Nordenskjold e t al 
(395) have shown th a t DNA strand  breaks induced in cu ltured  fibroblasts by 9-OH-BP are 
repaired  re la tiv e ly  rapidly com pared to  strand  breaks induced by BP-7,8-diol. I t is 
possible th a t some of the  m ateria l eluting as B (Fig.52a) is also due to  dC adducts which 
have been shown to elu te  in this region (214), how ever, in v itro  reac tio n  of an ti BPDE w ith 
dC in DNA occurs to  a  much sm aller ex ten t than  w ith either dG or dA (214) and DNA- 
adducts form ed by reac tio n  of anti BPDE w ith DNA did not co-chrom atograph w ith B 
(Fig. 5 2c).
Of g rea te r in te res t in the  presen t study was the observation of two la te r  eluting adducts,
D and E (Fig.52a), which co-chrom atographed w ith au then tic  an ti BPDE-dA m arkers
(Fig.52b). Je ffrey  e t al (393) showed th a t in v itro  reac tion  of an ti BPDE w ith dA resu lted
in four products designated 1* through 4' and th a t a  W aters ubondapak column, used in th is
work, could not com pletely  resolve 2' and 3V The resu lts  of the  p resen t study (Fig.52b)
are  in very good agreem ent w ith this evidence. R eaction  of an ti BPDE w ith DNA in v itro
produces several d^-bound products (Fig.52c), the major one, eluting in the  region of 7S
an ti BPDE-dA adducts 2' and 3' (Fig.52b) (393), has been shown to  arise  from reac tio n  of
an ti BPDE with the  exocyclic N ^-am ino group of dA (393). In co n trast to th is, in mouse
skin tre a te d  in vivo w ith BP, only two an ti BPDE-dA products, D and E w ere form ed
(Fig.52a). The major product, D, co-chrom atographed w ith 1* (Fig.52b), the an ti BPDE-dA
product shown to  resu lt from a  trans addition of the  exocyclic N —amino group of dA to
the  7R form of an ti BPDE (393). The minor dA adduct, E, co-chrom atographed w ith 4*
(Fig.52b), resu lting  from cis addition of the N^-am ino group of dA to the  7R form  of an ti
BPDE (393). Thus both an ti BPDE-dA adducts (D and E) and the m ajor an ti BPDE-dGt — —
product form ed in vivo are derived from 7R anti BPDE, as illu s tra ted  in Fig.55. The 7R 
form of an ti BPDE is the  m ajor product of the  s tereospecific  m etabolism  of BP or B P-7,8-  
diol by r a t  liver m icrosom es (201). T herefore the  resu lts  p resen ted  here  provide 
additional evidence th a t m etabolism  of BP in mouse skin is. highly s te reo se lec tiv e , in 
agreem ent with K oreeda e t al (213), but does not preclude the form ation  of o ther diol 
epoxides of BP which may in te ra c t w ith sites o ther than  DNA. R ecen t evidence has 
shown th a t anti BPDE binds to  DNA in mouse skin to a g rea te r ex ten t than its  isom er syn 
BPDE (396) and th is co rre la tes  w ith the ir carcinogenic potencies on mouse skin (291).
BP, applied in rep ea ted  doses, is a com plete carcinogen in mouse skin, in th a t i t  can 
function both as an in itia to r and a prom oter (19). The tum our response obtained when BP 
was repeated ly  applied to mouse skin could be m arkedly enhanced by the  sim ultaneous 
application of a co-carcinogen, such as catechol (388). It was in te resting  to  postu la te  th a t 
the co-carcinogen m ay be modifying the in itia tion  stage  of tum our induction by a lte ring
7R trans BPDE — dA 7R cis B P D E - d A
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Figure 55 Proposed DNA-bound p ro d u c ts  of 
Benzo(a)pyrene in m ouse  sk in
the q u an tita tive  or qualita tive  n a tu re  of BP-DNA-bound products form ed in the  skin of 
m ice tre a te d  w ith catecho l and BP. However, when Swiss m ice w ere tre a te d  top ically  
w ith catechol and BP in e ither single or rep ea ted  doses prior to top ical application of 
labelled BP, the  overall binding to  DNA and the re la tiv e  percen tage yield of adducts 
(Table XII) w ere v irtually  iden tica l to  those of mice tre a te d  w ith BP alone. Thus, as 
catecho l does not seem  to  a ffec t the ex ten t and n a tu re  of BP-DNA-bound products in 
mouse skin i t  is logical to  assume th a t its  action  as a  co-carcinogen re lies  on an a lte ra tio n  
in the prom oting ability  of BP, however, investigations into this w ere outside th e  scope of 
my work.
PAH, such as BA, are  e ffec tiv e  inducers of AHH in mouse skin (397), and i t  has been 
shown th a t w eakly carcinogenic PAH could m odify the tum ourigenicity  of both  BP and 
DMBA (387). In the  present study topical application of BA to m ice 24 hours prior to 
topical application of an in itia ting  dose of BP resu lted  in a sm all increase (20%) in the  
overall binding of BP to DNA in the  skin (Table XII) com pared to  anim als tre a te d  w ith BP 
alone. However, the  qualita tive  n a tu re  of the BP-DNA reac tion , nam ely the re la tiv e  
percen tage yield of deoxyribonucleoside adducts, was very sim ilar to th a t observed for 
anim als tre a te d  only w ith BP (Table XII). There was a slight increase in the  early  eluting 
m ateria l (fractions 1- 12), however, the relevance of this is unknown as this m a te ria l has 
not been identified .
Compounds such as 1-naphthol and diphenylacetic acid, which are  readily  m etabolised to 
sulphate and glucuronide conjugates (165,171), may be able to  s a tu ra te  conjugation 
m echanism s and thereby  render cells susceptible to  reac tiv e  species which would norm ally 
be adequately  detoxified. Thus, 1-naphthol and diphenylacetic acid were, applied top ically  
to  mice prior to  and following application of an in itia ting  dose of BP to  the  skin. There 
w ere no m ajor qualita tive  d ifferences in the n a tu re  of the  BP-DNA-bound products 
com pared to  control (Table XII), however, the diphenylacetic acid tre a tm e n t resu lted  in  a 
loss of anti BPDE-dA adducts. The reason for this is not known. Both compounds caused 
a  45% reduction in the gross binding of BP to DNA which one may expect if binding of BP 
to  DNA necessita ted  in itia l form ation of a sulphate or glucuronide conjugate. K inoshita 
and Gelboin (398) showed th a t, in the presence of DNA, B-glucuronidase cata lysed  
hydrolysis of BP-3-glucuronide resu lted  in a DNA-bound product which was not form ed by 
BP-3-glucuronide or 3-OH-BP alone. Such products, however, have not been iden tified  in 
in vivo system s and the  inhibition, by 1-naphthol, of BP-DNA binding in mouse skin m ay 
have been due to  anon -spec ific  e ffec t on Phase 1 m etabolism .
Although Brookes and Lawley (183) found th a t a good correlation  ex isted  betw een ex ten t 
of DNA reac tion  and carcinogenic index for a series of PAH on mouse skin, Phillips e t  al
(329*381) found no qualita tive  d ifference in the form ation of DNA adducts and no 
quan tita tive  d ifference in gross DNA reac tion  of BP in the skins of m ice being susceptible 
(Swiss), re s is tan t (DBA/2) or of in te rm ed ia te  response (C57BL/6) to  PAH-induced 
skin carcinogenesis. K akefuda and Y am am oto (392) found th a t reac tion  of an ti BPDE 
with dA in DNA caused a local denaturation  of the m olecule w hereas reac tion  with 
dG did not, however, Pulkrabek e t al (399) w ere unable to confirm  these observations. 
In order to investigate  the possible relevance of anti BPDE-dA adducts to carcinogenesis, 
the form ation of BP-DNA-bound products in the skins of th ree  s tra in s of m ice varying 
in the ir response to  skin tum our induction by PAH (382) was studied. No differences 
w ere observed in the overall ex ten t of DNA reac tion  in the skins of Swiss, DBA/2 
and C57BL/6 m ice tre a te d  with in itia ting  doses of BP(200nmoles) (Table XIH) HPLC 
analysis of the BP-DNA adducts form ed in the skins of th ree  m ice s tra ins (Figs. 
52a and 53) showed th a t, in all cases, the m ajor hydrocarbon-deoxyribonucleoside 
adduct, accounting for 60-70% of to ta l BP-DNA adducts, co-chrom atographed with 
C and resu lted  from reac tion  of anti BPDE w ith the exocyclic amino group of dG 
as shown by o ther workers (213). A nti BPDE-dA adducts (D and E) were p resen t 
in all s trains accounting for 3-5% of to ta l hydrocarbon-deoxyribonucleoside adducts 
(Table XH). No apparent stra in  d ifference in the form ation of an ti BPDE-dA adducts 
a t a single tim e point (24 hours) was observed, however, w ith p resen t methodology, 
the ex trem ely  sm all am ounts of anti BPDE-dA adducts form ed preclude the accu ra te  
study of possible s tra in  differences in the persistence of such lesions.
The form ation of BP-DNA adducts in v itro  w ere observed when skin m icrosom es, 
from C57BL/6 m ice, p re tre a ted  topically with 3MC, w ere incubated with BP and 
DNA, together w ithanN A D PH generating system . H PLC analysisoftheB P-deoxyribonucleoside 
adducts showed th a t several of the la te  eluting adducts co-chrom atographed with 
the m ajor DNA adducts form ed by reac tion  of BP-4j5-epoxide w ith DNA (Fig.54). 
These products collectively accounted for 25%-30% of the to ta l adducts and this 
seem s to agree with the resu lts of o ther workers (378) who used Sephadex LH-20 
to analyse the DNA adducts. Deoxyribonucleoside adducts w ere also p resen t which 
co-chrom atographed with anti BPDE-dA adducts l f,2* and 4’ (Fig.54b) how ever, 4’ 
also co-chrom atographed with one of the DNA adducts form ed when BP-4,5-epoxide 
reac ted  with DNA (Fig.54b), the re fo re  quan tita tive  analysis of the dA adducts or 
the BP-4,5-epoxide derived adducts was d ifficu lt. The two earlie r eluting products, 
B and C, co-chrom atographed with DNA adducts derived from reac tion  of a fu rth er 
m etabolite  of 9-0H-BP (see C hapter 1) or of anti BPDE (Fig.52c) respectively , w ith 
DNA. M icrosomal system s are devoid of co fac to rs  and, in ce rta in  cases, enzym es 
necessary for the detoxication and u ltim a te  excretion of reac tiv e  m etabo lites. Thus 
mouse skin m icrosom es in  vitro  could m etabolise BP to  its  K -region epoxide which
was then able to  re a c t with exogenously added DNA w hereas in vivo in mouse skin 
this m etabolite , if form ed, would probably be quickly conjugated with reduced glu tath ione 
and so would not be free  to re a c t with DNA. T herefore BP-4,5-epoxide-deoxyribonucleoside 
adducts are not form ed in DNA isolated  from mouse skin when BP is applied topically  
to m ice (Figs.52 and 53).
CHAPTER FOUR
BINDING OF BENZO(a)PYRENE TO DNA IN RESPIRATORY TISSUE IN VIVO AND IN
VITRO
Induction of pulm onary tum ours by benzo(a)pyrene and ethyl ca rbam ate  in A /JAX  m ice: 
Binding of benzo(a)pyrene to  DNA in mouse lung in vivo:
F orm ation of benzo(a)pyrene-DNA adducts in short term  explant cu ltures of peripheral r a t  
lung:
Benzo(a)pyrene-DNA adducts form ed in transform able r a t  trach ea l ep ithelia l (2C1) cells -  
relationship  betw een form ation of adducts and transform ation:
R at lung m icrosom al m ediated  binding of benzo(a)pyrene to  DNA.
In troduction
A t the turn  of the tw entieth  century  i t  was dem onstrated  th a t ta r  derivatives could 
induce skin tum ours in rabbit ear (9) and mouse skin (10). Several workers (13,400) 
subsequently showed th a t m ice tre a te d  with ce rta in  ta rs  also developed pulm onary 
tum ours, however, these w ere in itia lly  thought to  be secondary m etastases  from the 
prim ary  skin lesions. Murphy and Sturm  (401) showed th a t ro ta ting  applications of ta r  
over d iffe ren t areas of skin produced no cutaneous tum ours bu t resu lted  in 85% of the 
m ice developing m ultiple pulm onary tum ours. Following the publication of the rep o rt 
showing DB(a,h)A to  be a p o ten t carcinogen in mouse, skin (18) i t  was found th a t 
subcutaneous injection of the chem ical e lic ited  m ultiple pulm onary tum ours in 96% of 
s tra in  A mice before any subcutaneous sarcom as had developed (402). Investigations into 
the e ffec ts  of various rou tes of adm inistration  showed th a t, although several rou tes w ere 
e ffec tiv e  in inducing some pulm onary tum ours w ith PAH, intravenous in jection  was the  
most e ffec tiv e  rou te  (403).
N ettleship  e t al (404), whilst conducting irrad iation  experim ents in m ice under ethyl 
carbam ate  anaesthesia, noted a very high incidence of m ultiple pulm onary tum ours among 
the animals. Subsequent work established th a t ethyl carbam ate  was the causative agent 
and the same workers reported  th a t single in traperitonea l injections of e thy l ca rbam ate  
(lm g per g body weight) in stra in  A m ice produced m ultiple pulm onary tum ours in 100% of 
anim als by four m onths (99). Of several carbam ic acid esters  te s ted  for carcinogenicity  
ethyl carbam ate  was the most active (405). A recen t repo rt showed th a t vinyl carbam ate  
possessed g rea te r potency, both  as a m utagen and as a carcinogen, than ethy l ca rbam ate
i
(406). M etabolism studies in the mouse in vivo could not d e te c t vinyl carbam ate  as a 
m etabo lite  of ethyl carbam ate and so the mechanism of ac tivation  of e thy l ca rbam ate  is 
still not known. In two recen t reports Witschi e t al showed th a t bu ty la ted  hydroxytoluene, 
an agent known to cause cell p ro liferation  in mouse lung (407), could enhance the potency  
of ethyl carbam ate in producing mouse lung adenom as (408,409). The te tracy c lic  
d iterpene phorbol has also been shown to ex ert a prom oting action in mouse lung following 
in itia tion  of the animals shortly a fte r  b irth  w ith DMN (98).
S affio tti e t al dem onstrated th a t resp ira to ry  tra c t carcinom as which resem ble m ost 
human lung cancers, both in morphology and location, could be induced in ham sters  by 
in tra trach ea l instilla tion  of BP (410). The sam e workers showed th a t when h am ster 
tracheas were incubated in v itro  with BP, binding of the carcinogen to trach ea l ep ithelia l 
DNA occurred (411) and this binding was enhanced when tracheas w ere obtained from 
vitam in A defic ien t ham sters (412). O ther workers observed th a t BP, incubated  in v itro  
with ra t tracheas, becam e bound to trach ea l nucleic acids and binding was increased  by
pre-exposure of the anim als to c ig a re tte  smoke (413). H arris e t al found th a t cu ltured  
human bronchus could m etabolise PAH, in particu la r BP, to reac tiv e  species th a t becam e 
covalently  bound to  tissue m acrom olecules (414) including DNA (415). However, a  large 
interiridividual varia tion  was observed in the  binding of BP to  DNA (416). Subsequent 
work showed th a t (-) BP-7,8-diol was more active  in binding to  DNA than BP or severed of 
its  m etabo lites in cu ltu red  human bronchus (417), and th a t the  m ajor m etabo lite  derived 
from  (-) BP-7,8-diol was anti BPDE, iden tified  through its  fu rth er m etabolism  to  BP- 
te tro ls . R ecen t studies have shown th a t anti BPDE is a po ten t pulm onary carcinogen in 
newborn m ice whilst the syn isom er, although highly toxic, is less carcinogenic (291). I t 
was established th a t the m ajor BP-DNA and -RNA adducts form ed in cu ltu red  hum an and 
bovine bronchial explants exposed to BP w ere derived from trans addition of the 2-am ino 
group of dG (210) or guanosine (209), respectively , to  C-10 of the  7R form of an ti BPDE. 
Adducts derived from  BPDE have been shown to  rep resen t the m ajor DNA-bound products 
in human bronchial m ucosa (376) or peripheral human lung explants (418) incubated  w ith 
BP, or in liver and lung tissue in vivo following in jection of BP in to  m ice (419). Studies 
using human lung cells have shown th a t BP binds to  the sam e ex ten t to  both nucleosom al 
linker DNA (exposed) and to  nucleosom al core DNA (unexposed) (219). T rea tm en t of 
hum an lung cells w ith syn and an ti BPDE's caused fragm entation  of pa ren ta l DNA strands 
a f te r  th ree  hours (218) followed by a  slow elongation of the fragm ents, com pleted  in 
th irty  hours. The sam e human cell line w ere shown to  excise lesions induced in DNA by 
BP-4,5-epoxide fa r m ore rapidly than lesions induced by anti BPDE (379). Eastm an and 
Bresnick (420) have recen tly  shown th a t in vivo adm inistration of 3MC to  m ice re su lted  in 
a persis ten t binding of the hydrocarbon to  lung DNA and th a t the persistence of the 3MC- 
DNA adducts co rre la ted  with the  susceptib ility  of the mouse s tra in  to  pulm onary 
neoplasia.
Vahakangas e t al (421) found th a t the major BP-DNA adduct form ed in iso la ted  r a t  lungs, 
from 3M C -pretreated  anim als, perfused w ith BP was derived from BPDE. In co n tra s t to  
thisi lung m icrosom es from 3MC p re tre a te d  anim als, in the presence of DNA, ac tiv a ted  
BP to  severed DNA-bound products, the  m ajor one of which was derived from a fu rth e r 
m etabo lite  of 9-OH-BP, probably 9-0H-BP-4,5-epoxide (339). O ther workers have shown 
th a t lung m icrosom es from u n trea ted  m ice, in the presence of DNA, could a c tiv a te  BP to 
a m ultitude of reac tiv e  in term ed iates binding to DNA, including fu rth er m e tabo lites  of 
phenols, quinones and dihydrodiols (344).
The p resen t study has investigated  the form ation of prim ary pulm onary tum ours in s tra in  
A m ice tre a te d  w ith BP or ethyl carbam ate and the relationship  of BP-induced tum our 
form ation to BP-DNA binding in the lung. In collaboration with the N ational L aboratory ,
Oak Ridge, the  form ation of BP-DNA adducts in the trachea l ep ithelia l cell line, 2C1 has 
been investigated  in re la tion  to  the  transform ation  of these cells by BP and its  
m etabolites. M etabolic activation  of BP to DNA bound products by explants of r a t  lung 
was investigated  and com pared w ith DNA adducts form ed in exogenous DNA during 
incubation of r a t  lung m icrosom es and BP.
R esults
A sum m ary of the tum our experim ents is shown in Table XV. S train  A (A/Jax) m ice 
tre a te d  w ith ethyl carbam ate  showed a  high incidence of m ultiple pulm onary tum ours 
which was enhanced by p o s t-trea tm e n t of the anim als with^BHT. Animals tre a te d  with 
the  lower dose of BP (lOug/g) showed a  negligable tum our response, com pared to  controls, 
which was again enhanced when anim als were p o s t-trea ted  w ith BHT. T rea tm en t of m ice 
by single in jection  of a higher dose of BP (lOOug/g) showed a  high tum our incidence 
com pared to  controls. In no anim als w ere tum ours observed in organs o ther than the 
lungs.
Table XVI shows the relationship  of BP induced pulm onary tum ours in s tra in  A m ice to  the 
in vivo binding of BP to  DNA, in the  sam e tissue, using two doses of BP.
Table XVI. PULMONARY TUMOUR INDUCTION AND DNA-ADDUCT FORMATION 
IN A/JAX MICE TREATED WITH BENZO(a)PYRENE.
BP Pulm onary Tumour BP bound to
trea tm e n t Response3, DNAb
(ug BP/g body weight) (tumours/mouse) (pmoles BP/m g DNA)
10 0.19
i
2.1
100 9.40 15.3
3Mice w ere tre a te d  w ith BP or ( H)BP as described in M aterials and M ethods.
a) Tumours w ere assessed as described in Table XV.
b) 24 hours a f te r  trea tm e n t DNA was isolated , as described for hepatocy tes, and 
covalently bound hydrocarbon determ ined as described in M aterials and M ethods.
INDUCTION OF MULTIPLE PULMONARY TUMOURS IN 
A/JAX MICE BY BENZO (a) PYRENE AND ETHYL CARBAMATE
Initial
treatm ent Post-treatm ent
Pulmonary tumour 
response a 
(tumours/mouse)
BP (100 ug/g) 9.4
BP (10 ug/g) Com Oil 0.1
BP (10 ug/g) BHT (250 ug/g) 
weekly
0.8
Ethyl carbamate 
(1 mg/g)
Corn Oil 24.1
Ethyl carbamate 
(1 mg/g)
BHT (250 ug/g) 
weekly
27.5
A/JAX mice received single i.p. injections o f BP or ethyl 
carbamate at the doses indicated. Two groups were further 
treated with weekly i.p. injections o f BHT in corn oil at the dose 
indicated, as described in Mateials and Methods, while control 
groups received corn oil as indicated. Experiments were 
terminated after 18 weeks and the lungs excised and immersed in 
10% formal saline. The macroscopically visible tumours on the 
surfaces o f the lungs were counted using a disecting microscope. 
A group o f 10 untreated A/JAX mice exhibited a spontaneous 
pulmonary tumour incidence of 0.30 tumours/mouse.
CARCINOGENICITY OF BENZO (a) PYRENE AND SEVERAL 
OF ITS ACTIVATED METABOLITES IN THE TRACHEAL 
EPITHELIAL CELL LINE 2C1
Compound
Exposure
concentration3
(uM)
Incidence o f  
tumourigenic 
sublines after  
10 passages
Control
(0.2%  dimethyl 
sulphoxide)
0 0/4
BP 8 2/4
40 0/2
B P-7, 8 diol 4 2/4
20 3/4
Anti BPDE 0.08 4/4
0 .40 4/4
a) A single 24-hour exposure was used. Control cultures received
0.2% dimethyl sulphoxide, the solvent concentration used in all 
experim ental groups. Following exposure to the compounds, the 
cells were rinsed, fresh medium was added, and the cells were 
allowed to reach confluency. The medium used throughout was 
an enriched Waymouth MB 752/1 medium (GIBCO) containing 
additional amino acids, sodium pyruvate, insulin, hydrocortisone 
and 10% foetal bovine serum (Microbiological Asscoiates), as 
described previously (422).
b) Tumourigencicity was determined by inoculating 10 viable cells
1.m. into both thighs of 2 immunosuppressed isogeneic hosts. The 
innoculation site was palpated weekly over the 100-day 
observation period.
The higher dose of BP (lOOug/g) produced a 40-fold g rea te r tum our incidence than th a t 
observed using the  lower dose (lOug/g). Similarly th e re  was a 7.5-fold g rea te r binding of 
BP to  mouse lung DNA a t the high dose (lOOug/g) than  a t the lower dose (lOug/g).
Experim ents using the  non-turnourigenic pure ep ithelial cell line, 2C1 w ere perform ed in 
collaboration with Dr. V. E. S teele  and Dr. A. C. M archok. The 2C1 cell line was 
established following m ultiple exposures of adult r a t  trach ea l explants to  the  tum our 
prom oting agent TPA (422). The cells are  transform able by BP, BP-7,8-diol and anti 
BPDE (423), as sum m arised in Table XVII. In all cases the cells w ere exposed for a  24 
hour period to  BP or its  m etabolites a t the  doses ind icated . An in teresting  observation 
was th a t the incidence of tum ourigenic sublines was dependent on dose, such th a t BP a t an 
8um concentration  induced a 50% incidence while a t the higher concen tration , 40um, 
th e re  was a zero incidence (Table XVII). BP-7,8-diol and an ti BPDE induced 50% or 
g rea te r incidences of tum ourigenic sublines a t all doses tested* To investiga te  th e  
relationship  betw een DNA binding and transform ation , 2C1 cells w ere exposed to  
radiolabelled BP a t concentrations of 8uM (18Ci/mMole) and 40uM (3.6Ci/mMole) for 24 
hours and then the cells harvested  and forw arded to  the  U niversity  of Surrey. DNA was 
iso la ted  from the cells, and analysed for covalently  bound rad ioactiv ity .
Table XVHI. TUMOURIGENICITY OF 2C1 CELLS TREATED WITH BENZO(a)PYRENE 
AND THE EXTENT OF THE ASSOCIATED BENZO(a)PYRENE-DNA REACTION.
Exposure concentration Incidence of R eaction
of BP tum ourigenic w ithD N A b
(uM). sublines a fte r (pmoles BP/
10 passages.a mg DNA).
8 2/4 2 .0
40 0/4 2 .2
a) Assessm ent of tum ourigenicity  was as described in Table HI.
6 3b) 2C1 cells (10 cells/dish in 12ml of medium : see Table m ) w ere exposed to  ( H)-BP
(8uM or 40uM in 0.2% DMSO : 1.728 mCi/dish) for 24 hours. The cells w ere harvested  and 
DNA iso la ted  from the cell pe lle t as described in M aterials and Methods for hepatocy tes. 
DNA-bound rad ioactiv ity  was determ ined as outlined in M aterials and M ethods.
The DNA was hydrolysed and th e  resu lting  BP-deoxyribonucleoside adducts purified and 
analysed by HPLC (as described in M aterials and Methods). The resu lts  are  shown in 
Fig.56a. The m ajor BP-DNA adduct (Product C) form ed in cells tre a te d  w ith 8uM BP, 
making up 40% of the  to ta l adducts, co-chrom atographed w ith the  m ajor 
deoxyribonucleoside adduct form ed following reac tion  of an ti BPDE w ith dG. In con trast 
to  this, when DNA iso lated  from cells tre a te d  w ith 40uM BP was hydrolysed and analysed 
by HPLC, the deoxyribonucleoside adduct co-chrom atographing w ith C accounted for only 
14% of the  to ta l adducts. Thus the  concen tration  of BP m ost e ffic ien t in inducing high 
incidences of tum ourigenic sublines of 2C1 cells (8uM), as shown in Tables XVII and XVm, 
was also m ost e ffic ien t in form ing a hydrocarbon-deoxyribonucleoside adduct th a t co­
chrom atographed w ith the major product form ed by reac tio n  of an ti BPDE w ith dG 
(Fig. 5 6).
When hydrolysates of DNA obtained from short-term  explant cu ltures of peripheral r a t  
lung incubated w ith BP, w ere analysed by HPLC, the m ajor BP-DNA adduct, product C, 
co-chrom atographed with the m ajor deoxyribonucleoside adduct form ed by hydrolysis of 
DNA previously reac ted  w ith an ti BPDE (Fig.57a). A ppreciable quan tities of product B, 
the  BP-DNA adduct which co-chrom atographed with a fu rther m etabo lite  of 9-0H-BP 
(Fig.57b), w ere also form ed. Two BP-DNA adducts w ere observed which elu ted  slightly  
la te r  than product C, betw een fractions 50 and 100 (Fig.57a). P roducts e lu ting in th is 
region w ere also form ed when an ti BPDE reac ted  w ith DNA (Fig.57a and C hap ter Three). 
These products have previously been shown to co-chrom ^tograph with deoxyribonucleoside 
adducts form ed following reac tion  of an ti BPDE w ith dA (See C hapter Three).
In con trast to the resu lts  obtained using sho rt-te rm  explants of peripheral r a t  lung when 
ra t  lung m icrosom es from 3M C -pretreated  anim als w ere used to  m etabolically  a c tiv a te  
BP, the  major DNA-bound product form ed in exogenous DNA co-chrom atographed w ith 
the m ajor deoxyribonucleoside adduct (product B) form ed by hydrolysis o f DNA previously 
reac ted  w ith r a t  liver m icrosom ally ac tiv a ted  9-0H-BP (Fig.57b). L ittle , if any, m a te ria l 
'bo-chrom atographing with the  anti BPDE-deoxyribonucleoside products, C and D, was 
observed.
Legend to  F igure 56
BP-deoxyribonucleoside adducts form ed in transfo rm ab le  r a t  trac h ea l ep ithelia l 2C1 cells.
Cells w ere incubated  w ith ( H)BP (8uM or 40uM) for 24 hours and DNA was iso la ted  as
described  in M aterials  and M ethods for h epatocy tes. The DNA was hydrolysed and th e
re su lta n t deoxyribonucleoside adducts analysed by HPLC as described  in M aterials and
3
M ethods. The BP-DNA adducts form ed following tre a tm e n t of cells w ith 8uM ( H)BP (a, #- 
3- • )  or 40uM ( H)BP (a, o o) w ere iden tified  by co-chrom atography w ith
3
deoxyribonucleoside adducts form ed by reac tio n  of ( H)dG w ith an ti BPDE (b). R esults 
a re  expressed as dpm /fraction .
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Figure 56
Legend to  F igure 57
Id en tifica tio n  of BP-deoxyribonucleoside adducts. Endogenous DNA from  ra t  lung
3
explants incubated  w ith ( H)BP (2uM) or exogenous DNA previously incubated  w ith r a t -
3lung m icrosom es and ( H)BP (4.2uM) was hydrolysed to deoxyribonucleosides and analysed
by HPLC (o—o, a  and b respectively) as described in M aterials  and M ethods. The m ajor
BP-DNA adducts w ere iden tified  by co-chrom atography w ith deoxyribonucleoside adducts
3
form ed by hydrolysis of DNA previously re a c te d  w ith ( H) an ti BPDE (•— • ,  a) or
3m icrosom ally ac tiv a ted  ( H)9-0H-BP (•— • ,  b) as described in M aterials and M ethods. 
R esu lts  a re  expressed as dpm /fraction .
Figure 57
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Discussion
The tum our response observed in the lungs of A/JAX m ice tre a te d  w ith BP or ethyl 
carbam ate  confirm ed the resu lts  of earlie r workers (403). A t the  dose levels used, ethyl 
carbam ate  induced a  high incidence of m ultiple pulm onary tum ours and, in agreem ent 
w ith o ther workers (408,409), its  tum ourigenic potency was enhanced when the  anim als 
w ere p o s t- trea ted  weekly w ith BHT (Table XV). BP, adm inistered a t the highest dose of 
lOOug/g, produced approxim ately 9.40 pulm onary tum ours/anim al when in jected  i.p. in to  
A /JAX m ice, while the  lower dose of BP, lOug/g, e lic ited  a  negligible tum our response 
com pared to  u n trea ted  anim als (Table XV). When anim als tre a te d  w ith the  lower dose of 
BP (lOug/g) w ere fu rther tre a te d  by weekly injections of BHT the  pulm onary tum our 
incidence was slightly enhanced (Table XV). Several repo rts  from o ther workers showed 
th a t phenolic antioxidants such as BHT and bu ty lated  hydroxyanisole inhibited the 
carcinogenic action  of PAH in mouse lung (424), Forestom ach (425) and skin (426). 
However, these studies involved adm inistering the  antioxidant w ith the  carcinogen such 
th a t th e re  was a  reduction  in carcinogen oxidative m etabolism  and th e re fo re  a  reduction  
in the am ount of reac tiv e  electrophiles necessary  for in itia tion . Studies of the mechanism 
of inhibition of PAH-induced skin carcinogenesis by phenolic an tioxidants have been 
perform ed by Slaga and Bracken (426). They showed th a t top ical applications of BHT or 
bu ty la ted  hydroxyanisole to  m ice inhibited the binding of BP or DMBA to  exogenous DNA 
m ediated  by epiderm al hom ogenates from the  tre a te d  animals. In th e  p resen t study the 
anim als w ere tre a te d  w ith BHT one week a f te r  trea tm e n t w ith ethy l carbam ate  or BP,
thus the antioxidant would not in te rfe re  w ith the m etabolism  of the carcinogens during
3
in itia tion . When A/JAX m ice w ere in jected  with ( H)BP, in doses th a t induced a
i
significant (lOOug/g) or negligable (lOug/g) pulm onary tum our response, i t  becam e 
covalently  bound to  mouse lung DNA and the ex ten t o f  binding co rre la ted  w ith the  tum our 
incidence (Table XVI). Although the ex ten t of BP-DNA reac tio n  was re la tiv e ly  high (e.g. 
15pmoles/mg DNA), analysis of the  BP-deoxyribonucleoside adducts form ed was not 
possible because the specific ac tiv ity  of the ( H)-BP used was low, due to  the high doses 
of BP adm inistered, and only l-2m g of DNA w ere obtained from the  lungs of 5 anim als. 
However, using far lower doses than those used in this study, o ther workers have shown 
th a t the m ajor BP-deoxyribonucleoside adduct form ed in the  DNA of mouse lungs, 
following in vivo adm inistration of BP, was derived from reac tio n  of BPDE w ith DNA 
(419). In collaborative experim ents w ith Dr. T. J . Slaga it  was also observed th a t th e  
binding of ( H)-BP to mouse epiderm al DNA, and of g rea te r significance, th e  form ation  of 
BPDE-dG adducts, co rre la ted  with the induction of tum ours by BP in mouse epiderm is (see 
Final discussion). In general, good correlations have usually been observed betw een  the 
carcinogenicity  of chem icals and the ex ten t to  which they modify DNA (315).
In experim ents conducted in collaboration w ith Dr. V. E. S teele  and Dr. A. C. M archok
using the ra t  tracheal ep ithelia l cell line, 2C1, no correlation  was found to  exist betw een 
BP-induced m alignant transform ation  and the ex ten t of the re la ted  BP-DNA reac tion  
(Table XVHI). However, when the BP-m odified cellular DNA was hydrolysed to  
deoxyribonucleosides a correlation  was found to exist betw een cell transform ation  and the  
form ation of a BP-DNA adduct, C, which co-chrom atographed with the m ajor deoxyribon 
ucleoside adduct form ed following reac tion  of an ti BPDE and dG (Fig.56). O ther w orkers 
have shown this adduct to be due to trans addition of the exocyclic amino group of dG to 
th e  10-position of an ti BPDE. The concen tration  of BP m ost e ffec tiv e  in inducing 
m alignant inform ation of the cells (8uM : Tables XVII and XVIH) also resu lted  in a  g rea te r 
yield of DNA-bound products co-chrom atographing with anti BPDE-dG adducts (Fig.56). 
O ther w orkers had found th a t a correlation  existed betw een m am m alian cell-m ediated  
m utations induced by BP, and the ex ten t of form ation of associated  DNA adducts derived 
from anti BPDE (367), however, the  p resen t repo rt is the firs t tim e th a t the ex ten t of 
form ation of these hydrocarbon-DNA adducts has been re la ted  to  the m alignant 
transform ation  of cells.
L ittle  inform ation exists as to the susceptib ility  of the trachea l epithelium  of the r a t  to  
PAH-induced carcinogenesis (427). However, the peripheral regions of r a t  lung have been  
reported  to be susceptible to BP-induced carcinogenesis (440) and cu ltured  r a t  lung tissue 
has been shown to m etabolise BP to a proxim ate carcinogenic and m utagenic form , B P- 
7,8-diol (429). I t  was therefo re  of in te res t to investigate  the form ation of BP-DNA 
adducts when short-term  explant cultures of peripheral r a t  lung w ere incubated with BP. 
The m ajor DNA-bound product, C (32% of to ta l adducts), co-chrom atographed with the 
m ajor deoxyribonucleoside adduct form ed following reac tion  of an ti BPDE w ith DNA 
(Fig.57a), which o ther workers have iden tified  and characterised  as the  7R form of an ti 
BPDE bound to the exocyclic amino group of dG (207,210). However, also observed w ere 
significant quan tities of product B (26% of to ta l adducts) previously shown to co­
chrom atograph with the m ajor BP-DNA adduct form ed following m icrosom al ac tiv a tio n  of 
9-0H-BP in the presence of exogenous DNA (see C hapter 1) and probably due to  reac tion  
of 9-0H-BP-4,5-epoxide with a purine base/s  in th e  DNA (339). An in teresting  observation 
was th a t two BP-DNA adducts elu ted  betw een fractions 50 and 100 in the region of anti 
BPDE-dA adducts (see C hapter 3). P roduct D (Fig.57a) has previously been shown to  co­
chrom atograph with anti BPDE-dA adduct 1' (see previous chapter), rep o rted  to resu lt 
from trans addition of the exocyclic N ^-am ino group of dA to the 10-position of an ti 
BPDE (393). O ther workers have reported  only anti and syn BPDE-dG adducts when 
explants of peripheral human lung were incubated with BP (418), how ever, sign ificant 
am ounts of anti BPDE-dA adducts w ere form ed when cu ltured  r a t  trach eas  w ere 
incubated with BP (391).
An in teresting  resu lt was obtained when lung m icrosom es from 3M C -pretreated  ra ts  w ere 
incubated w ith BP and DNA. The m ajor DNA adduct formed, B, co-chrom atographed w ith 
a fu rther m etabo lite  of 9-OH-BP, probably 9-0H-BP-4,5-epoxide, bound to  one or more 
bases in DNA (339) (Fig.57b and as shown in C hapter 1). VahaKangas e t al (421) also 
observed this product as the  m ajor DNA adduct form ed when BP was m etabolised by lung 
m icrosom es from 3M C -pretreated  ra ts  in the  presence of DNA. Although the  p resen t 
study com pares BP-DNA adducts form ed in lung explants from u n trea ted  ra ts  w ith those 
form ed using lung m icrosom es from 3M C -pretreated  ra ts , earlie r resu lts  have shown th a t 
the  m etabolism  of BP by sh o rt-te rm  explant cultures of r a t  lung from  u n trea ted  ra ts  was 
very sim ilar to  th a t shown by iden tica l cultures from 3M C -pretreated  ra ts  (430). In 
sum m ary, r a t  trach ea l ep ithelial cells, peripheral r a t  lung explants and r a t  lung 
m icrosom es could m etabolise BP to  a  varie ty  of reac tiv e  species th a t could bind to  DNA. 
There was a  correlation  betw een the tum ourigenicity  of BP and the  ex ten t of the re la te d  
BP-DNA reac tion  in the lungs of A/JAX m ice in vivo.
CHAPTER FIVE
THE FORMATION AND PERSISTENCE OF BENZO(a)PYRENE-DEOXYRIBONUCLEOSIDE 
ADDUCTS IN RAT-SKIN DNA IN VIVO
The nature of benzo(a)pyrene-DNA adducts form ed in ra t  skin:
t
P ersis ten ce  of benzo(a)pyrene-deoxyribonucleoside adducts in DNA in ra t  skin.
Introduction
Although the carcinogenicity  and m etabolic activation  of PAH in mouse skin has been well 
docum ented (212,428), th e ir biological ac tiv ity  in the skin of o ther rodents has been 
largely  neg lected . Berenblum (431) dem onstrated  th a t the  rabb it, r a t  and guinea pig w ere 
much less susceptible to skin carcinogenesis induced by DMBA than m ice. R ecen tly  
Shubik (432) repo rted  th a t wound healing was an e ffec tiv e  prom oting stim ulus in rabb it 
skin, a f te r  DMBA in itia tion , in agreem ent w ith o ther workers (74). In the sam e rep o rt i t  
was shown th a t croton oil caused m arked epiderm al hyperplasia when applied top ically  to  
rabb its , ra ts  and guinea pigs, how ever, this trea tm e n t did not prom ote the form ation of 
tum ours following DMBA in itia tion . The Syrian golden ham ster proved particu la rly  
susceptible to  m elanocytic tum our form ation in response to  top ically  applied DMBA in 
doses well below those capable of inducing epithelia l tum ours in the  species (433). 
R ecen tly  G oerttle r e t  al (434) repo rted  th a t Syrian golden ham sters system ically  in itia ted  
w ith DMBA and topically  prom oted w ith TPA dem onstrated  a high incidence of benign 
m elanom as. Upon transp lan ta tion  to  norm al hosts, these tum ours rapidly underw ent 
m alignant grow th and developed pigm ented m etastases in severed organs, in common w ith 
the highly invasive human m alignant m elanom a. The sam e group have also studied tw o- 
stage  carcinogenesis in r a t  skin. They reported  th a t system ically  adm inistered DMBA 
followed by topically  applied TPA proved only a  weakly carcinogenic regim en, inducing 
papillom as in only 10% of tre a te d  animals (435). A repo rt by two Ita lian  workers no ted  
precancerous changes when BP was topically  applied to  consenting hum an individuals 
(321), however, present day knowledge and ethics, would not condone a fu rth er 
investigation of this type of study.
Having analysed the  DNA-bound products of BP in mouse-skin, a susceptib le tissue, i t  was 
of in te res t to  com pare and con trast the  na tu re  of the deoxyribonucleoside. adducts form ed 
following topical application of BP to  ra ts . The resu lts  obtained led to  a study of the  tim e 
course for the form ation of the individual BP-deoxyribonucleoside adducts.
R esults
3
When ( H)BP (200 nm oles/anim al) was topically  applied to ra ts  i t  was m etabolically  
ac tiv a ted  to  form s which becam e covalently  bound to  DNA in the skin. Hydrolysis of the  
DNA and analysis of the products by HPLC resu lted  in the  separation  of several 
deoxyribonucleoside adducts (Fig.58). 24 hours a f te r  trea tm e n t the m ajor product is C 
(33% of to ta l adducts), previously shown to  co-chrom atograph w ith the 7 R an ti BPDE-dG 
adduct obtained upon reac tion  of an ti BPDE w ith dG and DNA (C hapters 1 and 3 
respectively), and which has been well charac terised  by o ther w orkers (207,210). P roduct 
B, previously shown to  co-chrom atograph w ith a  fu rther m etabo lite  of 9-OH-BP bound to 
DNA (Chapter 1) was also p resen t in significant quantities (24% of to ta l adducts). The 
la te r  eluting product, D, co-chrom atographs with the 7R anti BPDE-dA adduct obtained 
by reac tio n  of anti BPDE w ith dA (Chapter 3) and whose ste reochem istry  has recen tly  
been elucidated  (393).
A minor product, I, eluting a t frac tion  52 was also observed. This did not co­
chrom atograph w ith any of th e  an ti BPDE-DNA adducts but was found to  have the  sam e 
elution tim e as a major DNA adduct form ed by reac tion  of syn BPDE w ith DNA (Fig.58).
A peak co-chrom atographing with th is product was also observed following incubation of 
DNA and BP-7,8-diol in the presence of r a t  liver m icrosom es, subsequent hydrolysis of the 
DNA and analysis of the  products by HPLC (Chapter 1).
Time course studies of the gross binding of BP to ra t-sk in  DNA showed a maximum level 
of binding at 12 hours (0.74 pm oles/m g DNA) though the  ex ten t of binding over a  period of 
48 hours exhibited a broad peak (Fig.59). Similar am ounts of binding w ere observed a t 
6,12 and 24 hours.
A fu rther investigation of this tim e course study was made by analysis of the  individual 
BP-deoxyribonucleoside adducts form ed a t the  d ifferen t tim e points. All th e  adducts, 
typified  by products B,C,D and I reached maximum concentrations in the  DNA a t 12 hours 
(Fig.60), though once again the tim e dependent concentrations of each adduct exhibited a 
broad profile over 48 hours. The major deoxyribonucleoside adduct a t m ost tim e points, 
product C, co-chrom atographed with a 7R an ti BPDE-dG m arker adduct obtained upon 
reac tion  of anti BPDE w ith DNA or dG and m ost probably arising through addition of the 
exocyclic amino group of dG to  position 10 of the hydrocarbon m etabo lite  (207,210). 12 
hours a f te r  trea tm e n t the concentrations of products B and C in ra t-sk in  DNA w ere 
alm ost iden tical (Fig.60). This study th e re fo re  represen ts the firs t in vivo system  in which 
deoxyribonucleoside adducts derived from BP m etabolites o ther than BPDE have 
contributed a significant proportion of the  DNA adducts form ed a fte r  tre a tm e n t of the  
animals with BP.
Legend to F igure 58
Form ation  of BP-deoxyribonucleoside adducts in  r a t  skin. Male W istar ra ts  (40—50g) 
w ere shaved 24 hours p rio r to trea tm e n t and ( H)BP (200 nmoles) applied to the  
tre a te d  a re a  in  acetone (200 ul). A nim als w ere killed 24 hours la te r  and DNA iso la ted  
from  the tre a te d  areas, purified and hydrolysed enzym ically  to deoxyribonucleosides 
which w ere analysed by HPLC (o—-o) as described in  M ateria ls  and M ethods. P a r tia l 
id en tifica tio n  of some adducts was obtained by co-chrom atography w ith deoxyribonucleoside 
adducts form ed by hydrolysis o f DNA previously re a c te d  w ith syn BPDE (•—•) as described 
in  M aterials  and M ethods.
Legend to Figure 59
i *
3
Analysis of ex ten t of BP-DNA reac tio n  when ra ts  were tre a te d  top ically  w ith ( H)BP 
(200 nmoles) as described for Fig.58 (above) and killed a t 6, 12, 24 and 48 hour tim e 
in te rv a ls  a f te r  tre a tm e n t. • DNA-bound BP was determ ined  as described in M aterials 
and M ethods.
Figure 58
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Legend to  F igure 60
Male W istar ra ts  (40-50 g) w ere shaved 24 hours prior to trea tm e n t.
3
Animals were trea ted  topically w ith ( H) BP (200 nmoles) and killed 6, 12, 
24 and 48 hours a f te r  trea tm e n t. DNA was isolated from  the  tre a te d  
areas of skin and hydrolysed enzym ically to deoxyribonucleosides as 
described in M aterials and M ethods. The amounts of BP- 
deoxyribonucleoside adducts form ed w ere calcu la ted  from  the  m ethanol 
soluble m ateria l eluting from sm all columns of Sephadex LH-20 when this 
m a te ria l was analysed by HPLC to  separa te  the  individual BP-DNA 
adducts.
Figure 60 Time course  of BP-DNA adduc ts  in
rat  skin
—• “  product C 
—o— product B 
—x— product  D 
— product  I
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Table XIX. BENZO(a)PYRENE-DEOXYRIBONUCLEOSIDE ADDUCTS FORMED IN RAT 
SKIN IN VIVO.
Hours a f te r  pm oles BP/ R elative adduct d istribu tion  (%)
trea tm e n t mg DNA A B C D I
6 0.69 12 28 24 8 6
12 0.74 12 24 23 6 6
24 0.73 9 29 31 6 9
48 0.50 7 20 41 3 8
R ats were
3
tre a te d  topically with H BP (200 nmoles) and sacrificed  a t the
tim es. DNA was isolated  from the  tre a te d  areas of skin and hydrolysed to deoxyribonucleosides 
which were analysed by HPLC, as described in M aterials and M ethods. R esults are 
of one typical; experim ent.
Discussion
Previous resu lts  have ascerta ined  th a t 200 nmoles of BP is a  tum our in itia tin g  dose n 
mouse skin (Chapter 3) and i t  was assumed th a t the sam e dose would no t be com pletely  
carcinogenic in r a t  skin. I t  m ay be th a t th is dose would not in itia te  tum our form ation  in 
r a t  skin bu t both tim e and expense prevented the  investigation of such a  tum our study.
The ex ten t of binding of BP to  DNA in r a t  skin 24 hours a f te r  tre a tm e n t (0.73 pm oles/m g 
DNA : Fig.59) was m arkedly lower than the  previous resu lts, a t  the  sam e tim e point, in 
mouse skin (3-5 pm oles/m g DNA : C hapter 3). This m arkedly lower ex ten t of DNA 
reac tion  in r a t  skin could partia lly  explain the  re la tiv e  resis tance  of th is tissue to  PA H - 
induced carcinogenesis.
A fter 24 hours exposure to  BP, r a t  skin DNA contained m ainly two deoxyribonucleoside 
adducts, B and C, toge ther accounting for approxim ately 50-60% of the  to ta l adducts (Fig. 
58 and Table XIX). P roduct C is m ost probably derived from 7R an ti BPDE, a  po ten t 
m utagenic (200,362) and carcinogenic (291) m etabo lite  of BP which induces single s trand  
breaks in DNA (389) and form s DNA adducts which are  re la tive ly  slowly excised (370,219). 
In con trast to  th is, product B is m ost probably derived from 9-OH-BP (339) (C hapter 1), a 
m etabo lite  of BP which has negligible carcinogenic (394), m utagenic (200) or tum our- 
in itia ting  ac tiv ity  (436) and which induces re la tive ly  rapidly repaired  s trand  breaks in 
cellu lar DNA (395).
i
Product I was ten ta tiv e ly  identified  by co-chrom atography w ith deoxyribonucleoside 
adducts form ed by reac tion  of syn BPDE with DNA. A product having a sim ilar elution 
position to product I has been reported  by o ther w orkers (391,437) and iden tified  as a syn 
BPDE-dG adduct. This adduct is also form ed during the mouse-skin m icrosom al m ediated  
binding of BP to DNA and in the DNA of mouse skin following topical application  of BP 
(Chapter 3).
Because the two major BP-DNA adducts form ed in r a t  skin, products B and C (Fig.58) -are 
derived from BP m etabolites d iffering g rea tly  in biological ac tiv ity , i t  was proposed th a t 
one might observe p re fe ren tia l persistence of one of the adducts, re la tiv e  to the  o ther, in 
the DNA. Thus, a situation  analogous to  th a t of AAF, which form s both p e rs is ten t (3-(dG- 
N -yl)AAF) and re la tive ly  easily rem oved (N-(dG-8-yl)-AAF) adducts in r a t  liver DNA in 
vivo (241), could be envisaged. A tim e course study of DNA-bound products of BP in r a t  
skin ind icated  th a t all the adducts showed sim ilar ra te s  of form ation and exhibited  sim ilar
degrees of persistence (Fig.60). A t the d ifferen t tim e points the percen tage distribution 
of adducts rem ained re la tive ly  constant (Table XIX), thus one cannot explain the re la tiv e  
resis tance  of r a t  skin to  BP induced carcinogenesis in term s of a p re fe ren tia l rem oval of 
the probable procarcinogenic lesion, product C, from DNA in the  skin. S ignificant 
am ounts of adducts derived from anti BPDE rem ained in r a t  skin DNA 48 hours a f te r  
trea tm e n t of the anim als w ith BP (Fig.60), a  situation  analogous to  th a t observed by 
several workers when m ice w ere tre a te d  topically  w ith BP (329,438,439).
In conclusion, BP-DNA adducts derived from anti BPDE constitu ted  approxim ately  30% of 
the to ta l adducts form ed in ra t-sk in  DNA following trea tm e n t of anim als w ith BP. 
Previous resu lts  showed th a t top ical application of BP to  mice resu lted  in 60% of the to ta l 
DNA adducts being derived from anti BPDE. Thus, species suscep tib ility  to  BP-induced 
skin carcinogenesis may be re la ted  to  both overall ex ten t of reac tio n  of BP w ith DNA in 
the skin (Table XIX and Table XI) and ex ten t of form ation of DNA adducts derived from 
an ti BPDE, product C in these studies (Table XIX and Table XI). The p resen t study has 
also dem onstrated  the form ation of significant am ounts of DNA adducts derived from  BP- 
phenols in vivo. However, p resent evidence indicates th a t such adducts are  probably no t 
c ritica l lesions in chem ical carcinogenesis.
The study of chem ical carcinogenesis has expanded vastly  over the  la st tw enty  years and 
an enormous num ber of chem icals have now been repo rted  to  cause cancer in 
experim ented anim als. In some cases however, the dose regim ens used are  g rea tly  in 
excess of the  estim ated  human exposure and there fo re  such resu lts  m ust, in rea lity , be 
viewed with g rea t caution.
The p resen t study is based on the  hypothesis th a t neoplastic change occurs as a resu lt of 
som atic m utation  and th a t in itia lly  th e re  m ust be some a lte ra tio n  in the genetic  m a teria l. 
The form ation  of deoxyribonucleoside adducts of chem ical carcinogens in cellu lar DNA 
and an analysis of the ir chem ical s tru c tu re  can indicate the type of dam age th a t occurs in 
the  DNA and w hether the dam age can be recognised and repaired  by enzym es.
A brief sum m ary of the  quan tita tive  analyses of BP-DNA bound products and the proposed 
prom utagenic lesion 7R trans BPDE-dG form ed in the v arie ty  of tissues exam ined in this 
study is shown in Table XX. The m ate ria l eluting as m ethanol-soluble from short columns 
of Sephadex LH-20 rep resen ts BP-deoxyribonucleoside adducts. In th e  m icrosom al 
experim ents approxim ately 50-60% of the  DNA hydrolysates e lu ted  as m ethanol-soluble 
adducts w hereas in the hepatocy te  and r a t  skin studies only 8% and 21% o f the m odified 
DNA elu ted  as BP-deoxyribonucleoside adducts. Both r a t  liver and r a t  skin a re  regarded  
as re la tiv e ly  re s is tan t to PAH-induced carcinogenesis. In strik ing co n trast to  these 
resu lts, 70-80% of the rad ioac tiv ity  associated  w ith DNA from the  skins of Swiss m ice 
following BP tre a tm e n t elu ted  as m ethanol-soluble products, an in te restin g  observation in 
view of the fac t th a t this mouse stra in  is susceptible to  BP-induced skin carcinogenesis. 
There is no apparent relationship betw een the susceptib ility  of the  mouse stra ins to  PAH- 
induced skin tum our in itia tion  (Swiss>C57BL/6 >  DBA/2) and the  am ounts of BP- 
deoxyribonucleoside products form ed in the skin of the th ree  s trains. Schreiber e t al (440) 
repo rted  th a t BP-Fe202 p artic les  produced predom inantly peripheral lung tum ours when 
instilled  in tra trach ea lly  into ra ts , and in the presen t studies using peripheral r a t  lung 
explants, 85% of the DNA hydrolysates from B P -trea ted  explants elu ted  as BP- 
deoxyribonucleoside adducts.
F u rther analysis of the m ethanol-soluble products showed th a t th e re  are  d is tinct 
d ifferences in the am ounts of 7R trans BPDE-dG product form ed in the  d iffe ren t tissues 
(Table XX). The m ost strik ing d ifferences w ere observed in the  skin DNA binding studies. 
In DNA from the skins of B P -trea ted  Swiss m ice 1.4 pmoles of 7R trans BPDE-dG w ere 
bound per mg of DNA w hereas in ra t  skin, the  equivalent experim ent yielded 0.06 pmoles 
7R trans BPDE-dG/mgDNA. One could there fo re  speculate th a t if one is working in the 
linear region of a dose-response curve, to obtain ra t  skin DNA m odified to  the sam e
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ex ten t as mouse-skin DNA one would have to adm inister 23 tim es the dose of BP th a t was 
given to the  mice, i.e. 23x200 nmoles = 4.6 umoles. I t would then be in teresting  to 
com pare the tum our response from 200 nm oles BP/m ouse, resulting in 2.7 
papillom as/m ouse in Swiss m ice (C hapter 3) w ith th a t from 4.6 umoles BP /r a t .  Such an 
experim ent would re la te  the im portance of the  7R-tra n s  BPDE-dG adduct to  tum our 
in itia tion . I t is also in teresting  to note th a t as a percen tage of the to ta l BP-DNA binding, 
the  7R-tran s  BPDE-dG products represen ts approxim ately 47% in mouse skin, a 
susceptible tissue, and only 9% in r a t  skin and 5% in hepatocy tes, representing  non- 
susceptible tissues. In the ra t lung explant studies, 20% of the  BP-DNA binding could be 
a ttr ib u ted  to 7R-tran s  BPDE-dG, thus, one could speculate th a t ra t  lung would be 
in te rm ed ia te  in susceptib ility  to BP betw een mouse skin and r a t  skin.
If one assumes th a t a m am m alian cell contains 6pg of DNA (441), then from the figures 
showing pm oles 7R-trans-BPDE-dG/mgDNA, the num ber of these lesions per ce ll can be 
calcu la ted  (figures shown in the la st column of Table XX). The num bers are  surprisingly 
high and a t firs t glance would indicate th a t carcinogenesis is an ine ffic ien t process, such
3
th a t in the Swiss mice 5x10 lesions/cell are  required to  induce 2.7 papillom as/m ouse.
3T herefore, for one papillom a, approxim ately 1.9x10 lesions/cell are necessary. R at skin 
2
exhibited only 2x10 lesions/cell in accordance with its  low susceptib ility  to  BP-induced 
carcinogenesis, however, r a t  hepatocy tes form ed 2480 lesions/cell, 50% of the  value for 
mouse skin. This is som ew hat surprising, if one ex trapo la tes these resu lts  to  ra t  liver, 
because r a t  liver is regarded as being rela tive ly  re s is tan t to PAH -induced carcinogenesis. 
There is no apparent relationship betw een the susceptib ility  of the d iffe ren t mouse 
strains to BP-induced carcinogenesis and the num ber of 7R trams BPDE-dG lesions form ed 
in DNA from the skin of mice of each stra in  (Table XX).
3
As previously indicated, in the skin of Swiss Mice 1.9x10 7R trans BPDE-dG lesions/cell
are  required to in itia te  the growth of 1 papillom a/m ouse. Although the sizes of genes
varies greatly , on average it can be estim ated  th a t each cell contains 1.9x 10^ genes (ref.
3  6440, pp 860 and 879). T herefore, 1.9x10 lesions/1.9x10 genes are  required  to  in itia te  1 
papillom a per mouse, i.e. 1 lesion for every 1000 genes. If an assum ption is m ade th a t 
tum our in itia tion  involves "hitting" one specific gene, the chance th a t 1 lesion in every 
1000 genes will be on the co rrec t gene is rem ote. Huberm an e t al (442) repo rted  th a t 
m utagenesis, re la ted  d irectly  to m odification of DNA, is 20 tim es less e ffic ien t than 
transform ation, the cellular equivalent of carcinogenesis. In the la tte r  study, how ever, 
m utagenesis was m easured a t a single locus only and the same group have shown th a t BP 
exhibits quan tita tive  d ifferences in m utagenesis a t d ifferen t loci (443). In the skin tum our 
studies involving Swiss m ice (C hapter 3), 60% of the mice developed papillom as. If only 
one gene was involved in tum our in itia tion, 1 lesion/1000 genes rep resen ts  a 0.1% chance
th a t the co rrec t gene will be hit, far below the 60% papillom a incidence observed in the 
m ice. I t  m ay b e , the re fo re , th a t transform ation  and carcinogenesis involve several genes, 
so th a t there  may be m ore than one route to carcinogenesis, such th a t, in mouse skin 
although only 1 lesion/1000 genes is p resen t, the  m odification of any one of tw enty  of the 
1000 genes may lead to carcinogenesis or transform ation . Thus carcinogenesis would be a 
m ore effic ien t process than m utagenesis, if the la t te r  were determ ined  a t only a single 
loci.
In a  recen t series of co llaborative experim ents w ith Dr. T. J . Slaga the  persis tence  of the 
BPDE-dG adduct in the skin of Senear m ice was studied. These m ice are  derived from 
CD-I m ice and are very susceptible to PAH-induced carcinogenesis. I t  was observed th a t 
the  ha lf-life  for this adduct was 4.5 days and th a t i t  was lost from the  DNA a t a  sim ilar 
ra te  to th a t of the to ta l DNA-bound BP (439) (Fig.6 l) . Subsequently i t  was found th a t the 
dose-response curve for B P -in itia ted  papillom as in Senear m ice paralle led  the  dose- 
response curve for BP binding to  epiderm al DNA in the sam e s tra in  of m ice (439) 
(Fig.62a). I t can therefo re , be deduced th a t a  causal relationship ex ists betw een  the  
form ation of BP-DNA bound products in mouse skin and the in itia tion  of papillom as by BP 
a t several doses of the carcinogen. In teresting ly , a  double logarithm ic p lo t of papillom a 
incidence against dose of BP yielded a sigmoidal curve which exhibited a slope of +1 in the 
linear range. This im plies th a t tum our in itia tion  in mouse skin is a  one-hit phenomenon, 
however, the nature of the single h it is a t p resen t unknown. The one h it could im ply th a t 
a single BP residue, m ost probably 7R an ti BPDE, is bound to a specific s ite  in the  DNA 
and this s tru c tu ra l a lte ra tio n  is enough to in itia te  the cell. A lte rna tive ly  severa l DNA 
m odifications may be necessary to constitu te  a single event resu lting  in in itia tion  of the  
cell.
In a recen t publication Guenthner e t al (444) repo rted  th a t Sephadex LH-20 analysis of 
DNA-adducts from ra t-liv e r hepatocytes tre a te d  w ith BP showed th a t a  product(s) derived 
from BPDE is the only detec tab le  adduct, in agreem ent with the d a ta  p resen ted  in this 
study (C hapter 2). The earlie r da ta  of Jernstrom  e t  al (348), im plicating 9-0H-BP as the  
p recursor of the m ajor DNA-adduct form ed from BP in hepatocy tes, is d ifficu lt to 
rationalise . I t  is possible th a t p rior to hydrolysis the m ajor DNA adduct is derived from 9 - 
OH-BP, possibly bound to phosphate groups (444), so th a t fluorescence analysis of th e  DNA 
would d e tec t mainly this product. However, during hydrolysis and tre a tm e n t of 
deoxyribonucleotides with alkaline phosphatase one would expect libera tion  of 9-0H-BP or 
its  phosphate conjugate, probably a t the K -region, if 9-0H-BP products w ere bound to  
phosphate. This type of product would probably be less polar than the w ater soluble 
unhydrolysed DNA and unmodified bases and so should elu te la te r  than  these p roducts on 
Sephadex LH-20 columns or elu te with the m ethanol-soluble adducts and then  be observed
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P ersis tence of DNA-bound products of BP in the epiderm is of fem ale  Senear m ice. 
Animals were shaved 48 hours prior to trea tm e n t and then  ( H)BP (100 nmoles) in 
acetone (200 ul) was topically  applied to the shaved area . The m ice w ere killed a t 
various in tervals up to 21 days a f te r  trea tm en t and epiderm al tissue was iso la ted  
from  the tre a te d  a rea  of skin by a  ho t/co ld  tre a tm e n t m ethod (378). DNA was iso la ted  
from the epiderm al tissue (378) and the to ta l bound BP was determ ined . The DNA 
was hydrolysed by sequential digestion w ith enzym es and the  hydrolysates chrom atographed 
an columns of Sephadex LH-20 as described in M aterials and M ethods. The am ounts 
of BPDE-dG adducts form ed were calcu la ted  from the am ount o f rad io ac tiv ity  eluting 
in th e  region o f BP-deoxyribonucleoside adducts from the Sephadex LH=20 columns.
Legend to  F igure 62
Fem ale Senear m ice (30 anim als per group) were shaved 48 hours prior to
trea tm e n t. For the tum our studies anim als were tre a te d  topically w ith BP
(varying doses) in acetone (200 ul) followed one week la te r  by tw ice
weekly applications of TPA (2 ug) in acetone (200 ul) for up to 16 weeks.
DNA binding experim ents in the  epidermis of the  m ice were conducted 
3
using ( H) BP (varying doses) and the anim als kiled 24 hours la te r. DNA 
isolation and determ ination  of DNA-bound BP w ere as described in Fig.
61.
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Figure 62
following HPLC analysis of the deoxyribonucleoside adducts. As y e t no evidence has 
em erged for 9-OH-BP derived phosphate conjugates using e ith er of the  la t te r  two 
chrom atographic system s (Chapter 2 and re f . 443).
The form ation of cLA-bound products of an ti BPDE in mouse skin rep resen ts  additional 
inform ation  as to  the qualita tive  ex ten t to which anti BPDE can m odify DNA in vivo. 
However, i t  was also in te resting  to  ra tionalise  why cis and trans addition of dA to  an ti 
BPDE occurs in the  ra tio  of approxim ately 1:5 while 7R anti BPDE-dG products are 
predom inantly  form ed by trans addition of dG to  the electrophile. Fig.63 ind icates a 
possible reason. The highly arom atic  s tru c tu re  of anti BPDE can stabalise  a  carbonium 
ion form ed a t position 10, as previously discussed by H ulbert (196). A nucleophile, such as 
dA, could then re a c t w ith this carbonium ion above or below the  plane of the  angular 
benzo ring resu lting  in trans or cis addition respectively  (Fig.63a). With dG, how ever, the  
nucleophile is m ore com plicated  and the keto-enol system  p resen t could be envisaged to 
in te ra c t w ith the epoxide-oxygen by H-bonding so th a t one would ge t a concerted  
mechanism of e lectron  tran sfe r and the form ation of a transition-like s ta te  ch a ra c te ris tic  
of S ^2  nucleophillic addition (Fig.63b). Such a mechanism would favour tran s  addition 
because the  epoxide oxygen is s te rica lly  fixed in a position below the  plane of the angular 
benzo ring in the  transition  s ta te . The nucleophillic addition of dA to  an ti BPDE through 
a carbonium ion (S ^ l mechanism) would be expected to yield 50% tran s  and 50% cis 
addition products. The resu lts  of the presen t studies in mouse skin do no t concur w ith this 
th eo re tica l pred ic tion  as the ra tio  obtained in vivo is 5:1, trans : cis. However, in  v itro  
reac tion  of an ti BPDE w ith dA yields sim ilar quan tities of trans and cis addition products 
(Fig.52b), the re fo re , the stereochem ical configuration of dA in DNA m ust influence the 
o rien ta tion  of its  reac tion  w ith an ti BPDE. Meehan and Straub (211) found th a t the  
secondary s tru c tu re  of DNA g reatly  a ffec ted  the asym etrical binding of the enantiom eric 
an ti BPDE's to dG but not to dA. They proposed th a t d ifferen t m echanism s exist for the 
reac tion  of anti BPDE with dG or dA in DNA. The presen t study is in agreem ent w ith 
these studies and has proposed d ifferen t reac tion  m echanism s (Fig.63) to  explain the  
stereochem istry  of the nucleophillic additions.
When m icrosom al preparations from ra t  liver or lung, and mouse skin w ere incubated  w ith 
BP and DNA a large quan tita tive  and qualita tive  variation  was observed in  the  form ation  
of BP—deoxyribonucleoside adducts (Figs.43a,54a and 57b). This must re f le c t the  d iffe ren t 
positional oxygenation specific ities of the d ifferen t cytochrom e P-450 m olecules in the 
d ifferen t tissues. In the studies using ra t- liv e r  or lung m icrosom al p reparations, the m ajor 
DNA-bound product was derived from 9-OH-BP whilst BP-4,5-epoxide-D NA  adducts 
rep resen ted  the m ajor products of the m ouse-skin m icrosom al m ediated  binding of BP to
anti BPDE— DNA adducts
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DNA. The m icrosom al system s are not good models for system s of in ta c t cellu lar 
a rch itec tu re , where the 7R trans BPDE-dG adduct was always the  m ajor adduct form ed 
from BP (Chapters 2-4). An in teres ting  study by Vaught e t al (445) showed th a t 
m icrosom es from placentas of smoking humans, in the presence of BP and DNA, form ed 
DNA adducts m ainly derived from BPDE. P lacen ta l m icrosom es from  non-sm okers w ere 
unable to do th is. This study th e re fo re  im plies th a t smoking during pregnancy could cause 
in itia ting  events in the foetus through m etabolic activation  of PAH by the  p lacen ta .
One of the  m ost in teresting  aspects of the  present study was the  sim ilarities in BP-DNA 
adducts produced in the  skins of m ice of d iffe ren t strains and known to  exhibit d ifferen t 
susceptib ilities to  PAH-induced carcinogenesis (Chapter 3). T herefore , th e re  seem to  be 
negligible d ifferences in both the qualita tive  and quan tita tive  aspects of in itia tion  among 
the d iffe ren t s trains. In prelim inary experim ents d ifferences w ere observed betw een the 
stra ins in the induction of ornithine decarboxylase (C57BL/6>Swiss >  DBA/2) and the 
developm ent of hyperp lasia (Swiss>DBA/2>C57BL/6) following top ical application of the  
tum our prom oter TPA (446). Thus, th e re  are  d ifferences in prom otion am ongst the 
d ifferen t strains and fu tu re  work will no doubt fu rther elucidate these d ifferences. I t 
would also be an in teresting  study to  p repare epiderm al cell cu ltu res from  the  skins of the 
d iffe ren t strains of m ice and investigate  possible d ifferences in DNA repair betw een the  
s tra ins which would be d ifficu lt in vivo. Mouse skin is not an easy tissue to work w ith and 
epiderm al cell cultures would enable a b e tte r  quan tita tive  study of the  binding of BP to  
DNA in re la tion  to m utagenesis a t d ifferen t loci. In the presen t study a rela tionship  was 
found to  exist betw een form ation of the  7R trans BPDE-dG adduct and transfo rm ation  in 
the epithelial cell line 2C1 (Chapter 4). This was essentially  a prelim inary  study and could
i
be extended to  epiderm al cell cultures from the d ifferen t stra ins of m ice so th a t one 
could re la te  cellu lar in itia tion  to  cellu lar neoplasia.
Although chem ical carcinogenesis is now a vast field  of study th e re  are  s till many areas 
th a t require fu rther study. New techniques are now being em ployed to  study the  ro le  of 
nucleic acid m odification in cancer. A single exam ple is the rece n t rep o rt by H aseltine e t 
al (447) who used a  DNA su bstra te  of defined sequence and m odified th is w ith an ti BPDE. 
Using polyacrylam ide gel electrophoresis they established th a t the m odified DNA was 
labile to strand  scission a t guanine, adenine and cytosine positions a t  bo th  alkaline and 
neu tra l pH. Thus, all the bases containing exocyclic amino groups m ay be im portan t 
m odification positions re la ted  to  m utagenesis or cancer.
It is the re fo re  evident th a t new techniques can provide additional inform ation  as to  w hat 
is probably the most com petitive a rea  of research  in the world, chem ical carcinogenesis.
Love is the only answer, h a te  is the root of cancer -  THEN 
T ru th  is ju st for the being, and as a  sight for seeing -  THEN 
Thoughts will be thought toge ther, soon in our minds forever -  THEN
As long as we see
There's only us who can change it
Only us to rearrange i t
A t the s ta r t of a new kind of day.
J .  Anderson
I wish I had the wisdom,
To find some simple words to make them  see,
The things th a t mean a lo t to them ,
D on't always hold the sam e values to me.
I need to care 
I need to share 
When the sands of tim e go drifting  by,
R esearch  will be my past and Til be me.
Anon
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